
<html lang="en"     class="pb-page"  data-request-id="7df64381-20f0-4ed4-b7d1-015fa433cb9b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.5b01296;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2016.59.issue-9;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="3-Oxo-hexahydro-1H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors" /></meta><meta name="dc.Creator" content="Gaëlle  Mariaule" /></meta><meta name="dc.Creator" content="Stéphane  De Cesco" /></meta><meta name="dc.Creator" content="Francesco  Airaghi" /></meta><meta name="dc.Creator" content="Jerry  Kurian" /></meta><meta name="dc.Creator" content="Paolo  Schiavini" /></meta><meta name="dc.Creator" content="Sylvain  Rocheleau" /></meta><meta name="dc.Creator" content="Igor  Huskić" /></meta><meta name="dc.Creator" content="Karine  Auclair" /></meta><meta name="dc.Creator" content="Anthony  Mittermaier" /></meta><meta name="dc.Creator" content="Nicolas  Moitessier" /></meta><meta name="dc.Description" content="Bicyclic chiral scaffolds are privileged motifs in medicinal chemistry. Over the years, we have reported covalent bicyclic prolyl oligopeptidase inhibitors that were highly selective for POP over a..." /></meta><meta name="Description" content="Bicyclic chiral scaffolds are privileged motifs in medicinal chemistry. Over the years, we have reported covalent bicyclic prolyl oligopeptidase inhibitors that were highly selective for POP over a..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 14, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01296" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01296" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01296" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01296" /></link>
        
    
    

<title>3-Oxo-hexahydro-1H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01296" /></meta><meta property="og:title" content="3-Oxo-hexahydro-1H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0016.jpeg" /></meta><meta property="og:description" content="Bicyclic chiral scaffolds are privileged motifs in medicinal chemistry. Over the years, we have reported covalent bicyclic prolyl oligopeptidase inhibitors that were highly selective for POP over a number of homologous proteins. Herein, we wish to report the structure-based design and synthesis of a novel class of POP inhibitors based on hexahydroisoindoles. A docking study guided the selection of structures for synthesis. The stereochemistry, decoration, and position within the molecule of the bicyclic scaffolds were assessed virtually. Following the synthesis of the best candidates, in vitro assays revealed that one member of this chemical series was more active than any of our previous inhibitors with a Ki of 1.0 nM. Additional assays also showed that the scaffold of this potent inhibitor, in contrast to one of our previously reported chemical series, is highly metabolically stable, despite the foreseen potential sites of metabolism. Interestingly, computer docking calculations accurately predicted the optimal features of the inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01296"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01296">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01296&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01296&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01296&amp;href=/doi/10.1021/acs.jmedchem.5b01296" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 4221-4234</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01146" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01428" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">3-Oxo-hexahydro-1<i>H</i>-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ga%C3%ABlle++Mariaule">Gaëlle Mariaule</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=St%C3%A9phane++De+Cesco">Stéphane De Cesco</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francesco++Airaghi">Francesco Airaghi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jerry++Kurian">Jerry Kurian</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paolo++Schiavini">Paolo Schiavini</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sylvain++Rocheleau">Sylvain Rocheleau</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Igor++Huski%C4%87">Igor Huskić</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karine++Auclair">Karine Auclair</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony++Mittermaier">Anthony Mittermaier</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicolas++Moitessier">Nicolas Moitessier</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montréal, Québec H3A 0B8, Canada</span></div><div class="corresp-info"><strong>*</strong>Phone: 514-398-8543. Fax: 514-398-3797. E-mail, <a href="/cdn-cgi/l/email-protection#47292e24282b2634692a282e332234342e2235072a24202e2b2b692426"><span class="__cf_email__" data-cfemail="92fcfbf1fdfef3e1bcfffdfbe6f7e1e1fbf7e0d2fff1f5fbfefebcf1f3">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01296&amp;href=/doi/10.1021%2Facs.jmedchem.5b01296" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 4221–4234</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 30, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 August 2015</li><li><span class="item_label"><b>Published</b> online</span>14 December 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 May 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01296" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01296</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4221%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGa%25C3%25ABlle%2BMariaule%252C%2BSt%25C3%25A9phane%2BDe%2BCesco%252C%2BFrancesco%2BAiraghi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D9%26contentID%3Dacs.jmedchem.5b01296%26title%3D3-Oxo-hexahydro-1H-isoindole-4-carboxylic%2BAcid%2Bas%2Ba%2BDrug%2BChiral%2BBicyclic%2BScaffold%253A%2BStructure-Based%2BDesign%2Band%2BPreparation%2Bof%2BConformationally%2BConstrained%2BCovalent%2Band%2BNoncovalent%2BProlyl%2BOligopeptidase%2BInhibitors%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4234%26publicationDate%3DMay%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01296"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1796</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">16</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01296" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;3-Oxo-hexahydro-1H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Gaëlle&quot;,&quot;last_name&quot;:&quot;Mariaule&quot;},{&quot;first_name&quot;:&quot;Stéphane&quot;,&quot;last_name&quot;:&quot;De Cesco&quot;},{&quot;first_name&quot;:&quot;Francesco&quot;,&quot;last_name&quot;:&quot;Airaghi&quot;},{&quot;first_name&quot;:&quot;Jerry&quot;,&quot;last_name&quot;:&quot;Kurian&quot;},{&quot;first_name&quot;:&quot;Paolo&quot;,&quot;last_name&quot;:&quot;Schiavini&quot;},{&quot;first_name&quot;:&quot;Sylvain&quot;,&quot;last_name&quot;:&quot;Rocheleau&quot;},{&quot;first_name&quot;:&quot;Igor&quot;,&quot;last_name&quot;:&quot;Huskić&quot;},{&quot;first_name&quot;:&quot;Karine&quot;,&quot;last_name&quot;:&quot;Auclair&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;Mittermaier&quot;},{&quot;first_name&quot;:&quot;Nicolas&quot;,&quot;last_name&quot;:&quot;Moitessier&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;4221-4234&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01296&quot;},&quot;abstract&quot;:&quot;Bicyclic chiral scaffolds are privileged motifs in medicinal chemistry. Over the years, we have reported covalent bicyclic prolyl oligopeptidase inhibitors that were highly selective for POP over a number of homologous proteins. Herein, we wish to report the structure-based design and synthesis of a novel class of POP inhibitors based on hexahydroisoindoles. A docking study guided the selection of structures for synthesis. The stereochemistry, decoration, and position within the molecule of the bicyclic scaffolds were assessed virtually. Following the synthesis of the best candidates, in vitro assays revealed that one member of this chemical series was more active than any of our previous inhibitors with a Ki of 1.0 nM. Additional assays also showed that the scaffold of this potent inhibitor, in contrast to one of our previously reported chemical series, is highly metabolically stable, despite the foreseen potential sites of metabolism. Interestingly, computer docking calculations accurately predicted the opt&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01296&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01296" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01296&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01296" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01296&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01296" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01296&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01296&amp;href=/doi/10.1021/acs.jmedchem.5b01296" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01296" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01296" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01296%26sid%3Dliteratum%253Aachs%26pmid%3D26619267%26genre%3Darticle%26aulast%3DMariaule%26date%3D2016%26atitle%3D3-Oxo-hexahydro-1H-isoindole-4-carboxylic%2BAcid%2Bas%2Ba%2BDrug%2BChiral%2BBicyclic%2BScaffold%253A%2BStructure-Based%2BDesign%2Band%2BPreparation%2Bof%2BConformationally%2BConstrained%2BCovalent%2Band%2BNoncovalent%2BProlyl%2BOligopeptidase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D9%26spage%3D4221%26epage%3D4234%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292398" title="Stereochemistry">Stereochemistry</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/jmcmar.2016.59.issue-9/20160512/jmcmar.2016.59.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Bicyclic chiral scaffolds are privileged motifs in medicinal chemistry. Over the years, we have reported covalent bicyclic prolyl oligopeptidase inhibitors that were highly selective for POP over a number of homologous proteins. Herein, we wish to report the structure-based design and synthesis of a novel class of POP inhibitors based on hexahydroisoindoles. A docking study guided the selection of structures for synthesis. The stereochemistry, decoration, and position within the molecule of the bicyclic scaffolds were assessed virtually. Following the synthesis of the best candidates, <i>in vitro</i> assays revealed that one member of this chemical series was more active than any of our previous inhibitors with a <i>K</i><sub><i>i</i></sub> of 1.0 nM. Additional assays also showed that the scaffold of this potent inhibitor, in contrast to one of our previously reported chemical series, is highly metabolically stable, despite the foreseen potential sites of metabolism. Interestingly, computer docking calculations accurately predicted the optimal features of the inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/59/9"><issue-title>Computational Methods for Medicinal Chemistry</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67423" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67423" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Proline oligopeptidase (POP, sometimes referred to as PREP) is a serine protease which cleaves short peptides at the α-carbonyl of a proline residue. POP was discovered in the mid-seventies, and its high concentration in the central nervous system (CNS) immediately drew attention.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Early studies attributed POP protease activity to the cleavage of neuropeptides and peptide hormones, and inhibition of this activity was first investigated with the discovery of the reversible covalent inhibitor Cbz-Pro-Prolinal (<b>1)</b> over 30 years ago (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> However, after significant medicinal chemistry efforts and clinical trials, this interest reached a plateau with covalent inhibitors such as JTP-4819 (<b>2</b>)<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> and KYP-2047 (<b>4</b>),<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> and noncovalent inhibitors such as S-17092 (<b>3</b>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> More recently, the potential of such inhibitors in the treatment of Alzheimer’s disease and Parkinson’s disease has spurred a second boost in the development of POP inhibitors.<a onclick="showRef(event, 'ref1 ref2 ref3 ref10'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref10">(1-3, 10)</a> Among the important findings are the establishment of an ability to disrupt protein–protein interactions,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> the significant reduction of α-synuclein levels <i>in vitro</i> and <i>in vivo</i> by POP inhibitors,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and the colocation of POP with α-synuclein and β-amyloid.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Elevated levels of POP in cancer cells have also been observed, and our previous work has demonstrated that inhibitors can block the POP protease activity in various cancer cell lines.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected POP inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2009, we disclosed a series of chiral bicyclic POP inhibitors illustrated with <b>5</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). These covalent inhibitors were found to be cell-permeant and showed enzyme inhibition in the high nanomolar range.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Three years later, we reported the discovery by virtual screening and docking-guided optimization of a hit molecule, <b>6</b>, which turned out to be five times more active than <b>5</b>.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In addition, we found that the introduction of bicyclic molecular scaffolds improved the metabolic stability of our POP inhibitors.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> However, some docking studies suggested that the potency of our current lead could be further improved before proceeding with <i>in vivo</i> testing, with the potency of <b>6</b> being 3 orders of magnitude weaker than the reported potency of <b>2</b> or <b>4</b>. We wish to report herein our successful efforts in the development of a novel class of POP inhibitors designed from <b>5</b> and <b>6</b>, and based on a novel bicyclic core.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Designed series of potential POP inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25086" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25086" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> POP Inhibitors</h3><div class="NLM_p last">A large fraction of the reported POP inhibitors are covalent inhibitors, reacting with the catalytic serine (Ser554). Covalent drugs can be extremely effective and profitable pharmaceuticals, yet to date, they have been all but ignored in structure-based drug design campaigns.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Until recently, concerns about their potential off-target reactivity and toxicity have often been raised.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Lately, however, a significant shift in medicinal chemists’ opinion about covalent drugs has been observed, with the advantages of covalent drugs becoming increasingly recognized: these include extremely high potencies, long residence times (slow off-rates), and high levels of specificity.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22 ref23 ref24">(19-24)</a> Following this trend, <b>5</b> and <b>6</b> were designed to be covalent inhibitors. However, unlike inhibitors such as <b>1</b> and <b>2</b> featuring a reactive carbonyl group, we focused our efforts on nitrile derivatives that are significantly less reactive and are likely to provide safer drugs.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design of Bicyclic Scaffolds</h3><div class="NLM_p">The promising activities of both chiral <b>5</b> and achiral scaffold-based <b>6</b> led us to design hybrid structures, i.e., chiral (as <b>5</b>) structures mimicking <b>6</b>. Thus, the aromatic ring was modified (i.e., virtually reduced) leading to several derivatives (<b>7</b>) built around scaffolds <b>8</b>. Docking studies confirmed that this class of scaffolds was accommodated very nicely in the binding site of POP when the stereochemistry was the one shown in <b>8a</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). We have previously reported a synthetic strategy toward these bicyclic scaffolds (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The use of a bicyclic scaffold is expected to improve the metabolic stability, as we have shown before, as well as the selectivity for POP. In addition, if the fit of these molecules in the POP binding site is optimal, rigidification is expected to reduce the entropic cost associated with ligand binding. Although the shift from achiral to chiral molecules may be perceived as a potential disadvantage, the excellent predicted fit in the binding site led us to further explore this chemical series. In addition, their synthesis is now optimized to the point where no more than two steps are necessary from either readily or commercially available aldehydes.</div><div class="NLM_p last">We have previously reported the synthesis of two diastereomeric members of this novel chemical series with R<sup>1</sup> = Me and R<sup>2</sup> = NH-Boc.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The developed synthetic strategy conveniently allows for diversification at R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup>.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Structure-Based Design</h3><div class="NLM_p">In order to evaluate the potential activity of <b>7</b> and other diversely functionalized and diastereomeric derivatives, we initiated a docking study using our in-house developed program F<span class="smallcaps smallerCapital">itted</span>, which was previously modified to account for covalent inhibition.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> To date, no crystal structure of the human isoform of POP has been reported (our biological evaluations are carried out on recombinant hPOP), but the high sequence homology of the binding site residues enables the use of porcine POP for docking experiments (97% identity with the human form).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Over 20 crystal structures of POP with or without an inhibitor bound are available and were first superposed. The seven most conformationally diverse structures (binding site RMSD greater than 0.2 Å) were identified using our program M<span class="smallcaps smallerCapital">atch</span>-U<span class="smallcaps smallerCapital">p</span> and further investigated. As shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, the backbone conformation does not vary significantly between structures, and none of the side-chains adopts a different conformation. Thus, although F<span class="smallcaps smallerCapital">itted</span> can be used in a flexible protein mode, rigid protein docking was expected to provide reliable results. It is worth noting that adding protein flexibility would have been appropriate if our objective was to design inhibitors structurally very different from the cocrystallized ligands as described in our previous large evaluation study.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Seven most conformationally different POP crystal structures. Left panel, global fold ribbon diagram; right panel, binding site residues. Co-crystallized inhibitors are shown in orange.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Through this docking study, we wished to focus our synthetic efforts toward structures with a high likelihood of being active. Analogues with diverse R<sup>1</sup> and R<sup>2</sup> groups were drawn and docked. The selection of R<sup>1</sup> and R<sup>2</sup> groups considered the synthetic feasibility. <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a shows the binding mode of Cbz-Pro-Pip-CN cocrystallized with POP.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> As with other cocrystallized ligands, this structure revealed two key hydrogen bonds with Arg643 and Trp595, a covalent bond with Ser554 and hydrophobic interactions with Phe173. Our compounds were docked and compared to this ligand cocrystallized structure (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b–f).</div><div class="NLM_p last">It was first envisaged that scaffold <b>8</b> could be decorated with a (<i>S</i>)-cyano-pyrrolidine (R<sup>3</sup> in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) to provide <b>7d</b>, <b>7e</b>, and <b>7a</b>, as hybrids of <b>5</b> and <b>6</b>, or alternatively converted into nitrile analogues such as <b>9a</b>.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Covalent Inhibition</h3><div class="NLM_p">The physical processes governing the action of covalent bond forming drugs differ fundamentally from those of noncovalent drugs. Covalent drugs inhibit their targets in a two-step fashion (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> First, they bind noncovalently (<i>E···I</i>) and then react to form a chemical bond (reversible in our present study) with their targets (<i>E–I</i>). Consequently, whereas the potency and selectivity of conventional noncovalent bond forming drugs are typically expressed in terms of equilibrium binding affinity, it is essential to consider the time-dependence of inhibition for covalent drugs (i.e., IC<sub>50</sub>’s vary over time for reversible covalent inhibitors).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Reaction scheme for covalent inhibition. <i>E</i>, enzyme; <i>I</i>, inhibitor; <i>E</i>···<i>I</i>, noncovalent complex; <i>k</i><sub>1</sub>, association rate constant; <i>k</i><sub>–1</sub>, dissociation rate constant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Docking Covalent Inhibitors</h3><div class="NLM_p">We previously found that our current scoring function could distinguish between inactive and active inhibitors and can be used successfully in prospective studies.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> However, it is not accurate enough to rank covalent inhibitors that are within 2 orders of magnitude in <i>K<sub>i</sub></i>. When optimizing our previous chemical series, we observed that the focus should be on the key interactions mentioned above. Selected docking data is summarized in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>. Both the scores computed using RankScore (a force field-based scoring function, the lower, the better) and MatchScore, which evaluates the match between the ligand and protein functional groups (the higher, the better), are given. MatchScore is instrumental in automatically measuring the key interactions, while RankScore evaluates other factors such as internal strain energy.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Selected Docking Data</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">scaffold</th><th class="colsep0 rowsep0" align="center" char=".">RankScore</th><th class="colsep0 rowsep0" align="center" char=".">MatchScore</th><th class="colsep0 rowsep0" align="center">binding</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="char" char=".">–15.9</td><td class="colsep0 rowsep0" align="char" char=".">107.9</td><td class="colsep0 rowsep0" align="left">covalent</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="char" char=".">–7.4</td><td class="colsep0 rowsep0" align="char" char=".">105.4</td><td class="colsep0 rowsep0" align="left">noncovalent</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><i>ent</i>-<b>8a</b></td><td class="colsep0 rowsep0" align="char" char=".">–9.4</td><td class="colsep0 rowsep0" align="char" char=".">116.2</td><td class="colsep0 rowsep0" align="left">noncovalent</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="char" char=".">–16.2</td><td class="colsep0 rowsep0" align="char" char=".">112.5</td><td class="colsep0 rowsep0" align="left">covalent</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="char" char=".">–15.3</td><td class="colsep0 rowsep0" align="char" char=".">109.5</td><td class="colsep0 rowsep0" align="left">covalent</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><i>ent</i>-<b>8a</b></td><td class="colsep0 rowsep0" align="char" char=".">–11.2</td><td class="colsep0 rowsep0" align="char" char=".">106.6</td><td class="colsep0 rowsep0" align="left">noncovalent</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="char" char=".">–13.8</td><td class="colsep0 rowsep0" align="char" char=".">105.1</td><td class="colsep0 rowsep0" align="left">covalent</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">iPr</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="char" char=".">–10.3</td><td class="colsep0 rowsep0" align="char" char=".">97.1</td><td class="colsep0 rowsep0" align="left">noncovalent</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">Bn</td><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="char" char=".">–9.9</td><td class="colsep0 rowsep0" align="char" char=".">104.2</td><td class="colsep0 rowsep0" align="left">noncovalent</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CbzNH</td><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="char" char=".">–16.0</td><td class="colsep0 rowsep0" align="char" char=".">69.9</td><td class="colsep0 rowsep0" align="left">covalent</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">BnO</td><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="char" char=".">–14.6</td><td class="colsep0 rowsep0" align="char" char=".">94.0</td><td class="colsep0 rowsep0" align="left">covalent</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">BnCONH</td><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="char" char=".">–16.2</td><td class="colsep0 rowsep0" align="char" char=".">83.5</td><td class="colsep0 rowsep0" align="left">covalent</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="char" char=".">–12.2</td><td class="colsep0 rowsep0" align="char" char=".">113.4</td><td class="colsep0 rowsep0" align="left">noncovalent</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">ent-<b>9a</b></td><td class="colsep0 rowsep0" align="char" char=".">–10.2</td><td class="colsep0 rowsep0" align="char" char=".">64.0</td><td class="colsep0 rowsep0" align="left">covalent</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">–15.6</td><td class="colsep0 rowsep0" align="char" char=".">107.6</td><td class="colsep0 rowsep0" align="left">covalent</td></tr></tbody></table></div></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structure-based design of potential covalent POP inhibitors. (a) Cocrystallized ligand (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xdw">2xdw</a>) together with known inhibitor <b>4</b> docked; (b) <b>8a</b>, R<sup>1</sup> = Me, R<sup>2</sup> = Bn; (c) <b>8a</b>, R<sup>1</sup> = H, R<sup>2</sup> = Bn; (d) <b>8b</b>, R<sup>1</sup> = Me, R<sup>2</sup> = Bn; (e) <b>8a</b>, R<sup>1</sup> = H, R<sup>2</sup> = CbzNH; (f) <b>8a</b>, R<sup>1</sup> = <i>i</i>-Pr, R<sup>2</sup> = Bn.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It is worth mentioning that a docking mode in which both noncovalent and covalent binding were investigated concomitantly was used. The results shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> were collected for the lowest-in-energy poses, although in half of the cases, both covalent and noncovalent poses were proposed by F<span class="smallcaps smallerCapital">itted</span>. Care must be taken when analyzing the data as, in contrast to noncovalent binding, kinetic and thermodynamic factors control whether the binding will be covalent. If the lowest-energy pose is covalent, it suggests that the fit of the compound (first equilibrium in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) favorably positions the nitrile group leading to covalent inhibition. This mode of binding is optimal. If the lowest-energy pose is noncovalent but the second lowest-energy pose is covalent and with a score within 1–2 kcal/mol of the best pose, we still considered targeting the covalent molecule. In these cases, we anticipate that the affinities of the covalent and noncovalent inhibitors are comparable (uncertainties in our predicted binding energies are on the order of a few kcal/mol); however, we expect the covalent molecule to have more favorable binding kinetics, i.e., longer bound lifetimes. The relatively high energy barrier to breaking the covalent bond leads in general to lower values of the dissociation constant, <i>k</i><sub><i>off</i></sub>. Thus, when noncovalent binding was suggested by the docking program, a close look at the other proposed poses was required. In addition, when docking potential covalent inhibitors, the reactivity of the warhead may differ. In the present study, only nitrile derivatives with expected similar reactivity were investigated.</div><div class="NLM_p">First, the docking indicated that the diastereomeric scaffold <b>8a</b> with the absolute configuration shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> was preferred over the other diastereomers including <b>8b</b> and ent-<b>8a</b> to form a covalent bond with the enzyme (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, entries 1–3 and 4–6). The same trend was consistently observed when docking was carried out with other R<sup>1</sup> and R<sup>2</sup> groups. According to our prediction, increasing the size of R<sup>1</sup> would result in weaker binding when R<sup>1</sup> exceeded one carbon and even in noncovalent binding with R<sup>1</sup> = iPr and Ph <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, entries 1, 4, and 7–9). The data collected for R<sup>2</sup> were more ambiguous. For example, while RankScore suggested that R<sup>2</sup> = BnCONH with R<sup>1</sup> = H should be optimal (entry 12), MatchScore indicated that R<sup>2</sup> = H should be favored (entry 4). As a reference, a highly active compound (<b>4</b>) was docked and scored (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Interestingly, our best scoring designed inhibitor was predicted to be as strong as this subnanomolar compound (entries 4 and 15, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a).</div><div class="NLM_p last">As the key interactions were featured by the cocrystallized compound shown in yellow in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a, this compound was overlaid with our docked compounds, thus revealing whether the key interactions and overall binding were retained. For example, while the compounds shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b, c, and e appeared to bind in a manner similar to that of the cocrystallized ligand, the two compounds shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>d (built around scaffold <b>8b</b>) or <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>f (with a large R<sup>1</sup> group) were not predicted to retain all of the key interactions with POP. This predicted loss of interactions was more accurately measured by MatchScore than by RankScore.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Synthetic Strategy</h3><div class="NLM_p">We have previously reported an expedient synthesis of <b>10a</b> and <b>10b</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>) and more recently optimized the synthetic protocol and investigated an observed solvent effect.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> This new protocol enabled the selective precipitation of the major diastereomer, hence removing the need for extensive chromatography. We envisaged taking advantage of this synthetic strategy and probing its application to other analogues by varying R<sup>1</sup> and R<sup>2</sup>.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Generic structure of potential POP inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Synthesis of Bicyclic Scaffolds Varying R<sup>1</sup> and R<sup>2</sup></h3><div class="NLM_p">According to the docking study, as long as R<sup>1</sup> is small enough, the potential inhibitor should fit in the POP binding site. These computational investigations were also indicating that R<sup>2</sup> of different sizes should fit, although with the shorter group preferred, and that the stereochemistry of the scaffold was critical. Accordingly, we restricted R<sup>1</sup> to only hydrogen and methyl, selected four groups of different lengths for R<sup>2</sup>, and focused on scaffold <b>8a</b>, which is synthetically more accessible. The synthesis of these scaffolds required the conversion of two aldehydes into the corresponding hydrazides <b>12a</b>–<b>c</b>, alkoxyamine <b>12d</b>, and amines <b>12e</b> and <b>12f</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Scaffold Synthesis</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Yields are given in parentheses.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Isolated yield for the first step (<b>11</b> to <b>12a</b>–<b>f</b>).</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Isolated yield of the major diastereomer from <b>12a</b>–<b>f</b> to <b>13a</b>–<b>f</b>.</p></div></div><div></div></div><div class="NLM_p">The initial formation of the unsaturated hydrazides or amines was achieved by a solventless condensation (R<sup>1</sup> = Me) or in methanol (R<sup>1</sup> = H). The chemoselective reduction was next achieved with dimethylamino borane for products <b>12a</b>–<b>d</b> and with NaBH<sub>4</sub> for products <b>12e</b>–<b>f</b>, as reported previously.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The six intermediates were subsequently reacted with maleic anhydride leading to mixtures of <i>exo</i><b>13a</b>–<b>f</b> and <i>exo</i><b>13a</b>–<b>f</b> products, with the <i>exo</i> adducts being the major isomers.</div><div class="NLM_p">During our optimization of the synthetic methodology,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> we solved the difficult separation of the diastereomers through diastereoselective precipitation. We were very pleased that this stereoselective precipitation was also possible with the proposed substitutions at position R<sup>2</sup>. Thus, treatment of the diastereomeric mixture with a mixture of ether and hexane (or dichloromethane) led to selective precipitation of the major <i>exo</i> adduct in most cases (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). The relative stereoselectivity of the scaffolds was determined by 1D NOE and 2D NOESY experiments on the scaffolds and some derivatives as reported previously (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> We were also pleased to obtain crystals of <b>13d</b> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). Consequently, the selective precipitation of the <i>exo</i> adduct was unambiguously confirmed by X-ray crystallographic analysis.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <sup>1</sup>H NMR spectrum of (a) a mixture of <i>endo</i> and <i>exo</i> adducts <b>14d</b> and <b>13d</b>; (b) <i>exo</i> adduct <b>13d</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Stereochemistry of scaffolds <b>13b</b> ascertained by NOESY and the structure of <b>13d</b> determined by X-ray crystallography (oxygens in red, nitrogen in blue, carbons in gray, and hydrogens in light gray).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">This optimized strategy not only provided a single isolated diastereomer but also eliminated the need for chromatographic purification of the polar bicyclic scaffolds. In the case of <b>13c</b>, the precipitation was more problematic and was difficult to reproduce. The mixture remaining in the mother liquor was not further investigated.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Synthesis of Potential Inhibitors</h3><div class="NLM_p">The synthesis of various derivatives of <b>7</b> is shown on <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>. Following the strategy described above, the scaffolds <b>13a</b>–<b>f</b> with the <i>exo</i> configuration were diastereopure yet racemic.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Compound <b>13a</b> was next converted into the corresponding nitrile derivative <b>9a</b> by an amidation/dehydration sequence in reasonable yields. As the modeling study suggested that this series should not lead to significant activity, no other derivatives were prepared. The potential covalent inhibitors <b>7a</b>–<b>f</b> and <b>16a</b>–<b>f</b> were accessed by coupling with (<i>S</i>)-cyano-pyrrolidine, while their noncovalent counterparts <b>15a</b>–<b>f</b> were prepared as racemic mixtures through coupling with pyrrolidine. Although the scaffold <b>8a</b> was our priority, <i>ent</i>-<b>8a</b> analogues were produced along with <b>8a</b> analogues. The other scaffolds (R<sup>1</sup> = other than H and methyl) were not synthesized since the docking study predicted that increased steric bulk at that position would either affect the potency (RankScore) or disrupt the covalent binding.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Potential POP Inhibitor Synthesis</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0012.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0013.gif" alt="" id="fx4" /></img><div></div></div><div class="NLM_p">Extensive chromatographic work enabled the separation of the diastereomers resulting from coupling the racemic scaffolds (including <i>rac-</i><b>13d</b>) to enantiopure (<i>S</i>)-cyano-pyrrolidine. While the relative stereochemistry of <i>rac</i><b>-13d</b> and other scaffolds was assigned by X-ray crystallography and NMR spectroscopy, determination of the stereochemistry of the resulting pairs of diastereomers (such as enantiopure <b>7d</b> and <b>16d</b> from <i>rac</i>-<b>13d</b>) was difficult until we managed to crystallize <b>16d</b> (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). While crystallography assigned the relative stereochemistry, the absolute stereochemistry was derived knowing the absolute stereochemistry of (<i>S</i>)-cyano-pyrrolidine, which was coupled in this process. Interestingly, the NMR spectra of <b>7d</b> and <b>16d</b> were significantly different revealing a mixture of rotamers for <b>16d</b> only. Similarly, <b>7c</b> and <b>7e</b> appeared as a single averaged conformation on NMR spectra, while the NMR signatures of <b>16c</b> and <b>16e</b> were more complex (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). Using the crystal structure as a starting point and the NMR similarities, we were able to ascertain the relative and absolute stereochemistries of these 12 compounds. This solved a structural assignment challenge that was foreseen to be difficult.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structure of <b>16d</b> (oxygens in red, nitrogens in blue, carbons in gray, and hydrogens in light gray) as determined by X-ray crystallography and <sup>1</sup>H NMR spectra of the enantiopure compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Biological Evaluations</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Inhibition of POP</h3><div class="NLM_p">As discussed above, the binding is a two-step process, including a fast binding and a slow covalent bond formation. Thus, the inhibition potencies were measured after equilibria were reached. With this in mind, the 19 synthesized compounds were assessed for their inhibitory potency on recombinant human POP (<a class="ref internalNav" href="#tbl4" aria-label="Tables 4">Tables 4</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) and their activities compared to our computational predictions (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). Gratifyingly, an excellent match between experimental data and computational predictions was observed. In order to summarize the information gained, we will examine the most notable results of this study.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibition of POP</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0014.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0015.gif" alt="" id="fx6" /></img><div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Tight Binding Inhibition with <b>4</b> and <b>7e</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">inhibitor</th><th class="colsep0 rowsep0" align="center">Morrison <i>K</i><sub><i>i</i></sub> (tight binder) (nM)</th><th class="colsep0 rowsep0" align="center">regular <i>K</i><sub><i>i</i></sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">0.92 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.95 ± 0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7e</b></td><td class="colsep0 rowsep0" align="left">0.75 ± 0.02</td><td class="colsep0 rowsep0" align="left">1.33 ± 0.15</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Docking-Based Predictions vs Experiments</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">prediction</th><th class="colsep0 rowsep0" align="center">example</th><th class="colsep0 rowsep0" align="center">experiment</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">scaffold on the left side > scaffold on the right side</td><td class="colsep0 rowsep0" align="left"><b>9</b> vs <b>7</b></td><td class="colsep0 rowsep0" align="left">correct</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">covalent more active than noncovalent</td><td class="colsep0 rowsep0" align="left"><b>7</b> vs <b>15</b></td><td class="colsep0 rowsep0" align="left">correct</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">stereochemistry: 3S,4R,7R > 3R,4S,7S</td><td class="colsep0 rowsep0" align="left"><b>7e</b> vs <b>16e</b></td><td class="colsep0 rowsep0" align="left">correct</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R<sup>1</sup> = H, Me equally tolerated</td><td class="colsep0 rowsep0" align="left"><b>15e</b>, <b>15f</b></td><td class="colsep0 rowsep0" align="left">Me tolerated but less than H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R<sup>2</sup> = Bn > OBn > C(O)CH<sub>2</sub>Ph > NHCbz</td><td class="colsep0 rowsep0" align="left"><b>16a</b>, <b>16c</b>, <b>16d</b>, <b>16e</b></td><td class="colsep0 rowsep0" align="left">correct</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b> and <b>7e</b> should be equally potent</td><td class="colsep0 rowsep0" align="left"><b>4</b> vs <b>7e</b></td><td class="colsep0 rowsep0" align="left">correct</td></tr></tbody></table></div></div><div class="NLM_p">First, we noted that rigidifying the right side of the cocrystallized structure (i.e., compound <b>9a</b>) did not lead to any noticeable activity and was, as predicted, detrimental to binding. Second, the potentially covalent inhibitors (featuring a nitrile group) were found to be more potent than their noncovalent counterparts. For example, <b>15d</b> is 3 orders of magnitude less active than <b>7d</b>. This difference is much more pronounced than that in our previous chemical series for which an order of magnitude was the norm. Third, the absolute stereochemistry of the scaffold was a key factor, as demonstrated with <b>16c</b>, <b>16d</b>, <b>16e</b>, and <b>16f</b> being micromolar at best, while <b>7c</b>, <b>7d</b>, <b>7e</b>, and <b>7f</b> were nanomolar inhibitors with <b>7e</b> being the most active (<i>K</i><sub><i>i</i></sub> = 1 nM). There are cases (i.e, fluoxetine, an antidepressant)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> in which the changes in stereochemistry do not substantially affect the potency. In the case of noncovalent drugs, their position and orientation within the binding site can adjust to optimize interactions. However, the formation of a covalent bond provides less opportunity for the drug to adjust its binding. As a result, the stereochemistry difference between <b>7e</b> and <b>16e</b>, although four bonds away from the “covalent group”, was not tolerated. Fourth, the introduction of an R<sup>1</sup> group even as small as methyl was detrimental to the activity (<b>15e</b> vs <b>15f</b>, <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). This observation was in line with the predictions. Fifth, the size of the R<sup>2</sup> group can be used to modulate the affinity. Our docking study showed that a benzyl group (<b>7e</b>: <i>K</i><sub><i>i</i></sub> = 1.0 nM) would be the optimal size, while longer chains would be tolerated, with the best fit for benzyl and the worst with Cbz. The increasing size of this appendage correlated with a predicted increase in distance from the side chain of Phe173.</div><div class="NLM_p">Our survey of the field revealed that the hydrophobic interaction is not as critical for the binding as are the two above-mentioned hydrogen bonds and the covalent bond.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In agreement with these previous observations, disrupting this hydrophobic interaction led to decreased potency, although less pronounced than breaking the covalent bond or the hydrogen bonds.</div><div class="NLM_p">In a previous report, Venäläinen et al. reported a <i>K</i><sub><i>i</i></sub> of 0.023 nM for inhibitor <b>4</b>,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> nearly 2 orders of magnitude more potent than <b>7e</b> (<i>K</i><sub><i>i</i></sub> = 1.0 nM), while our docking studies indicated similar activities for these two compounds. In order to compare the two inhibitors under the same conditions, we carried out a second set of experiments with <b>7e</b> and <b>4</b> following the procedure of Venäläinen et al., who computed the <i>K</i><sub><i>i</i></sub> using the Morrison equation which considers tight binding.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In our experiments (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>), we observed that <b>4</b> and <b>7e</b> were nearly as potent.</div><div class="NLM_p last">Overall, this study identified a highly potent POP inhibitor (<b>7e</b>, <i>K</i><sub><i>i</i></sub> = 1.0 nM), exhibiting potency on par with the most active compounds reported to date (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) including those moved to clinical trials.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Metabolism Studies</h3><div class="NLM_p last">One of the concerns that was raised while this work was ongoing was the numerous possible sites of metabolism on this class of scaffolds. In fact, our first chemical series illustrated by <b>5</b> was terminated due to the high complexity of its metabolism, leading to several potentially toxic metabolites.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The epoxidation of aromatic rings and double bonds by cytochrome P450 enzymes present in the liver is one of the major causes of drug withdrawal and therefore should be carefully examined early in the drug discovery and development process.<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35-37)</a> In our lead compound <b>7e</b>, both the double bonds and the <i>N</i>-benzyl moiety may lead to reactive metabolites and/or low metabolic stability (reduced half-life). In fact, the former may be prone to epoxidation leading, while the latter may undergo <i>N</i>-dealkylation. Unexpectedly, <b>7e</b> was found to be very stable in human liver microsomes (Cl<sub>int</sub> = 4 μL/min/mg protein) and even more stable than our previous lead <b>6</b>. Under the experimental conditions used, no N-debenzylated products were observed, and only trace amounts of mono-oxidation metabolites were detected.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The first use of 3-oxo-hexahydro-1<i>H</i>-isoindole-4-carboxylic acid as a chiral drug template is presented. Structure-based guided design and efficient synthesis led to the discovery of a highly potent POP inhibitor (<b>7e</b>) exhibiting single digit nanomolar activity (<i>K</i><sub><i>i</i></sub> = 1.0 nM), significantly lower than that of our previous hit (<b>6</b>, <i>K</i><sub><i>i</i></sub> = 23.0 nM) and similar to the potencies of POP inhibitors which have entered clinical trials such as KYP-2047.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In addition, this novel lead molecule <b>7e</b> showed improved metabolic stability over our previous leads. Thus, <b>7e</b> will now be moved to <i>in vivo</i> studies.</div><div class="NLM_p">Interestingly, this chemical series was also used to assess our computational predictions and confirmed that the current version of F<span class="smallcaps smallerCapital">itted</span> can be used to guide the design of active covalent inhibitors.</div><div class="NLM_p last">This successful study together with our previous reports improves our understanding of the geometrical requirements for optimal POP inhibition as well as our comprehension of covalent inhibition, in both computational and experimental perspectives.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11632" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11632" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Protein Expression</h3><div class="NLM_p last"><i>E. coli</i> BL21 competent cells were transformed with pETM10 hPOP. A starter culture of LB medium (100 mL) containing kanamycin (50 mg mL<sup>–1</sup>) was inoculated with one colony and was incubated overnight at 37 °C with shaking. After 16 h, four cultures of LB (4 × 1000 mL) containing kanamycin (50 mg mL<sup>–1</sup>) were inoculated with the overnight culture (20 mL). The inoculated cultures were incubated at 37 °C and 220 rpm until the OD600 was between 0.3 and 0.5 (3 h). The temperature was lowered to 18 °C, IPTG was added (final concentration of 0.5 mM), and induction was allowed to proceed for 5 h. Cells were harvested by centrifugation (4000<i>g</i>, 15 min, 4 °C), and the pellet was resuspended in suspension buffer (50 mL) [Tris-HCl (10 mM), NaCl (300 mM), β-mercaptoethanol (5 mM), imidazole (1 mM), and 5% glycerol, pH 8] and sonicated for four cycles (2 min of sonication/2 min of rest; pulse, 0.5 intensity; duty, 0.5), while the sample was kept on ice (Branson sonifier 450, Emerson industrial automation, United States). After sonication, the sample was centrifuged (40000<i>g</i>, 30 min, 4 °C), and the supernatant was used immediately for POP purification. An affinity column was used (10 mL, Toyopearl, AF-Chelate-650M) for purification. The supernatant was applied at a flow rate of 0.5 mL min<sup>–1</sup> to a column previously equilibrated with 5 column volumes of NiSO<sub>4</sub> (0.2 M) followed by 5 column volumes of suspension buffer. The column was then washed with suspension buffer until the absorbance at 280 nm returned to basal level. The column was then rinsed with 5 column volumes of washing buffer [Tris-HCl (20 mM), NaCl (300 mM), β-mercaptoethanol (5 mM), imidazole (15 mM), and 5% glycerol, pH 8]. The elution was then performed with 4 column volumes of elution buffer [Tris-HCl (20 mM), NaCl (300 mM), β-mercaptoethanol (5 mM), imidazole (500 mM), and 5% glycerol, pH 8]. Fractions (4 mL) were collected during the entire elution. Fractions testing positive for POP activity (REF) were analyzed by SDS–PAGE and stained with phastgel blue R (GE Healthcare, sweden). POP-containing fractions were combined and subjected to size exclusion chromatography (HiLoad 16/60 Superdex75 prep grade on a Amersham Biosciences FPLC system) with [Tris-HCl (20 mM), NaCl (150 mM), benzamidine (5 mM), EDTA (1 mM), β-mercaptoethanol [5 mM], and 5% glycerol, pH 8] as the running buffer. The purified enzyme was dialyzed into the appropriate buffer. Recombinant hPOP was quantified by measuring the absorbance at 280 nm using an extinction coefficient calculated by the following equation (ε = nTrp*5000 + nTyr*1490 + nCys*125, 129090 L·mol<sup>–1</sup>·cm<sup>–1</sup> for POP<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a>). Aliquots of the recombinant enzyme were prepared and immediately frozen with liquid nitrogen and stored at −80 °C.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> POP Activity Assays</h3><div id="sec6_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Chemicals and Reagents</h4><div class="NLM_p last">ZGP-pNA was obtained from Bachem (Bubendorf, Switzerland).</div></div><div id="sec6_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> IC<sub>50</sub>/<i>K</i><sub><i>i</i></sub> Measurement</h4><div class="NLM_p last">The reactions were performed in microtiter plates of 96 wells. For each reaction, the activity buffer (A.B.) (140 μL, sodium phosphate (20 mM), NaCl (150 mM), β-mercaptoethanol (5 mM), EDTA (2 mM), 10% glycerol, and 0.5 mg/mL BSA, pH 8) was preincubated for 30 min at 30 °C with hPOP (20 μL, 10 nM in A.B.) and with the corresponding inhibitor solution (20 μL) or activity buffer (controls). Stock inhibitors were prepared in DMSO (100 mM); dilutions for inhibitor evaluation were prepared from the stock in the activity buffer. A control experiment with the same DMSO concentration was performed. After preincubation, ZGP-pNA (20 μL, 0.8 mM in A.B., final concentration of 80 μM) was added, and the formation of the product was followed by absorbance at 405 nm every 30 s. Initial velocity was measured for each concentration of inhibitor and compared to the initial velocity of reactions that did not contain inhibitor. The IC<sub>50</sub> value was defined as the inhibitor concentration causing a 50% decrease in activity. The <i>K</i><sub>i</sub> was defined as IC<sub>50</sub>/(1+([S]/<i>K</i><sub>m</sub>)). The <i>K</i><sub>m</sub> of the substrate has been measured by monitoring the initial velocity of the enzymatic reaction of 1 nM of hPOP with various concentrations of substrate. Data obtained were <i>K</i><sub>m</sub> = 74.6 μM; <i>k</i><sub>cat</sub> = 20.56 s<sup>–1</sup>.</div></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Morrison <i>K</i><sub><i>i</i></sub></h3><div class="NLM_p last">For <b>7e</b>, since the <i>K</i><sub><i>i</i></sub> was in the same range as the enzyme concentration used in the assay, the Morrison equation was used.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The same protocol as the IC<sub>50</sub> was used with the appropriate concentration range. Initial velocities were determined in the presence (<i>v</i><sub>i</sub>) and the absence (<i>v</i><sub>0</sub>) of the inhibitor, and the subsequent ratio (<i>v</i><sub>i</sub>/<i>v</i><sub>o</sub>) was plotted against the inhibitor concentration and fitted to the Morrison equation:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/jm-2015-01296v_m001.gif" alt="" /></img></span>where <i>E</i> is the active enzyme concentration in the assay (1 nM here), <i>I</i> is the inhibitor concentration, and <i>K</i><sub class="stack"><i>i</i></sub><sup class="stack"><i>app</i></sup> is the apparent dissociation constant of the inhibitor. Similarly to that for the IC<sub>50</sub>, knowing the Henri–Michaelis–Menten constant (<i>K</i><sub><i>m</i></sub> = 74.6 μM) and the substrate concentration used in the assay ([S] = 80 μM), it is possible to compute the true dissociation constant following this equation:<span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/jm-2015-01296v_m002.gif" alt="" /></img></span></div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Metabolism</h3><div class="NLM_p last">Analyses were performed on an Agilent 1100 modular system equipped with an autosampler, a quaternary pump system, a photodiode array UV detector, a quadrupole MS detector, and a ChemStation (for LC 3D A.09.03) data system. Separation was achieved using a Zorbax Eclipse XDB-C18 150 mm × 4.6 mm, 5 μm. Elution consisted of a gradient step from 99% mobile phase A (H<sub>2</sub>O) and 1% mobile phase B (CH<sub>3</sub>CN), to 99% phase B over 20 min, at a flow rate of 1 mL/min. The absorption was recorded at 220 nm.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Docking</h3><div class="NLM_p last">For the docking study, we used our docking program F<span class="smallcaps smallerCapital">itted</span><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (F<span class="smallcaps smallerCapital">orecaster</span> platform<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a>), which was previously modified to account for covalent inhibitors.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The compounds were prepared for docking using our program S<span class="smallcaps smallerCapital">mart</span> and docked to a protein structure prepared from the PDB file using P<span class="smallcaps smallerCapital">repare</span> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XDW">2XDW</a>) and further processed for use in docking studies using P<span class="smallcaps smallerCapital">rocess</span>. The docking was carried out with Ser554 identified as a catalytic residue susceptible to forming a covalent bond with reactive groups. F<span class="smallcaps smallerCapital">itted</span> uses a genetic algorithm as a conformational search algorithm. A maximum number of generation of 200 and a convergence criterion Diff_N_Best 0.25 (converged when the 20 lowest-in-energy individuals were within 0.25 kcal/mol) were used. These parameters ensured a more exhaustive conformation search. Default values were used for all the other parameters.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Crystallography</h3><div class="NLM_p last">Crystal and molecular structures of <b>13d</b> and <b>16d</b> were determined by single crystal X-ray diffraction. Diffraction measurements were made on a Bruker D8 APEX2 X-ray diffractometer instrument using graphite-monochromated Mo<i>K</i><sub>α</sub> (λ = 0.71073 Å) radiation. The X-ray diffraction data sets were collected using the ω scan mode over the 2θ range up to 54° at 100 K. The structures were solved by direct methods implemented in SHELXS and refined using SHELXL.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Structure refinement was performed on <i>F</i><sup>2</sup> using all data, and hydrogen atoms were modeled with appropriate riding-hydrogen models on the carbon centers. Calculations were performed, and the drawings were prepared using the WINGX<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> suite of crystallographic programs. Compound <b>13d</b> crystallizes in a centrosymmetric space group <i>P</i>2<sub>1</sub>/<i>n</i> and is not enantiopure. Compound <b>16d</b> crystallizes in an enantiomorphic space group <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>. There was insufficient anomalous scattering from the crystal due to the crystal diffracting poorly overall, even at a 100 K. Attempts to isolate a more suitable one were either unsuccessful or resulted in a crystal of approximately the same quality. The absolute structure of compound <b>16d</b> was determined in reference to a known chiral center which does not change in the synthetic procedure. Structures have been deposited with the Cambridge Structural Database, deposition codes CCDC 1430175-1430176.</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Synthesis</h3><div class="NLM_p">All commercially available reagents were used without further purification unless otherwise stated. The 4 Å molecular sieves were dried at 100 °C prior to use. Optical rotations were measured on a JASCO DIP 140 in a 1 dm cell at 20 °C. FTIR spectra were recorded using a PerkinElmer Spectrum One FT-IR. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on Varian Mercury 400 MHz, 300 MHz, or Unity 500 spectrometers. Chemical shifts are reported in ppm using the residual of deuterated solvents as internal standard. Thin layer chromatography visualization was performed by UV or by development using KMnO<sub>4</sub>, H<sub>2</sub>SO<sub>4</sub>/MeOH, or Mo/Ce solutions. Chromatography was performed on silica gel 60 (230–40 mesh). Low resolution mass spectrometry was performed by ESI using a Thermoquest Finnigan LCQ Duo. High resolution mass spectrometry was performed by EI peak matching (70 eV) on a Kratos MS25 RFA double focusing mass spectrometer or by ESI on a Ion Spec 7.0 T FTMS at McGill University. Prior to biological testing, reversed phase HPLC was used to verify the purity of compounds on an Agilent 1100 series instrument equipped with a VWD-detector, a C18 reverse column (Agilent, Zorbax Eclipse XDB-C18 150 mm 4.6 mm, 5 μm), and UV detection at 254 or 220 nm. All tested compounds were at least 95% pure. All measured purities are listed in <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. HPLC Analysis of Purity</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" char="." /></col><col align="left" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">retention time (min)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">purity (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left" char=".">16.4</td><td class="colsep0 rowsep0" align="left" char=".">90.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15a</b><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left" char=".">18.0</td><td class="colsep0 rowsep0" align="left" char=".">97.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="left" char=".">18.8</td><td class="colsep0 rowsep0" align="left" char=".">96.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15c</b><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left" char=".">16.7</td><td class="colsep0 rowsep0" align="left" char=".">98.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15d</b></td><td class="colsep0 rowsep0" align="left" char=".">17.5</td><td class="colsep0 rowsep0" align="left" char=".">96.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15e</b></td><td class="colsep0 rowsep0" align="left" char=".">18.6</td><td class="colsep0 rowsep0" align="left" char=".">96.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15f</b></td><td class="colsep0 rowsep0" align="left" char=".">19.5</td><td class="colsep0 rowsep0" align="left" char=".">95.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left" char=".">17.3</td><td class="colsep0 rowsep0" align="left" char=".">96.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left" char=".">17.1</td><td class="colsep0 rowsep0" align="left" char=".">99.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left" char=".">18.1</td><td class="colsep0 rowsep0" align="left" char=".">96.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left" char=".">18.1</td><td class="colsep0 rowsep0" align="left" char=".">98.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left" char=".">16.0</td><td class="colsep0 rowsep0" align="left" char=".">99.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16c</b><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left" char=".">15.7</td><td class="colsep0 rowsep0" align="left" char=".">98.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7d</b><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left" char=".">17.1</td><td class="colsep0 rowsep0" align="left" char=".">92.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16d</b></td><td class="colsep0 rowsep0" align="left" char=".">17.2</td><td class="colsep0 rowsep0" align="left" char=".">97.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7e</b><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left" char=".">17.6</td><td class="colsep0 rowsep0" align="left" char=".">98.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16e</b></td><td class="colsep0 rowsep0" align="left" char=".">17.6</td><td class="colsep0 rowsep0" align="left" char=".">95.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7f</b><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left" char=".">18.7</td><td class="colsep0 rowsep0" align="left" char=".">98.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16f</b><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left" char=".">18.7</td><td class="colsep0 rowsep0" align="left" char=".">95.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Conditions: (95% water, 5% methanol, and 1 mL/min).</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">UV detection at 220 nm.</p></div></div></div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> General Procedure for the Reductive Amination of Aldehydes</h3><div class="NLM_p last">To a solution of Cbz-hydrazide or amine (1 equiv) in MeOH (concentration of 1 M) was added a solution of dienal (1 equiv) in DCM dropwise. The mixture was stirred for 30 min at room temperature. The solution was cooled to 0 °C, and Me<sub>2</sub>NH·BH<sub>3</sub> (1.5 equiv) was added slowly, followed by a solution of pTSA (6 equiv) in MeOH (concentration 1 M). After stirring for another 2 h, a solution of Na<sub>2</sub>CO<sub>3</sub>(aq) (2-fold dilution, 10% w/v) was added, and the mixture was stirred for 2 h then concentrated under reduced pressure, extracted with CH<sub>2</sub>Cl<sub>2</sub>, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude product was purified by flash chromatography with eluent Hex/EtOAc to afford the desired product.</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Benzyl 2-((2<i>E</i>)-penta-2,4-dienyl)hydrazinecarboxylate (<b>12a</b>)</h3><div class="NLM_p last">Yield: 73%. IR (film) ν<sub>max</sub> (cm<sup>–1</sup>) 3314.85, 2972.36, 2891.14, 1686.76; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ (ppm) 7.45–7.30 (m, 5H), 6.32 (dt, <i>J</i> = 16.7, 10.2 Hz, 1H), 6.25–6.15 (m, 1H), 5.76–5.62 (m, 1H), 5.20 (d, <i>J</i> = 16.5 Hz, 1H), 5.14 (s, 2H), 5.11–5.02 (m, 1H), 3.58–3.48 (m, 2H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ (ppm) 157.2, 136.3, 136.0, 134.5, 129.2, 128.6 128.3, 128.2, 117.5, 67.1, 53.5; HRMS (ESI+) for C<sub>13</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub> (M + H) calcd, 233.12900; found, 233.12770.</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Benzyl 2-((2<i>E</i>,4<i>E</i>)-hexa-2,4-dienyl)hydrazinecarboxylate (<b>12b</b>)</h3><div class="NLM_p last">Yield: 94%. IR (film) ν<sub>max</sub> (cm<sup>–1</sup>) 3274.60, 3019.77, 2912.85, 1702.27; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ (ppm) 7.31 (s, 5H), 6.72 (bs, 1H), 6.06 (m, 2H), 5.64 (dq, <i>J</i> = 6.7, 13.5 Hz, 1H), 5.51 (dd, <i>J</i> = 7.1, 14.6 Hz, 1H), 5.10 (s, 2H), 4.25 (bs, 1H), 3.45 (d, <i>J</i> = 5.4 Hz, 2H), 1.72 (d, <i>J</i> = 6.6 Hz, 3H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ (ppm) 157.2, 136.2, 134.3, 130.9, 129.8, 128.6, 128.2, 128.2, 125.8, 67.0, 25.3, 18.1; HRMS (ESI+) for C<sub>14</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>Na (M + Na) calcd, 269.1266; found, 269.1265.</div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>E</i>)-<i>N</i>′-(Penta-2,4-dien-1-yl)-2-phenylacetohydrazide (<b>12c</b>)</h3><div class="NLM_p last">White solid. <i>R</i><sub><i>f</i></sub> = 0.15 (Hex/EtOAc, 5:5). Yield: 55%. IR (film) ν<sub>max</sub> (cm<sup>–1</sup>) 3275, 3083, 2924, 1645, 1454, 1348, 1005; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) 7.45–7.07 (m, 5H), 6.26 (dt, <i>J</i> = 16.8, 10.2 Hz, 1H), 6.08 (dd, <i>J</i> = 15.2, 10.5 Hz, 1H), 5.66–5.50 (m, 1H), 5.14 (d, <i>J</i> = 16.6 Hz, 1H), 5.05 (d, <i>J</i> = 10.1 Hz, 1H), 4.29 (bs, 1H), 3.49 (s, 2H), 3.38 (bd, <i>J</i> = 5.6 Hz, 2H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ (ppm) 170.5, 136.3, 134.8, 134.2, 129.4 (2C), 129.2, 129.0 (2C), 127.5, 117.6, 53.6, 42.1; HRMS (ESI + ) for C<sub>13</sub>H<sub>17</sub>N<sub>2</sub>O (M + H) calcd, 217.1335; found, 217.1337.</div></div><div id="sec6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>E</i>)-<i>O</i>-Benzyl-<i>N</i>-(penta-2,4-dien-1-yl)hydroxylamine (<b>12d</b>)</h3><div class="NLM_p last">Colorless oil. Yield: 31%. <i>R</i><sub><i>f</i></sub> = 0.36 (Hex/EtOAc, 9:1); IR (film) υ<sub>max</sub> (cm<sup>–1</sup>) 3265, 3087, 1603; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm) 7.37–7.28 (m, 5H), 6.34 (dt, <i>J</i> = 15.0, 10.0 Hz, 1H), 6.25–6.20 (m, 1H), 5.77 (dt, <i>J</i> = 15.0 Hz, 5.0 Hz, 1H), 5.19 (d, <i>J</i> = 15.0 Hz, 1H), 5.08 (d, <i>J</i> = 10 Hz, 1H), 4.72 (s, 2H), 3.58 (d, <i>J</i> = 5.0 Hz, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ (ppm) 137.9, 136.6, 134.2, 129.6, 128.6, 128.5, 128.0, 117.3, 76.4, 54.1; HRMS (ESI+) for C<sub>12</sub>H<sub>16</sub>NO (M + H) calcd, 190.1226; found, 190.1201.</div></div><div id="sec6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>E</i>)-<i>N</i>-Benzylpenta-2,4-dien-1-amine (<b>12e</b>)</h3><div class="NLM_p last">A solution of dienal (800 mg, 9.74 mmol) and benzylamine (1.04 g, 9.74 mmol) was stirred 2 h at room temperature. Then, the reaction mixture was cooled to 0 °C and allowed to stir for an additional 30 min. To the mixture was added NaBH<sub>4</sub> (1.47 g, 38.96 mmol), and the resulting mixture was allowed to stir for 2 h. The reaction mixture was quenched with H<sub>2</sub>O and extracted with DCM. The combined organic layer was washed with 10% NaOH, brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The crude product was chromatographed on silica gel with eluent Hex/EtOAc 9:1, to give a colorless oil. Yield: 500 mg (31%). <i>R</i><sub><i>f</i></sub> = 0.23 (Hex/EtOAc 7:3). Spectral data were consistent with data reported in the literature.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div></div><div id="sec6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (2<i>E</i>,4<i>E</i>)-<i>N</i>-Benzylhexa-2,4-dien-1-amine (<b>12f</b>)</h3><div class="NLM_p last">After stirring a solution of hexadienal (2.07 g, 21.6 mmol) and benzylamine (2.35 mL, 21.6 mmol) in MeOH (18 mL) for 2 h at room temperature, the mixture was cooled to 0 °C and allowed to stir for an additional 30 min. To the mixture was added NaBH<sub>4</sub> (1,6 g, 43.2 mmol), and the resulting mixture was allowed to stir for an additional hour. The reaction mixture was quenched with H<sub>2</sub>O and extracted with DCM. The combined organic layer was washed with NaOH 10%, brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The crude product was chromatographed on silica gel gel with eluent Hex/EtOAc 9:1, to give a yellow oil. Yield: 2,6 g (64%). <i>R</i><sub><i>f</i></sub> = 0.35 (Hex/EtOAc 5:5). Spectral data were consistent with data reported in the literature.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div></div><div id="sec6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> General Procedure for Lactam Formation/Diels–Alder Reaction</h3><div class="NLM_p last">To a solution of diene (1 equiv) in CHCl<sub>3</sub> (to a concentration of 0.25M) was added maleic anhydride (1 equiv). After stirring for 15 h, the solution was concentrated under reduced pressure, and the two diastereomers were separable by precipitation in a mixture of ether/DCM or by flash chromatography (Hex/EtOAc) to afford the <i>exo</i> product.</div></div><div id="sec6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>rac</i>-(3a<i>S</i>,4<i>S</i>,7a<i>S</i>)-2-(((benzyloxy)carbonyl)amino)-3-oxo-2,3,3a,4,5,7a-hexahydro-1<i>H</i>-isoindole-4-carboxylic Acid (<b>13a</b>)</h3><div class="NLM_p last">White solid. Yield: 99% (for all isomers) <i>exo</i> adduct: 65%. IR (film) ν<sub>max</sub> (cm<sup>–1</sup>) 3030, 2941, 2922, 2853, 1739, 1720, 1709; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) 7.40–7.20 (m, 5H), 5.77 (bd, <i>J</i> = 10.0 Hz, 1H), 5.67 (bd, <i>J</i> = 6.9 Hz, 1H), 5.14 (s, 2H), 3.58 (dd, <i>J</i> = 7.5, 7.4 Hz, 1H), 3.50–3.41 (m, 1H), 3.40–3.31 (m, 1H), 3.10–3.00 (m, 1H), 2.68 (bd, <i>J</i> = 20.0 Hz, 1H), 2.45–2.40 (m, 1H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ (ppm) 175.4 (2C), 155.3, 135.5, 128.6, 128.5 (2C), 128.3 (2C), 127.8, 125.1, 67.8, 45.1, 40.3, 35.8, 32.7, 28.1; HRMS (ESI-) for C<sub>17</sub>H<sub>17</sub>N<sub>2</sub>O<sub>5</sub> (M – H) calcd, 329.11430; found, 329.11429.</div></div><div id="sec6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>rac</i>-(3a<i>S</i>,4<i>R</i>,5<i>S</i>,7a<i>R</i>)-2-(((Benzyloxy)carbonyl)amino)-5-methyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1<i>H</i>-isoindole-4-carboxylic Acid (<b>13b</b>)</h3><div class="NLM_p last">White solid. Yield: 55%. IR (film) ν<sub>max</sub> (cm<sup>–1</sup>) 3251, 3024, 2960, 1706; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) 7.38–7.30 (m, 5H), 7.23 (brs, NH), 5.76 (d, <i>J</i> = 9.6 Hz, 1H), 5.60 (d, <i>J</i> = 9.6 Hz, 1H), 5.19–5.12 (m, 2H), 3.56 (t, <i>J</i> = 7.2 Hz, 1H), 3.46–3.33 (m, 2H), 2.99–2.92 (m, 3H), 2.42 (d, <i>J</i> = 7.2 Hz, 1H), 1.15 (d, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ (ppm) 175.8, 174.6, 155.5, 135.7, 134.1, 128.9, 128.7, 128.5, 124.4, 67.9, 42.9, 42.5, 33.3, 32.9, 21.8; HRMS (ESI+) for C<sub>18</sub>H<sub>20</sub>N<sub>2</sub>O<sub>5</sub>Na (M + Na) calcd, 367.1269; found, 367.1275.</div></div><div id="sec6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>rac</i>-(3a<i>S</i>,4<i>R</i>,7a<i>R</i>)-3-oxo-2-(2-Phenylacetamido)-2,3,3a,4,5,7a-hexahydro-1<i>H</i>-isoindole-4-carboxylic Acid (<b>13c</b>) and <i>rac</i>-(3a<i>S</i>,4<i>R</i>,7a<i>S</i>)-3-oxo-2-(2-Phenylacetamido)-2,3,3a,4,5,7a-hexahydro-1<i>H</i>-isoindole-4-carboxylic Acid (<b>14c</b>)</h3><div class="NLM_p last">White solid. Yield: 48%. <i>R</i><sub><i>f</i></sub> = 0.24 (DCM/MeOH, 97:3). IR (film) ν <sub>max</sub> (cm<sup>–1</sup>) 3214, 3027, 2924, 1716, 1670, 1661, 1195; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.31 (s, 0.5H), 7.84 (s, 0.5H), 7.41–7.27 (m, 5H), 5.98–5.83 (m, 0.5H), 5.78 (d, <i>J</i> = 10.0 Hz, 0.5H), 5.68 (dd, <i>J</i> = 10.0, 3.4 Hz, 0.5H), 5.57 (d, <i>J</i> = 9.4 Hz, 0.5H), 3.94 (dd, <i>J</i> = 15.2, 8.3 Hz, 0.5H), 3.61 (dd, <i>J</i> = 10.6, 6.7 Hz, 2H), 3.56–3.44 (m, 1.5H), 3.41 (dd, <i>J</i> = 7.5, 3.4 Hz, 0.5H), 3.33 (dd, <i>J</i> = 7.9, 3.4 Hz, 0.5H), 3.20 (d, <i>J</i> = 9.1 Hz, 0.5H), 3.07 (bs, 0.5H), 2.94 (bs, 0.5H), 2.87–2.76 (m, 0.5H), 2.70 (d, <i>J</i> = 18.8 Hz, 0.5H), 2.56–2.39 (m, 1H), 2.38–2.22 (m, 0.5H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 176.0, 175.9, 174.0, 170.5, 170.1, 167.5, 133.9, 133.5, 129.5, 129.47, 129.2, 129.0, 128.7, 128.0, 127.7, 127.5, 126.9, 125.2, 53.8, 52.4, 45.1, 41.4, 41.3, 40.5, 39.2, 36.0, 33.1, 32.7, 28.2, 23.7; HRMS (ESI−) for C<sub>17</sub>H<sub>17</sub>N<sub>2</sub>O<sub>4</sub> (M – H) calcd, 313.1194; found, 313.1193.</div></div><div id="sec6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>rac</i>-(3a<i>R</i>,4<i>S</i>,7a<i>S</i>)-2-(Benzyloxy)-3-oxo-2,3,3a,4,5,7a-hexahydro-1<i>H</i>-isoindole-4-carboxylic Acid (<b>13d</b>)</h3><div class="NLM_p last">White solid. Yield: 59%. <i>R</i><sub><i>f</i></sub> = 0.24 (Hex/EtOAc 7:3). IR (film) ν<sub>max</sub> (cm<sup>–1</sup>) 3030, 1734, 1709; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) 7.44–7.42 (m, 2H), 7.39–7.36 (m, 3H), 5.71–5.64 (m, 2H), 5.00 (s, 2H), 3.39 (dd, <i>J</i> = 8.0, 3.6 Hz, 1H), 3.22 (t, <i>J</i> = 7.2 Hz, 1H), 3.04 (dd, <i>J</i> = 10.8, 7.6 Hz, 1H), 2.82–2.71 (m, 2H), 2.49–2.41 (m, 1H), 2.27 (dd, <i>J</i> = 12.4, 3.6 Hz, 1H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ (ppm) 176.0, 170.4, 135.3, 129.9 (2C), 129.1, 128.7 (2C), 127.9, 125.0, 77.5, 51.4, 44.9, 35.9, 31.9, 28.0; HRMS (ESI+) for C<sub>16</sub>H<sub>17</sub>NO<sub>4</sub>Na (M + Na) calcd, 310.1055; found, 310.1049.</div></div><div id="sec6_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>rac</i>-(3a<i>R</i>,4<i>S</i>,7a<i>S</i>)-2-Benzyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1<i>H</i>-isoindole-4-carboxylic Acid (<b>13e</b>)</h3><div class="NLM_p last">White solid. Yield: 65%. <i>R</i><sub><i>f</i></sub>= 0.29 (Hex/AcOEt, 4:6). IR (film) ν <sub>max</sub> (cm<sup>–1</sup>) 3028, 1722, 1697, 1650; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm) 9.15 (brs, OH), 7.36–7.24 (m, 5H), 5.79 (dd, <i>J</i> = 10, 1.5 Hz, 1H), 5.72–5.69 (m, 1H), 4.53 (s, 2H), 3.45 (dd, <i>J</i> = 8.0, 3.5 Hz, 1H), 3.34 (dd, <i>J</i> = 8.5, 6.5 Hz, 1H), 3.01 (t, <i>J</i> = 10.5 Hz, 1H), 2.94 (brs, 1H), 2.80 (d, <i>J</i> = 19.0 Hz, 1H), 2.49–2.44 (m, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ (ppm) 175.3, 174.7, 136.3, 128.9 (2C), 128.2, 128.1 (2C), 127.8, 125.3, 49.6, 47.1, 47.0, 36.5, 34.8, 28.2; HRMS (ESI+) for C<sub>16</sub>H<sub>17</sub>NO<sub>3</sub>Na (M + Na) calcd, 294.1106; found, 294.1096.</div></div><div id="sec6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>rac</i>-(3a<i>S</i>,4<i>R</i>,5<i>S</i>,7a<i>R</i>)-2-Benzyl-5-methyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1<i>H</i>-isoindole-4-carboxylic Acid (<b>13f</b>)</h3><div class="NLM_p last">White solid. Yield: 51%. <i>R</i><sub><i>f</i></sub> = 0.46 (Hex/AcOEt, 3:7); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) 7.35–7.22 (m, 5H), 5.73 (d, <i>J</i> = 10.0 Hz, 1H), 5.61–5.59 (m, 1H), 4.51 (s, 2H), 3.32 (t, <i>J</i> = 8.4 Hz, 1H), 3.05 (d, <i>J</i> = 3.6 Hz, 1H), 3.02–2.97 (m, 2H), 2.88–2.81 (m, 1H), 2.42 (d, <i>J</i> = 12.8 Hz, 1H), 1.16 (d, <i>J</i> = 7.6 Hz, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ (ppm) 175.9, 174.9, 136.4, 134.2, 128.9 (2C), 128.1 (2C), 127.7, 124.6, 49.5, 46.9, 44.4, 43.3, 34.6, 33.5, 22.0. Spectral data were consistent with data reported in the literature.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div></div><div id="sec6_22_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>rac</i>-Benzyl ((3a<i>R</i>,7<i>R</i>,7a<i>S</i>)-7-Cyano-1-oxo-3,3a,7,7a-tetrahydro-1<i>H</i>-isoindol-2(6<i>H</i>)-yl)carbamate (<b>9a</b>)</h3><div class="NLM_p last">Acid <b>13a</b> (170 mg, 0.51 mmol) was dissolved, under argon atmosphere, in THF (6.4 mL), then TEA (115 μL, 0.82 mmol) was added, and the reaction was cooled at −15 °C. Then, EtCO<sub>2</sub>Cl was added, and the reaction was stirred at −15 °C. After 15 min, a solution of NH<sub>4</sub>OH (30% in water) was added, and the reaction was stirred 15 h at room temperature. The reaction was extracted 3 times with EtOAc. The organic phases were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude product was directly used in the next reaction step. To a cooled solution of the amide (21 mg, 0.064 mmol) in THF (1 mL) was added TEA (27 μL, 0.191 mmol). After stirring, TFAA (13.5 μL, 0.096 mmol) was added at 0 °C, and the reaction mixture was stirred for 1 h at 0 °C. Then, the reaction was quenched with water and extracted with CHCl<sub>3</sub> (3×). The organic phases were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude product was purified by flash chromatography (Hex/EtOAc 5:5), to give nitrile <b>9a</b> as a white solid (15 mg, 75%). <i>R</i><sub><i>f</i></sub> = 0.35 (1:1 Hex/AcOEt). IR (film) ν<sub>max</sub> (cm<sup>–1</sup>): 3278, 2923, 2241, 1754, 1738, 1711; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ (ppm) 7.45–7.29 (m, 5H), 6.94 (bs, 1H), 5.92 (d, 1H, <i>J</i> = 9.8 Hz), 5.74–5.65 (m, 1H), 5.26–5.06 (m, 2H), 3.70–3.42 (m, 3H), 3.21–2.99 (m, 1H), 2.63–2.54 (m, 2H), 2.46 (bd, <i>J</i> = 9.4 Hz, 1H); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ (ppm) 154.9, 135.3, 128.6 (2C), 128.5 (2C), 128.2, 126.0, 125.6, 119.4, 68.0, 51.9, 44.7, 33.5, 29.8, 23.6; HRMS (ESI + ) for C<sub>17</sub>H<sub>17</sub>N<sub>3</sub>O<sub>3</sub>Na (M + Na) calcd, 334.1162; found, 334.1160.</div></div><div id="sec6_22_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>rac</i>-Benzyl((4<i>R</i>,7a<i>R</i>)-3-oxo-4-(pyrrolidine-1-carbonyl)-1,3,3a,4,5,7a-hexahydro-2<i>H</i>-isoindol-2-yl)carbamate (<b>15a</b>)</h3><div class="NLM_p last">Acid <b>13a</b> (100 mg, 0.304 mmol) was dissolved, under argon atmosphere, in DMF (3.5 mL). The solution was cooled to 0 °C, and TEA (212 μL, 1.52 mmol) was added followed by PivCl (55 μL, 0.455 mmol). After 1 h, pyrrolidine (124 μL, 1.52 mmol) was added, and the mixture was stirred overnight at room temperature. The reaction was quenched with H<sub>2</sub>O and extracted with EtOAc, and the organic phases washed with 1 M HCl, saturated NaHCO<sub>3</sub>, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was chromatographed on silica gel (Hex/EtOAc 2:8) to afford the product <b>15a</b> as a white solid (19 mg, 16%). <i>R</i><sub><i>f</i></sub> = 0.29 (AcOEt). IR (film) υ<sub>max</sub> (cm<sup>–1</sup>) 3211, 2970, 2876, 1744, 1715, 1617, 1454, 1228; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm) 7.37–7.32 (m, 5H), 6.85 (brs, NH), 5.87 (d, <i>J = </i> 10.0 Hz, 1H), 5.71 (d, <i>J = </i> 10.0 Hz, 1H), 5.15 (brs, 2H), 4.06–4.01 (m, 1H), 3.57–3.53 (m, 2H), 3.42–3.39 (m, 4H), 2.50–2.46 (m, 1H), 2.35 (d, <i>J = </i> 20.0 Hz, 1H), 1.95–1.90 (m, 2H), 1.88–1.74 (m, 2H), 1.25 (brs, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ (ppm) 172.1, 155.1, 135.6, 128.7, 128.5, 127.5, 125.9, 68.0, 52.6, 47.0, 46.6, 46.0, 33.3, 32.3, 29.8, 28.5, 26.3, 24.4; HRMS (ESI+) for C<sub>21</sub>H<sub>26</sub>N<sub>3</sub>O<sub>4</sub> (M+ H) calcd, 384.1918; found, 384.1907.</div></div><div id="sec6_22_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>rac</i>-Benzyl((3a<i>S</i>,4<i>R</i>,5<i>S</i>,7a<i>R</i>)-5-methyl-3-oxo-4-(pyrrolidine-1-carbonyl)-1,3,3a,4,5,7a-hexahydro-2<i>H</i>-isoindol-2-yl)carbamate (<b>15b</b>)</h3><div class="NLM_p last">Acid <b>13b</b> (150 mg, 0.435 mmol) was dissolved, under argon atmosphere, in DMF (4.2 mL). The solution was cooled to 0 °C, and TEA (304 μL, 2.177 mmol) was added followed by PivCl (75 μL, 0.610 mmol). After 1 h, pyrrolidine (193 μL, 2.177 mmol) was added, and the mixture was stirred overnight at room temperature. The reaction was quenched with H<sub>2</sub>O, extracted with EtOAc, and the organic phases washed with 1 M HCl, saturated NaHCO<sub>3</sub>, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was chromatographed on silica gel (Hex/EtOAc 75:25) to afford the product <b>15b</b> as a white solid (105 mg, 61%). <i>R</i><sub><i>f</i></sub> = 0.19 (Hex/EtOAc 2:8). IR (film) υ<sub>max</sub> (cm<sup>–1</sup>) 3209, 2958, 2872, 1743, 1715, 1617, 1453, 1230; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm) 7.34–7.32 (m, 5H), 6.74 (brs, NH), 5.84 (d, <i>J = </i> 10.0 Hz, 1H), 5.61 (d, <i>J = </i> 10.0 Hz, 1H), 5.18–5.11 (m, 2H), 4.06–4.01 (m, 1H), 3.57–3.40 (m, 6H), 3.00 (d, <i>J</i> = 4.0 Hz, 1H), 2.57–2.56 (m, 1H), 2.42 (brs, 1H), 1.95–1.91 (m, 2H), 1.89–1.74 (m, 2H), 1.16 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ (ppm) 173.8, 172.1, 155.2, 135.7, 133.8, 128.6, 128.4, 125.0, 67.7, 52.4, 47.0, 46.0, 44.3, 41.3, 33.9, 32.4, 26.2, 24.3, 22.4; HRMS (ESI+) for C<sub>22</sub>H<sub>28</sub>N<sub>3</sub>O<sub>4</sub> (M+ H) calcd, 398.2074; found, 398.2068.</div></div><div id="sec6_22_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>rac</i>-<i>N</i>-((3a<i>S</i>,4<i>R</i>,7a<i>R</i>)-3-Oxo-4-(pyrrolidine-1-carbonyl)-1,3,3a,4,5,7a-hexahydro-2<i>H</i>-isoindol-2-yl)-2-phenylacetamide (<b>15c</b>)</h3><div class="NLM_p last">Acid <b>13c</b> (200 mg, 0.636 mmol) was dissolved, under argon atmosphere, in DMF (6 mL). The solution was cooled to 0 °C, and TEA (443 μL, 3.18 mmol) was added followed by PivCl (110 μL, 0.890 mmol). After 1 h, pyrrolidine (282 μL, 3.18 mmol) was added, and the mixture was stirred overnight at room temperature. The reaction was quenched with H<sub>2</sub>O, extracted with EtOAc, and the organic phases washed with 1 M HCl, saturated NaHCO<sub>3</sub>, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The <i>exo</i> compound was selectively precipitated using ether and afforded the pure compound <b>15c</b> as a white solid (70 mg, 30%). <i>R</i><sub><i>f</i></sub> = 0.13 (EtOAc). IR (film) υ<sub>max</sub> (cm<sup>–1</sup>) 3232, 3026, 2974, 2874, 1729, 1686, 1613, 1454, 1348; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) 7.77 (brs, NH), 7.35–7.27 (m, 5H), 5.85 (d, <i>J = </i> 10.0 Hz, 1H), 5.70–5.67 (m, 1H), 3.99–3.93 (m, 1H), 3.60 (s, 2H), 3.49–3.34 (m, 6H), 2.53–2.46 (m, 2H), 2.31 (d, <i>J = </i> 18.4 Hz, 1H), 1.95–1.73 (m, 5H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ (ppm) 173.4, 172.3, 169.8, 133.9, 129.5 (2C), 129.1 (2C), 127.5, 127.3, 126.1, 52.4, 47.0, 46.4, 46.0, 41.5, 33.3, 32.5, 28.4, 26.3, 24.4; HRMS (ESI+) for C<sub>21</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub>Na (M+ Na) calcd, 390.1788; found, 390.1790.</div></div><div id="sec6_22_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>rac</i>-(3a<i>R</i>,7<i>R</i>,7a<i>S</i>)-2-(Benzyloxy)-7-(pyrrolidine-1-carbonyl)-2,3,3a,6,7,7a-hexahydro-1<i>H</i>-isoindol-1-one (<b>15d</b>)</h3><div class="NLM_p last">Acid <b>13d</b> (150 mg, 0.522 mmol) was dissolved, under argon atmosphere, in DMF (5 mL). The solution was cooled to 0 °C, and TEA (364 μL, 2.61 mmol) was added followed by PivCl (90 μL, 0.731 mmol). After 1 h, pyrrolidine (232 μL, 2.61 mmol) was added, and the mixture was stirred overnight at room temperature. The reaction was quenched with H<sub>2</sub>O, extracted with EtOAc, and the organic phases washed with 1 M HCl, saturated NaHCO<sub>3</sub>, brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was chromatographed on silica gel (Hex/EtOAc 2:8) to afford the product <b>15d</b> as a white solid (90 mg, 51%). <i>R</i><sub><i>f</i></sub> = 0.25 (Hex/EtOAc 2:8). IR (film) υ<sub>max</sub> (cm<sup>–1</sup>) 3480, 2951, 1705, 1634; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) 7.40–7.37 (m, 2H), 7.35–7.32 (m, 3H), 5.75–5.71 (m, 1H), 5.53–5.49 (m, 1H), 4.93 (q, <i>J</i> = 8.8 Hz, 2H), 3.55–3.37 (m, 5H), 3.15–3.09 (m, 2H), 2.95 (dd, <i>J</i> = 6.8, 2.4 Hz, 1H), 2.89 (dd, <i>J</i> = 6.4, 3.6 Hz, 1H), 2.25–2.19 (m, 1H), 2.15–2.11 (m, 1H), 1.97–1.90 (m, 2H), 1.88–1.79 (m, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ (ppm) 172.6, 170.9, 135.2, 129.8 (2C), 129.0, 128.6 (2C), 127.3, 125.9, 76.9, 52.1, 46.8, 46.0, 39.9, 35.7, 29.2, 26.3, 24.3, 24.1; HRMS (ESI+) for C<sub>20</sub>H<sub>24</sub>N<sub>2</sub>O<sub>3</sub>Na (M+ Na) calcd, 363.1679; found, 363.1688.</div></div><div id="sec6_22_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (3a<i>R</i>,7<i>R</i>,7a<i>S</i>)-2-Benzyl-7-(pyrrolidine-1-carbonyl)-2,3,3a,6,7,7a-hexahydro-1<i>H</i>-isoindol-1-one (<b>15e</b>)</h3><div class="NLM_p last">Acid <b>13e</b> (150 mg, 0.553 mmol) was dissolved, under argon atmosphere, in DMF (5.3 mL). The solution was cooled to 0 °C, and TEA (385 μL, 2.764 mmol) was added followed by PivCl (95 μL, 0.774 mmol). After 1 h, pyrrolidine (245 μL, 2.764 mmol) was added, and the mixture was stirred 15 h at room temperature. The reaction was quenched with H<sub>2</sub>O, extracted with EtOAc, and the organic phases washed with 1 M HCl, saturated NaHCO<sub>3</sub>, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was chromatographed on silica gel (Hex/EtOAc 2:8) to afford the product <b>15e</b> as a white solid (105 mg, 58%). <i>R</i><sub><i>f</i></sub> = 0.16 (Hex/EtOAc 2:8). IR (film) υ<sub>max</sub> (cm<sup>–1</sup>) 3211, 2970, 2876, 1744, 1715, 1617, 1454, 1228; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm) 7.32–7.15 (m, 5H), 5.83 (dd, <i>J</i> = 9.6, 1.6 Hz, 1H), 5.69–5.65 (m,1H), 4.59 (d, <i>J</i> = 15.0 Hz, 1H), 4.27 (d, <i>J</i> = 15.0 Hz, 1H), 4.21–4.15 (m, 1H), 3.51–3.42 (m, 5H), 3.32–3.28 (m, 1H), 2.90 (dd, <i>J</i> = 10.8, 8.8 Hz, 1H), 2.50–2.40 (m, 1H), 2.36–2.32 (m, 2H), 2.03–1.75 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ (ppm) 173.7, 172.5, 136.8, 128.8 (2C), 128.1 (2C), 127.6, 127.5, 126.4, 49.7, 48.5, 47.1, 46.9, 45.9, 34.0, 33.7, 29.1, 26.4, 24.5; HRMS (ESI+) for C<sub>20</sub>H<sub>24</sub>N<sub>2</sub>O<sub>2</sub>Na (M+ Na) calcd, 347.1730; found, 347.1737.</div></div><div id="sec6_22_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (3a<i>R</i>,6<i>S</i>,7<i>R</i>,7a<i>S</i>)-2-Benzyl-6-methyl-7-(pyrrolidine-1-carbonyl)-2,3,3a,6,7,7a-hexahydro-1<i>H</i>-isoindol-1-one (<b>15f</b>)</h3><div class="NLM_p last">Acid <b>13f</b> (200 mg, 0.70 mmol) was dissolved, under argon atmosphere, in DMF (6.7 mL). The solution was cooled to 0 °C, and TEA (488 μL, 3.50 mmol) was added followed by PivCl (121 μL, 0.98 mmol). After 1 h, pyrrolidine (311 μL, 3.50 mmol) was added, and the mixture was stirred 15 h at room temperature. The reaction was quenched with H<sub>2</sub>O, extracted with EtOAc, and the organic phases washed with 1 M HCl, saturated NaHCO<sub>3</sub>, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was chromatographed on silica gel (Hex/EtOAc 5:5) to afford the product <b>15f</b> as a white solid (168 mg, 71%). <i>R</i><sub><i>f</i></sub> = 0.34 (Hex/EtOAc 3:7). IR (film) υ<sub>max</sub> (cm<sup>–1</sup>) 2954, 2868, 1698, 1637, 1423, 1355, 1250; <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm) 7.32–7.29 (m, 2H), 7.26–7.23 (m, 1H), 7.20–7.18 (m, 2H), 5.79 (dt, <i>J</i> = 10.0, 1.5 Hz, 1H), 5.57 (dt, <i>J</i> = 10.0, 3.5 Hz, 1H), 4.62 (d, <i>J</i> = 15.0 Hz, 1H), 4.23 (d, <i>J</i> = 15.0 Hz, 1H), 4.19–4.14 (m, 1H), 3.54–3.43 (m, 4H), 3.29 (dd, <i>J</i> = 8.5, 7.5 Hz, 1H), 3.04 (d, <i>J</i> = 4.5 Hz, 1H), 2.89 (dt, <i>J</i> = 11.0, 8.5 Hz, 1H), 2.58–2.53 (m, 1H), 2.31 (dd, <i>J</i> = 13.0, 4.5 Hz, 1H), 2.01–1.76 (m, 4H), 1.14 (d, <i>J</i> = 7.0 Hz, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ (ppm) 174.0, 172.3, 136.8, 133.8, 128.8 (2C), 128.1 (2C), 127.5, 125.5, 49.6, 47.1, 46.9, 46.1, 46.0, 41.6, 34.4, 34.2, 26.3, 24.4, 22.5; HRMS (ESI+) for C<sub>21</sub>H<sub>27</sub>N<sub>2</sub>O<sub>2</sub> (M+ H) calcd, 339.2067; found, 339.2062.</div></div><div id="sec6_22_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Benzyl ((3a<i>S</i>,4<i>R</i>,7a<i>R</i>)-4-((<i>S</i>)-2-Cyanopyrrolidine-1-carbonyl)-3-oxo-1,3,3a,4,5,7a-hexahydro-2<i>H</i>-isoindol-2-yl)carbamate (<b>7a</b>) and Benzyl ((3a<i>R</i>,4<i>S</i>,7a<i>S</i>)-4-((<i>S</i>)-2-Cyanopyrrolidine-1-carbonyl)-3-oxo-1,3,3a,4,5,7a-hexahydro-2<i>H</i>-isoindol-2-yl)carbamate (<b>16a</b>)</h3><div class="NLM_p last">Acid <b>13a</b> (189 mg, 0.572 mmol) was dissolved, under argon atmosphere, in DCM (4 mL). The solution was cooled to 0 °C, and TEA (400 μL, 2.86 mmol) was added followed by PivCl (70 μL, 0.572 mmol). After 1 h, a solution of (<i>S</i>)-cyano-pyrrolidine (184 mg, 0.686 mmol) and TEA (400 μL, 2.86 mmol) in DCM (2 mL) was added, and the solution was stirred overnight at room temperature. The reaction was quenched with H<sub>2</sub>O, extracted with EtOAc, and the organic phases washed with 1 M HCl, saturated NaHCO<sub>3</sub>, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was chromatographed on silica gel (Hex/EtOAc 2:8) to afford the products <b>7a</b> (20 mg) and <b>16a</b> (50 mg) as white solids (70 mg, 34%). IR (film) υ<sub>max</sub> (cm<sup>–1</sup>) 3269, 2980, 2956, 1742, 1714, 1651, 1431, 1312, 1232. <u class="uu">Data for <b>7a</b></u>: <i>R</i><sub><i>f</i></sub> = 0.42 (EtOAc); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ (ppm) 7.37–7.31 (m, 5H), 6.93 (brs, NH), 5.88 (d, <i>J = </i> 10.0 Hz, 1H), 5.72 (d, <i>J = </i> 10.0 Hz, 1H), 5.14 (brs, 2H), 4.67 (brs, 1H), 4.10–4.06 (m, 1H), 3.60–3.56 (m, 2H), 3.43–3.35 (m, 3H), 2.54–2.37 (m, 3H), 2.17–2.09 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ (ppm) 173.5, 172.8, 155.1, 135.5, 128.7 (3C), 128.6, 128.4, 127.2, 125.9, 118.7, 68.0, 52.6, 46.9, 46.6, 46.4, 33.2, 32.3, 30.1, 28.1, 25.3; HRMS (ESI+) for C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub>Na (M+ Na) calcd, 431.1690; found, 431.1678. <u class="uu">Data for <b>16a</b></u>: <i>R</i><sub><i>f</i></sub> = 0.46 (EtOAc); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.38–7.31 (m, 5H), 6.87 (brs, 0.4NH), 6.69 (brs, 0.6NH), 5.87–5.84 (m, 1H), 5.80–5.70 (m, 1.6H), 5.20–5.11 (m, 2H), 4.68–4.66 (m, 0.5H), 4.52–4.47 (m, 0.5H), 3.66–3.54 (m, 1.7H), 3.51–3.34 (m, 3H), 3.30–3.14 (m, 1.3H), 2.86 (d, <i>J</i> = 10.0 Hz, 0.3H), 2.59–2.38 (m, 3H), 2.33–2.01 (m, 4.5H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ (ppm) 172.6, 172.4, 155.1, 154.9, 135.6, 135.4, 128.8, 128.7, 128.6, 128.4, 128.1, 127.5, 125.6, 124.9, 119.5, 118.6, 68.2, 68.0, 52.8, 52.5, 47.8, 47.1, 46.7, 46.7, 46.6, 46.2, 34.2, 33.9, 32.5, 32.3, 30.1, 28.6, 28.5, 25.5, 23.2; HRMS (ESI+) for C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub>Na (M+ Na) calcd, 431.1690; found, 431.1684.</div></div><div id="sec6_22_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Benzyl ((3a<i>S</i>,4<i>R</i>,5<i>S</i>,7a<i>R</i>)-4-((<i>S</i>)-2-Cyanopyrrolidine-1-carbonyl)-5-methyl-3-oxo-1,3,3a,4,5,7a-hexahydro-2<i>H</i>-isoindol-2-yl)carbamate (<b>7b</b>) and Benzyl ((3a<i>R</i>,4<i>S</i>,5<i>R</i>,7a<i>S</i>)-4-((<i>S</i>)-2-cyanopyrrolidine-1-carbonyl)-5-methyl-3-oxo-1,3,3a,4,5,7a-hexahydro-2<i>H</i>-isoindol-2-yl)carbamate (<b>16b</b>)</h3><div class="NLM_p last">Acid <b>13b</b> (212 mg, 0.616 mmol) was dissolved, under argon atmosphere, in DMF (4.1 mL). The solution was cooled to 0 °C, and BOP (381 mg, 0.862 mmol) was added, followed by (<i>S</i>)-cyano-pyrrolidine (264 mg, 0.985 mmol) and TEA (429 μL, 3.078 mmol). The mixture was stirred for 15 h at room temperature. The reaction was quenched with H<sub>2</sub>O and extracted with EtOAc, and the organic layer was washed with 1 M HCl, saturated NaHCO<sub>3</sub>, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The crude product was chromatographed on silica gel (Hex/EtOAc 2:8) to afford the products <b>7b</b> (98 mg) and <b>16b</b> (68 mg) as white solids (166 mg, 64%). IR (film) υ<sub>max</sub> (cm<sup>–1</sup>) 3256, 2959, 2875, 1708, 1645, 1498, 1427, 1301, 1231. <u class="uu">Data for <b>7b</b></u>: <i>R</i><sub><i>f</i></sub> = 0.58 (EtOAc); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.38–7.31 (m, 5H), 6.73 (brs, NH), 5.86 (d, <i>J = </i> 9.6 Hz, 1H), 5.64–5.61 (m, 1H), 5.18–5.11 (m, 2H), 4.67 (brs, 1H), 4.12–4.06 (m, 1H), 3.65–3.55 (m, 2H), 3.48–3.36 (m, 2H), 2.95 (d, <i>J</i> = 4.4 Hz, 1H), 2.65–2.60 (m, 1H), 2.46–2.38 (m, 1H), 2.22–2.09 (m, 4H), 1.18 (d, <i>J</i> = 7.6 Hz, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ (ppm) 173.8, 172.7, 155.1, 135.5, 133.7, 128.7 (3C), 128.6, 128.5, 125.0, 118.7, 68.0, 52.5, 46.9, 46.6, 44.3, 41.2, 33.7, 32.5, 30.0, 25.3, 22.4; HRMS (ESI+) for C<sub>23</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub>Na (M+ Na) calcd, 445.1846; found, 445.1836. <u class="uu">Data for <b>16b</b></u>: <i>R</i><sub><i>f</i></sub> = 0.70 (EtOAc); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.37–7.33 (m, 5H), 6.85 (brs, 0.4NH), 6.66 (brs, 0.6NH), 5.84 (d, <i>J = </i> 10.0 Hz, 1H), 5.73 (dd, <i>J = </i> 7.6, 1.2 Hz, 0.5H), 5.70–5.61 (m, 1H), 5.21–5.11 (m, 2H), 4.67–4.65 (m, 0.5H), 4.50–4.46 (m, 0.5H), 3.66–3.14 (m, 5H), 3.12–3.03 (m, 1H), 2.70–2.67 (m, 0.5H), 2.59–2.53 (m, 1H), 2.33–2.02 (m, 4H), 1.22–1.13 (m, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ (ppm) 172.5, 172.4, 155.2, 154.9, 135.4, 134.5, 133.8, 128.8 (2C), 128.7 (2C), 128.4, 124.8, 124.2, 119.6, 118.5, 68.3, 68.1, 52.8, 52.5, 47.9, 46.7, 46.2, 42.0, 41.6, 34.1, 33.9, 32.6, 32.4, 32.2, 30.2, 25.5, 23.3, 22.1, 21.9; HRMS (ESI+) for C<sub>23</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub>Na (M+ Na) calcd, 445.1846; found, 445.1839.</div></div><div id="sec6_22_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i>-((3a<i>S</i>,4<i>R</i>,7a<i>R</i>)-4-((<i>S</i>)-2-Cyanopyrrolidine-1-carbonyl)-3-oxo-1,3,3a,4,5,7a-hexahydro-2<i>H</i>-isoindol-2-yl)-2-phenylacetamide (<b>7c</b>) and <i>N</i>-((3a<i>R</i>,4<i>S</i>,7a<i>S</i>)-4-((<i>S</i>)-2-Cyanopyrrolidine-1-carbonyl)-3-oxo-1,3,3a,4,5,7a-hexahydro-2<i>H</i>-isoindol-2-yl)-2-phenylacetamide (<b>16c</b>)</h3><div class="NLM_p last">The acid <b>13c</b> (700 mg, 2.23 mmol) was dissolved, under argon atmosphere, in DMF (15 mL). The solution was cooled to 0 °C, and BOP (1.38 g, 3.12 mmol) was added, followed by (<i>S</i>)-cyano-pyrrolidine (956 mg, 3.56 mmol) and TEA (1.5 mL, 11.13 mmol). The mixture was stirred 15 h at room temperature. The reaction was quenched with H<sub>2</sub>O, extracted with EtOAc, and the organic layer was washed with 1 M HCl, saturated NaHCO<sub>3</sub>, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The crude product was chromatographed on silica gel (Hex/EtOAc 2:8 to EtOAc/MeOH 8:2) to afford the products <b>7c</b> (70 mg) and <b>16c</b> (59 mg) as white solids (129 mg, 15%). IR (film) υ<sub>max</sub> (cm<sup>–1</sup>) 3271, 3027, 2926, 1727, 1680, 1649, 1428, 1345, 1188. <u class="uu">Data for <b>7c</b></u>: <i>R</i><sub><i>f</i></sub> = 0.15 (AcOEt); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ (ppm) 7.37–7.29 (m, 5H), 5.88 (dd, <i>J = </i> 9.6, 1.2 Hz, 1H), 5.73–5.69 (m, 1H), 4.68–4.65 (m, 1H), 4.06–4.00 (m, 1H), 3.64–3.59 (m, 3H), 3.49–3.32 (m, 4H), 2.57–2.49 (m, 2H), 2.38 (d, <i>J</i> = 18.0 Hz, 1H), 2.23–2.08 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ (ppm) 173.1, 172.9, 169.7, 133.6, 129.5 (2C), 129.2 (2C), 127.8, 127.1, 126.0, 118.7, 52.5, 46.9, 46.5, 46.2, 41.7, 33.2, 32.4, 30.1, 28.0, 25.4; HRMS (ESI+) for C<sub>22</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub> (M + H) calcd, 393.1921; found, 393.1924. <u class="uu">Data for <b>16c</b></u>: <i>R</i><sub><i>f</i></sub> = 0.25 (EtOAc); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ (ppm) 8.04 (brs, 0.5NH), 7.66 (brs, 0.5NH), 7.35–7.28 (m, 5H), 5.83 (td, <i>J</i> = 11.0, 1.0 Hz, 1H), 5.76–5.73 (m, 1H), 5.70–5.67 (m, 0.5H), 4.63 (d, <i>J</i> = 5.5 Hz, 0.5H), 4.38 (t, <i>J</i> = 7.0 Hz, 0.5H), 3.60–3.56 (m, 2.5H), 3.51–3.32 (m, 4H), 3.28–3.22 (m, 0.5H), 3.16–3.10 (m, 0.5H), 2.60 (td, <i>J</i> = 13.0, 5.0 Hz, 1H), 2.50–2.42 (m, 1H), 2.33–2.00 (m, 5H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ (ppm) 173.4, 172.9 (2C), 172.5, 169.9, 169.6, 133.9, 133.7, 129.5 (2C), 129.4 (2C), 129.1 (2C), 129.0 (2C), 127.9, 127.6, 127.5, 127.1, 125.8, 125.0, 119.4, 118.7, 52.6, 52.3, 47.7, 47.0, 46.7, 46.6, 46.3, 46.1, 41.4, 41.2, 34.1, 33.7, 32.5, 32.4, 32.2, 30.1, 28.5, 28.3, 25.4, 23.1; HRMS (ESI+) for C<sub>22</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub> (M + H) calcd, 393.1921; found, 393.1934.</div></div><div id="sec6_22_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>S</i>)-1-((3a<i>S</i>,4<i>R</i>,7a<i>R</i>)-2-(Benzyloxy)-3-oxo-2,3,3a,4,5,7a-hexahydro-1<i>H</i>-isoindole-4-carbonyl)pyrrolidine-2-carbonitrile (<b>7d</b>) and (<i>S</i>)-1-((3a<i>R</i>,4<i>S</i>,7a<i>S</i>)-2-(Benzyloxy)-3-oxo-2,3,3a,4,5,7a-hexahydro-1<i>H</i>-isoindole-4-carbonyl)pyrrolidine-2-carbonitrile (<b>16d</b>)</h3><div class="NLM_p last">Acid <b>13d</b> (215 mg, 0.748 mmol) was dissolved, under argon atmosphere, in DMF (5 mL). The solution was cooled to 0 °C, and BOP (463 mg, 1.047 mmol) was added, followed by (<i>S</i>)-cyano-pyrrolidine (321 mg, 1.197 mmol) and TEA (521 μL, 3.741 mmol). The mixture was stirred for 15 h at room temperature. The reaction was quenched with H<sub>2</sub>O, extracted with EtOAc, and the organic layer was washed with 1 M HCl, saturated NaHCO<sub>3</sub>, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The crude product was chromatographed on silica gel (Hex/EtOAc 2:8) to afford the products <b>7d</b> (100 mg) and <b>16d</b> (80 mg) as white solids (180 mg, 66%). IR (film) υ<sub>max</sub> (cm<sup>–1</sup>) 2926, 2880, 2238, 1708, 1648. <u class="uu">Data for <b>7d</b></u>: <i>R</i><sub><i>f</i></sub> = 0.25 (AcOEt); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.42–7.36 (m, 5H), 5.78 (dd, <i>J</i> = 10.0, 2.0 Hz, 1H), 5.71–5.66 (m, 1H), 4.98–4.89 (m, 2H), 4.71–4.68 (m, 1H), 4.19–4.13 (m, 1H), 3.65–3.59 (m, 1H), 3.41 (t, <i>J</i> = 7.2 Hz, 1H), 3.36–3.33 (m, 1H), 3.31–3.23 (m, 1H), 3.01 (dd, <i>J</i> = 10.8, 7.2 Hz, 1H), 2.52–2.36 (m, 2H), 2.27–2.09 (m, 5H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ (ppm) 172.7, 169.7, 135.3, 129.7 (2C), 129.0, 128.7 (2C), 127.3, 125.6, 118.7, 77.4, 51.2, 46.9, 46.6, 46.1, 33.2, 31.5, 30.1, 28.2, 25.3; HRMS (ESI+) for C<sub>21</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>Na (M + Na) calcd, 388.1630; found, 388.1641. <u class="uu">Data for <b>16d</b></u>: <i>R</i><sub><i>f</i></sub> = 0.33 (Hex/EtOAc 2:8); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.45–7.34 (m, 5H), 5.88 (d, <i>J</i> = 6.8 Hz, 0.5H), 5.76–5.67 (m, 2H), 5.00–4.87 (m, 2H), 4.74 (dd, <i>J</i> = 7.2, 2.0 Hz, 0.5H), 4.62 (td, <i>J</i> = 8.8, 2.0 Hz, 0.5H), 3.68–3.62 (m, 0.5H), 3.48–3.34 (m, 2.5H), 3.19–3.13 (m, 0.5H), 3.05–2.97 (m, 2H), 2.46–2.03 (m, 7H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ (ppm) 172.6, 172.3, 169.7, 169.5, 135.5, 135.1, 129.9 (2C), 129.7 (2C), 129.1, 129.0, 128.8 (2C), 128.7 (2C), 128.0, 127.5, 125.4, 124.7, 119.6, 118.6, 77.9, 51.4, 51.1, 47.7, 47.2, 46.7, 46.5, 46.4, 46.1, 34.3, 34.1, 32.3, 31.8, 31.1, 30.2, 28.6, 28.6, 25.6, 23.1; HRMS (ESI+) for C<sub>21</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>Na (M + Na) calcd, 388.1632; found, 388.1634.</div></div><div id="sec6_22_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>S</i>)-1-((3a<i>S</i>,4<i>R</i>,7a<i>R</i>)-2-Benzyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1<i>H</i>-isoindole-4-carbonyl)pyrrolidine-2-carbonitrile (<b>7e</b>) and (<i>S</i>)-1-((3a<i>R</i>,4<i>S</i>,7a<i>S</i>)-2-Benzyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1<i>H</i>-isoindole-4-carbonyl)pyrrolidine-2-carbonitrile (<b>16e</b>)</h3><div class="NLM_p last">Acid <b>13e</b> (158 mg, 0.582 mmol) was dissolved, under argon atmosphere, in DMF (6 mL). The solution was cooled to 0 °C, and BOP (360 mg, 0.815 mmol) was added, followed by (<i>S</i>)-cyano-pyrrolidine (250 mg, 0.932 mmol) and TEA (406 μL, 2.910 mmol). The mixture was stirred 15 h at room temperature. The reaction was quenched with H<sub>2</sub>O and extracted with EtOAc, and the organic layer was washed with 1 M HCl, saturated NaHCO<sub>3</sub>, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The crude product was chromatographed on silica gel with eluent (Hex/EtOAc 3:7) to afford the products <b>7e</b> (43 mg) and <b>16e</b> (20 mg) as white solids (63 mg, 31%). IR (film) υ<sub>max</sub> (cm-1) 3476, 2968, 2043, 1689, 1632. <u class="uu">Data for <b>7e</b></u>: <i>R</i><sub><i>f</i></sub> = 0.28 (AcOEt); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ (ppm) 7.36–7.28 (m, 3H), 7.22–7.20 (m, 2H), 5.89–5.86 (m, 1H), 5.74–5.70 (m, 1H), 4.79–4.77 (m, 1H), 4.60 (d, <i>J = </i> 14.5 Hz, 1H), 4.31–4.25 (m, 2H), 3.71–3.67 (m, 1H), 3.47–3.39 (m, 2H), 3.35 (dd, <i>J</i> = 9.0, 7.5 Hz, 1H), 2.97 (dd, <i>J</i> = 11.0, 8.5 Hz, 1H), 2.56–2.49 (m, 1H), 2.46–2.44 (m, 1H), 2.40 (dd, <i>J</i> = 12.5, 4.5 Hz, 1H), 2.29–2.16 (m, 4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ (ppm) 173.5, 173.2, 136.6, 128.9 (2C), 128.0 (2C), 127.7, 127.3, 126.3, 118.8, 49.8, 48.3, 47.0, 46.9, 46.6, 34.1, 33.6, 30.2, 28.6, 25.4; HRMS (ESI+) for C<sub>21</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub>Na (M + Na) calcd, 372.1682; found, 372.1681. <u class="uu">Data for <b>16e</b></u>: <i>R</i><sub><i>f</i></sub> = 0.44 (Hex/EtOAc 2:8); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.33–7.24 (m, 3H), 7.20–7.14 (m, 2H), 6.07 (dd, <i>J</i> = 7.2, 1.6 Hz, 0.5H), 5.84–5.80 (m, 1H), 5.76–5.67 (m, 1H), 4.77–4.71 (m, 0.5H), 4.55 (dd, <i>J = </i> 15.2, 6.4 Hz, 1H), 4.35 (d, <i>J</i> = 15.2 Hz, 0.5H), 4.24 (d, <i>J</i> = 14.8 Hz, 0.5H), 3.70–3.64 (m, 0.5H), 3.55–3.52 (m, 0.5H), 3.49–3.40 (m, 2H), 3.35–3.30 (m, 1H), 3.23–3.08 (m, 1H), 3.00–2.92 (m, 1H), 2.50–2.47 (m, 2H), 2.40–2.22 (m, 3H), 2.18–2.05 (m, 2H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ (ppm) 173.6, 172.9, 172.8, 136.5, 136.4, 129.0, 128.9 (2C), 128.1, 128.0 (2C), 127.9, 127.8, 127.7, 127.6, 126.1, 125.4, 119.7, 118.6, 49.9, 49.4, 48.6, 48.6, 47.8, 47.2, 47.0, 46.8, 46.7, 46.2, 34.8, 34.5, 34.3, 34.2, 32.3, 30.2, 29.2, 29.0, 25.6, 23.2; HRMS (ESI+) for C<sub>21</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub>Na (M + Na) calcd, 372.1682; found, 372.1692.</div></div><div id="sec6_22_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (<i>S</i>)-1-((3a<i>S</i>,4<i>R</i>,5<i>S</i>,7a<i>R</i>)-2-Benzyl-5-methyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1<i>H</i>-isoindole-4-carbonyl)pyrrolidine-2-carbonitrile (<b>7f</b>) and (<i>S</i>)-1-((3a<i>R</i>,4<i>S</i>,5<i>R</i>,7a<i>S</i>)-2-Benzyl-5-methyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1<i>H</i>-isoindole-4-carbonyl)pyrrolidine-2-carbonitrile (<b>16f</b>)</h3><div class="NLM_p last">Acid <b>13f</b> (300 mg, 1.051 mmol) was dissolved, under argon atmosphere, in DMF (7 mL). The solution was cooled to 0 °C, and BOP (651 mg, 1.471 mmol) was added, followed by (<i>S</i>)-cyano-pyrrolidine (451 mg, 1.680 mmol) and TEA (733 μL, 5.256 mmol). The mixture was stirred 15 h at room temperature. The reaction was quenched with H<sub>2</sub>O, extracted with EtOAc, and the organic layer was washed with 1 M HCl, saturated NaHCO<sub>3</sub>, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The crude product was chromatographed on silica gel (Hex/EtOAc 4:6) to afford the products <b>7f</b> (120 mg) and <b>16f</b> (159 mg) as white solids (279 mg, 73%). IR (film) υ<sub>max</sub> (cm<sup>–1</sup>) 3027, 2960, 2873, 1690, 1647, 1425, 1351. <u class="uu">Data for <b>7f</b></u>: <i>R</i><sub><i>f</i></sub> = 0.54 (AcOEt); <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.34–7.27 (m, 3H), 7.19–7.17 (m, 2H), 5.82 (dt, <i>J</i> = 10.0, 2.0 Hz, 1H), 5.59 (dt, <i>J</i> = 10.0, 2.8 Hz, 1H), 4.76–4.74 (m, 1H), 4.59 (d, <i>J</i> = 14.8 Hz, 1H), 4.27–4.20 (m, 2H), 3.69–3.65 (m, 1H), 3.43–3.30 (m, 2H), 2.99 (d, <i>J</i> = 4.8 Hz, 1H), 2.93 (dd, <i>J</i> = 10.8, 8.8 Hz, 1H), 2.67–2.59 (m, 1H), 2.34 (dd, <i>J</i> = 12.4, 4.8 Hz, 1H), 2.27–2.14 (m, 4H), 1.18 (d, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ (ppm) 173.7, 173.1, 136.6, 133.7, 128.9 (2C), 128.0 (2C), 127.7, 125.4, 118.9, 49.7, 47.0, 47.0, 46.6, 46.1, 41.5, 34.3, 34.1, 30.2, 25.4, 22.5; HRMS (ESI+) for C<sub>22</sub>H<sub>26</sub>N<sub>3</sub>O<sub>2</sub> (M + H) calcd, 364.2019; found, 364.2015. <u class="uu">Data for <b>16f</b></u>: <i>R</i><sub><i>f</i></sub> = 0.63 (EtOAc); <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ (ppm) 7.33–7.25 (m, 3H), 7.20–7.15 (m, 2H), 5.99 (dd, <i>J</i> = 7.5, 1.5 Hz, 0.6H), 5.79 (dt, <i>J</i> = 10.0, 2.0 Hz, 1H), 5.65–5.59 (m, 1H), 4.73–4.70 (m, 0.6H), 4.58 (d, <i>J</i> = 15.0 Hz, 0.6H), 4.52 (d, <i>J</i> = 15.0 Hz, 0.4H), 4.36 (d, <i>J</i> = 15.0 Hz, 0.4H), 4.22 (d, <i>J</i> = 15.0 Hz, 0.6H), 3.68–3.64 (m, 0.6H), 3.49–3.39 (m, 1H), 3.34–3.30 (m, 1H), 3.20–3.07 (m, 2H), 2.98–2.92 (m, 1H), 2.71–2.66 (m, 0.6H), 2.61–2.57 (m, 0.4H), 2.43 (dd, <i>J</i> = 13.0, 5.0 Hz, 1H), 2.37–2.25 (m, 2H), 2.18–2.05 (m, 2H), 1.20 (d, <i>J</i> = 7.5 Hz, 1.6H), 1.16–1.08 (m, 1.4H); <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ (ppm) 173.9, 173.2, 172.8, 136.5, 136.4, 134.4, 133.8, 128.9 (2C), 128.9 (2C), 128.0 (2C), 128.0 (2C), 127.9, 119.9, 118.6, 49.8, 49.3, 47.9, 47.2, 47.1, 46.8, 46.7, 46.4, 46.2, 45.9, 42.5, 42.1, 34.5, 34.4, 34.4, 34.3, 32.3, 30.2, 25.6, 23.3, 22.1, 22.0; HRMS (ESI+) for C<sub>22</sub>H<sub>25</sub>N<sub>3</sub>O<sub>2</sub>Na (M + Na) calcd, 386.1839; found, 386.1822.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01296">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47827" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47827" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01296" class="ext-link">10.1021/acs.jmedchem.5b01296</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental details (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01296/suppl_file/jm5b01296_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Crystallographic data (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01296/suppl_file/jm5b01296_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01296/suppl_file/jm5b01296_si_001.pdf">jm5b01296_si_001.pdf (6.28 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01296/suppl_file/jm5b01296_si_002.csv">jm5b01296_si_002.csv (2.35 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01296" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01608" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01608" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicolas Moitessier</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montréal, Québec H3A 0B8, Canada</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f19f98929e9d9082df9c9e9885948282989483b19c9296989d9ddf9290"><span class="__cf_email__" data-cfemail="147a7d777b7875673a797b7d607167677d7166547977737d78783a7775">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gaëlle Mariaule</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montréal, Québec H3A 0B8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stéphane De Cesco</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montréal, Québec H3A 0B8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesco Airaghi</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montréal, Québec H3A 0B8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jerry Kurian</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montréal, Québec H3A 0B8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paolo Schiavini</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montréal, Québec H3A 0B8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylvain Rocheleau</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montréal, Québec H3A 0B8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Igor Huskić</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montréal, Québec H3A 0B8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karine Auclair</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montréal, Québec H3A 0B8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony Mittermaier</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montréal, Québec H3A 0B8, Canada</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d717e5278-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30328" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30328" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank CIHR for funding (operating grant). S.D.C. thanks FQRNT for a scholarship. Natural Sciences and Engineering Research Council of Canada (NSERC) for a grant to K.A., and the FRQNT Center in Green Chemistry and Catalysis (CGCC) at McGill University (Canada).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i62" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i62"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i63" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i63"> Abbreviations Used</h2><tr><td class="NLM_term">BOP</td><td class="NLM_def"><p class="first last">benzotriazol-1-yl-oxy-tris(dimethylamino)-phosphoniumhexafluorophosphate</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">Piv</td><td class="NLM_def"><p class="first last">pivaloyl</p></td></tr><tr><td class="NLM_term">POP</td><td class="NLM_def"><p class="first last">prolyl oligopeptidase</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">trimethylamine</p></td></tr><tr><td class="NLM_term">TFAA</td><td class="NLM_def"><p class="first last">trifluoroacetic anhydride</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72641" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72641" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 45 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lawandi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber-Lemaire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Inhibitors of prolyl oligopeptidases for the therapy of human diseases: Defining diseases and inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3423</span><span class="NLM_x">–</span> <span class="NLM_lpage">3438</span><span class="refDoi"> DOI: 10.1021/jm901104g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901104g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFOmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3423-3438&author=J.+Lawandiauthor=S.+Gerber-Lemaireauthor=L.+Juillerat-Jeanneretauthor=N.+Moitessier&title=Inhibitors+of+prolyl+oligopeptidases+for+the+therapy+of+human+diseases%3A+Defining+diseases+and+inhibitors&doi=10.1021%2Fjm901104g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Prolyl Oligopeptidases for the Therapy of Human Diseases: Defining Diseases and Inhibitors</span></div><div class="casAuthors">Lawandi, Janice; Gerber-Lemaire, Sandrine; Juillerat-Jeanneret, Lucienne; Moitessier, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3423-3438</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Over the past 2 decades, researchers have linked abnormal mammalian prolyl oligopeptidase (POP) activity to neurol. disorders.  To better understand and treat these different diseases and to minimize toxicity and side effects, inhibitors of POP must be potent and also selective for the target enzyme.  Given the many seemingly similar enzymes grouped under proline-specific proteases, we aim to first highlight the similarities and differences between a few of the enzymes of this family.  In a subsequent part of this Perspective, we will focus on one proline-specific peptidase, POP, and discuss the structure-activity relationship of inhibitors developed as potential therapeutic drugs treating neurol. disorders.  Furthermore, we will discuss two possible pharmacophores, one encompassing features to achieve selectivity for POP over other proline-specific proteases and another one ranking features to improve inhibitor potency.  We believe that the data collected within this review will guide the future development of novel, selective POP inhibitors as more effective candidate drugs (CDs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPbicA2SUUkrVg90H21EOLACvtfcHk0lhUMBRrNrFDpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFOmuw%253D%253D&md5=433f511b0177657def61ec228d9a2517</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm901104g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901104g%26sid%3Dliteratum%253Aachs%26aulast%3DLawandi%26aufirst%3DJ.%26aulast%3DGerber-Lemaire%26aufirst%3DS.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DInhibitors%2520of%2520prolyl%2520oligopeptidases%2520for%2520the%2520therapy%2520of%2520human%2520diseases%253A%2520Defining%2520diseases%2520and%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3423%26epage%3D3438%26doi%3D10.1021%2Fjm901104g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lambeir, A. M.</span><span> </span><span class="NLM_article-title">Translational research on prolyl oligopeptidase inhibitors: The long road ahead</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span><span class="refDoi"> DOI: 10.1517/13543776.2011.587803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1517%2F13543776.2011.587803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=21679099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns12msL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=977-981&author=A.+M.+Lambeir&title=Translational+research+on+prolyl+oligopeptidase+inhibitors%3A+The+long+road+ahead&doi=10.1517%2F13543776.2011.587803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Translational research on prolyl oligopeptidase inhibitors: the long road ahead</span></div><div class="casAuthors">Lambeir, Anne-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">977-981</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Despite the fact that some have passed early phases of clin. trials, no prolyl oligopeptidase inhibitors are currently on the market.  Yet, since 2003, there has been a boost in patent applications claiming prolyl oligopeptidase inhibitors for the treatment of Alzheimer's and Parkinson's diseases, and other neurodegenerative and psychiatric disorders.  While experts in the field call for innovative scaffolds to develop more potent inhibitors with more favorable properties, they also relate a lack of knowledge of the toxicol., bioavailability, pharmacokinetics and pharmacodynamics of existing compds. that hinders their assessment.  Yet, with the current insights, it is difficult to correlate specific inhibitor effects with the postulated functions of prolyl oligopeptidase in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRSBH4ms2c2LVg90H21EOLACvtfcHk0lgn57PFSivgGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns12msL0%253D&md5=f88cc200387e4cb4a590d6c2c600626e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.587803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.587803%26sid%3Dliteratum%253Aachs%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26atitle%3DTranslational%2520research%2520on%2520prolyl%2520oligopeptidase%2520inhibitors%253A%2520The%2520long%2520road%2520ahead%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D977%26epage%3D981%26doi%3D10.1517%2F13543776.2011.587803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">López, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarragó, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giralt, E.</span><span> </span><span class="NLM_article-title">Low molecular weight inhibitors of Prolyl Oligopeptidase: A review of compounds patented from 2003 to 2010</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1023</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span><span class="refDoi"> DOI: 10.1517/13543776.2011.577416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1517%2F13543776.2011.577416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=21539473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A280%3ADC%252BC3Mnht1SmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1023-1044&author=A.+L%C3%B3pezauthor=T.+Tarrag%C3%B3author=E.+Giralt&title=Low+molecular+weight+inhibitors+of+Prolyl+Oligopeptidase%3A+A+review+of+compounds+patented+from+2003+to+2010&doi=10.1517%2F13543776.2011.577416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Low molecular weight inhibitors of Prolyl Oligopeptidase: a review of compounds patented from 2003 to 2010</span></div><div class="casAuthors">Lopez Abraham; Tarrago Teresa; Giralt Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Expert opinion on therapeutic patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1023-44</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Prolyl Oligopeptidase (POP) is a serine peptidase that cleaves post-proline bonds in short peptides.  Besides the direct hydrolytic regulation function over peptides, neuropeptides and peptide hormones, POP is probably involved in the regulation of the inositol pathway and participates in protein-protein interactions.  Experimental data show that POP inhibitors have neuroprotective, anti-amnesic and cognition-enhancing properties.  These compounds are considered therapeutic agents of interest for the treatment of cognitive deficits related to neuropsychiatric and neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.  Recent findings pointed to the involvement of POP in angiogenesis, although the exact mechanism is still under study.  AREAS COVERED:  This review comprises patents and patent applications involving POP inhibitors patented between 2003 and 2010, classified as peptidomimetics, heteroaryl ketones and alkaloids.  The binding processes and the mechanisms of inhibition of these inhibitors are also discussed, together with their in vivo effects.  EXPERT OPINION:  The major part of the repertory of POP inhibitors derived from systematical modification of the canonical compound benzyloxycarbonyl-prolyl-prolinal (ZPP).  Nevertheless, only two of them have progressed into the clinical trials.  One possible reason for this failure is the lack of studies concerning pharmacodynamics, pharmacokinetics and toxicity, together with the absence of suitable animal models.  Moreover, POP is still not a well-defined therapeutic target.  Further studies are required for the elucidation of the biological role of POP and to validate the therapeutic action of inhibitors in cognitive processes.  In contrast, the involvement of POP in protein-protein interactions together with the recent evidences in angiogenesis opens alternative approaches to the traditional active site-directed inhibitors, as well as new therapeutic applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQx4uguBhbB49hSDZx9hyjKfW6udTcc2ebUxcxwrnyvVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mnht1SmtQ%253D%253D&md5=83b58a36c971774516e7635ac1fae5dc</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.577416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.577416%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez%26aufirst%3DA.%26aulast%3DTarrag%25C3%25B3%26aufirst%3DT.%26aulast%3DGiralt%26aufirst%3DE.%26atitle%3DLow%2520molecular%2520weight%2520inhibitors%2520of%2520Prolyl%2520Oligopeptidase%253A%2520A%2520review%2520of%2520compounds%2520patented%2520from%25202003%2520to%25202010%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D1023%26epage%3D1044%26doi%3D10.1517%2F13543776.2011.577416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Cunningham, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, B.</span><span> </span><span class="NLM_article-title">Identification and initial characterisation of a N-benzyloxycarbonyl-prolyl-prolinal (Z-Pro-prolinal)-insensitive 7-(N-benzyloxycarbonyl-glycyl-prolyl-amido)-4- methylcoumarin (Z-Gly-Bro-NH-Mec)-hydrolysing peptidase in bovine serum</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">900</span><span class="NLM_x">–</span> <span class="NLM_lpage">903</span><span class="refDoi"> DOI: 10.1111/j.1432-1033.1997.00900.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1111%2Fj.1432-1033.1997.00900.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=9108263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADyaK2sXisVert7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1997&pages=900-903&author=D.+F.+Cunninghamauthor=B.+O%E2%80%99Connor&title=Identification+and+initial+characterisation+of+a+N-benzyloxycarbonyl-prolyl-prolinal+%28Z-Pro-prolinal%29-insensitive+7-%28N-benzyloxycarbonyl-glycyl-prolyl-amido%29-4-+methylcoumarin+%28Z-Gly-Bro-NH-Mec%29-hydrolysing+peptidase+in+bovine+serum&doi=10.1111%2Fj.1432-1033.1997.00900.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and initial characterization of a N-benzyloxycarbonyl-prolyl-prolinal (Z-Pro-prolinal)-insensitive 7-(N-benzyloxycarbonyl-glycyl-prolyl-amido)-4-methylcoumarin (Z-Gly-Pro-NH-Mec)-hydrolyzing peptidase in bovine serum</span></div><div class="casAuthors">Cunningham, Damian F.; O'Connor, Brendan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">900-903</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Prolyl endopeptidase is an enzyme, which cleaves on the carboxyl side of Pro within peptide substrates.  Its broad specificity towards bioactive peptides has led to its implication in various disease states including neurodegenerative and psychiatric disorders.  This assocn. was based primarily on the abnormal levels of activity obsd. following the enzymes detection with the reportedly specific fluorimetric substrate, 7-(N-benzyloxycarbonyl-glycyl-prolyl-amido)-4-methylcoumarin (2-Gly-Pro-NH-Mec).  The discovery and preliminary characterization of a Z-Gly-Pro-NH-Mec-hydrolyzing activity was reported that is distinct from prolyl oligopeptidase (prolyl endopeptidase).  Following the prodn. of serum from bovine whole blood, Z-Gly-Pro-NH-Mec hydrolysis in serum was detd. to be 7.2 U/mg protein.  In the presence of 350 nM Z-Pro-prolinal, a specific inhibitor of prolyl endopeptidase, residual Z-Gly-Pro-NH-Mec hydrolysis of 2.6 U/mg protein was obsd.  This residual activity was resistant to inhibition by Z-Pro-prolinal at concns. in excess of 200 times its reported Ki value for prolyl endopeptidase and could not be inhibited under conditions of prolonged incubation with the inhibitor.  Following cation-exchange chromatog., Z-Gly-Pro-NH-Mec-hydrolyzing activity was resolved into 2 distinct entities.  The first was inhibited by Z-Pro-prolinal, demonstrated activity towards the thyroliberin analog, 7-(pyroglutamyl-histidyl-prolyl)-4-methylcoumarin (Glp-His-Pro-NH-Mec), and was catalytically enhanced under reduced assay conditions.  This activity was subsequently designated prolyl endopeptidase.  The second activity was totally resistant to Z-Pro-prolinal inhibition, demonstrated no activity towards Glp-His-Pro-NH-Mec, and was unaffected when assayed under reduced conditions.  It was subsequently designated Z-Pro-prolinal-insensitive Z-Gly-Pro-NH-Mec-hydrolyzing peptidase (ZIP).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPJed2zfz-y7Vg90H21EOLACvtfcHk0lgn57PFSivgGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisVert7w%253D&md5=5b2ef7ead8e3fad351eaffcaed99d319</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1997.00900.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1997.00900.x%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DD.%2BF.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DB.%26atitle%3DIdentification%2520and%2520initial%2520characterisation%2520of%2520a%2520N-benzyloxycarbonyl-prolyl-prolinal%2520%2528Z-Pro-prolinal%2529-insensitive%25207-%2528N-benzyloxycarbonyl-glycyl-prolyl-amido%2529-4-%2520methylcoumarin%2520%2528Z-Gly-Bro-NH-Mec%2529-hydrolysing%2520peptidase%2520in%2520bovine%2520serum%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1997%26volume%3D244%26spage%3D900%26epage%3D903%26doi%3D10.1111%2Fj.1432-1033.1997.00900.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Toide, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinoda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uemura, A.</span><span> </span><span class="NLM_article-title">A novel propyl endopeptidase inhibitor, JTP-4819, with potential for treating Alzheimer’s disease</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1016/S0166-4328(97)86059-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2FS0166-4328%2897%2986059-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1997&pages=147-151&author=K.+Toideauthor=M.+Shinodaauthor=Y.+Iwamotoauthor=T.+Fujiwaraauthor=K.+Okamiyaauthor=A.+Uemura&title=A+novel+propyl+endopeptidase+inhibitor%2C+JTP-4819%2C+with+potential+for+treating+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0166-4328%2897%2986059-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0166-4328%2897%2986059-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-4328%252897%252986059-7%26sid%3Dliteratum%253Aachs%26aulast%3DToide%26aufirst%3DK.%26aulast%3DShinoda%26aufirst%3DM.%26aulast%3DIwamoto%26aufirst%3DY.%26aulast%3DFujiwara%26aufirst%3DT.%26aulast%3DOkamiya%26aufirst%3DK.%26aulast%3DUemura%26aufirst%3DA.%26atitle%3DA%2520novel%2520propyl%2520endopeptidase%2520inhibitor%252C%2520JTP-4819%252C%2520with%2520potential%2520for%2520treating%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D1997%26volume%3D83%26spage%3D147%26epage%3D151%26doi%3D10.1016%2FS0166-4328%2897%2986059-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Jarho, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venäläinen, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huuskonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiaans, J. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Horsman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallén, E. A. A.</span><span> </span><span class="NLM_article-title">A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5605</span><span class="NLM_x">–</span> <span class="NLM_lpage">5607</span><span class="refDoi"> DOI: 10.1021/jm049503w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049503w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotVShs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5605-5607&author=E.+M.+Jarhoauthor=J.+I.+Ven%C3%A4l%C3%A4inenauthor=J.+Huuskonenauthor=J.+A.+M.+Christiaansauthor=J.+A.+Garcia-Horsmanauthor=M.+M.+Forsbergauthor=T.+Jarvinenauthor=J.+Gyntherauthor=P.+T.+M%C3%A4nnist%C3%B6author=E.+A.+A.+Wall%C3%A9n&title=A+cyclopent-2-enecarbonyl+group+mimics+proline+at+the+P2+position+of+prolyl+oligopeptidase+inhibitors&doi=10.1021%2Fjm049503w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A Cyclopent-2-enecarbonyl Group Mimics Proline at the P2 Position of Prolyl Oligopeptidase Inhibitors</span></div><div class="casAuthors">Jarho, Elina M.; Venaelaeinen, Jarkko I.; Huuskonen, Juhani; Christiaans, Johannes A. M.; Forsberg, Markus M.; Jaervinen, Tomi; Gynther, Jukka; Maennistoe, Pekka T.; Wallen, Erik A. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5605-5607</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">With the aim to replace the natural amino acid proline by a proline mimetic structure, a cyclopent-2-enecarbonyl moiety was studied at the P2 position of prolyl oligopeptidase (POP) inhibitors.  The cyclopent-2-enecarbonyl moiety proved to be an excellent proline mimetic at the P2 position of POP inhibitors.  The replacement is particularly useful when increased lipophilicity is needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqRoDNZvMpULVg90H21EOLACvtfcHk0liHUsM1V-YBxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotVShs74%253D&md5=31b6a16d9ee708b2e298a4658feff356</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm049503w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049503w%26sid%3Dliteratum%253Aachs%26aulast%3DJarho%26aufirst%3DE.%2BM.%26aulast%3DVen%25C3%25A4l%25C3%25A4inen%26aufirst%3DJ.%2BI.%26aulast%3DHuuskonen%26aufirst%3DJ.%26aulast%3DChristiaans%26aufirst%3DJ.%2BA.%2BM.%26aulast%3DGarcia-Horsman%26aufirst%3DJ.%2BA.%26aulast%3DForsberg%26aufirst%3DM.%2BM.%26aulast%3DJarvinen%26aufirst%3DT.%26aulast%3DGynther%26aufirst%3DJ.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DWall%25C3%25A9n%26aufirst%3DE.%2BA.%2BA.%26atitle%3DA%2520cyclopent-2-enecarbonyl%2520group%2520mimics%2520proline%2520at%2520the%2520P2%2520position%2520of%2520prolyl%2520oligopeptidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5605%26epage%3D5607%26doi%3D10.1021%2Fjm049503w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Jalkanen, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakkarainen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venäläinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kääriäinen, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarho, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, M. M.</span><span> </span><span class="NLM_article-title">Brain pharmacokinetics of two prolyl oligopeptidase inhibitors, JTP-4819 and KYP-2047, in the rat</span> <span class="citation_source-journal">Basic Clin. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span><span class="refDoi"> DOI: 10.1111/j.1742-7843.2011.00747.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1111%2Fj.1742-7843.2011.00747.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=21707925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Sqt7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2011&pages=443-451&author=A.+J.+Jalkanenauthor=J.+J.+Hakkarainenauthor=M.+Lehtonenauthor=T.+Ven%C3%A4l%C3%A4inenauthor=T.+M.+K%C3%A4%C3%A4ri%C3%A4inenauthor=E.+Jarhoauthor=M.+Suhonenauthor=M.+M.+Forsberg&title=Brain+pharmacokinetics+of+two+prolyl+oligopeptidase+inhibitors%2C+JTP-4819+and+KYP-2047%2C+in+the+rat&doi=10.1111%2Fj.1742-7843.2011.00747.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Brain pharmacokinetics of two prolyl oligopeptidase inhibitors, JTP-4819 and KYP-2047, in the rat</span></div><div class="casAuthors">Jalkanen, Aaro J.; Hakkarainen, Jenni J.; Lehtonen, Marko; Venalainen, Tetta; Kaariainen, Tiina M.; Jarho, Elina; Suhonen, Marjukka; Forsberg, Markus M.</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">443-451</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Prolyl oligopeptidase (PREP) inhibitors are potential drug candidates for the treatment of neurol. disorders, but little is known about their ability to cross the blood-brain barrier and to reach the target site.  This study characterizes brain pharmacokinetics of two potent PREP inhibitors, JTP-4819 and KYP-2047.  Firstly, the in vitro permeability (Papp) of JTP-4819 and KYP-2047 through a bovine brain microvessel endothelial cell monolayer was assessed.  Then, the in vivo brain/blood ratio was detd. for the total brain and plasma concns. and also for the unbound extracellular drug concns. after a single dose (50 μmol/kg i.p.).  KYP-2047 had a significantly higher Papp than JTP-4819.  In vivo, KYP-2047 had higher total and unbound brain/blood ratios.  KYP-2047 was equally distributed between the cortex, hippocampus and striatum.  In the case of JTP-4819, the unbound brain extracellular concns. could not be readily predicted from the unbound blood levels, probably because of its poor membrane penetration properties.  KYP-2047 displayed a better ability to reach the intracellularly located brain PREP, and it inhibited this enzyme more effectively than JTP-4819 after an equimolar single dose.  In conclusion, KYP-2047 showed better brain penetration characteristics than JTP-4819 both in vitro and in vivo.  KYP-2047 is a brain-penetrating, potent and long-acting PREP inhibitor; thus, it represents a convenient pharmacol. tool for assessing the potential of PREP as a drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomgOXgI1UeVrVg90H21EOLACvtfcHk0liHUsM1V-YBxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Sqt7nO&md5=0da407ae5d96cf8c3dd4f9d09a275515</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2011.00747.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2011.00747.x%26sid%3Dliteratum%253Aachs%26aulast%3DJalkanen%26aufirst%3DA.%2BJ.%26aulast%3DHakkarainen%26aufirst%3DJ.%2BJ.%26aulast%3DLehtonen%26aufirst%3DM.%26aulast%3DVen%25C3%25A4l%25C3%25A4inen%26aufirst%3DT.%26aulast%3DK%25C3%25A4%25C3%25A4ri%25C3%25A4inen%26aufirst%3DT.%2BM.%26aulast%3DJarho%26aufirst%3DE.%26aulast%3DSuhonen%26aufirst%3DM.%26aulast%3DForsberg%26aufirst%3DM.%2BM.%26atitle%3DBrain%2520pharmacokinetics%2520of%2520two%2520prolyl%2520oligopeptidase%2520inhibitors%252C%2520JTP-4819%2520and%2520KYP-2047%252C%2520in%2520the%2520rat%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2011%26volume%3D109%26spage%3D443%26epage%3D451%26doi%3D10.1111%2Fj.1742-7843.2011.00747.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Venäläinen, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Horsman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalkanen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallén, E. A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarho, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiaans, J. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span> </span><span class="NLM_article-title">Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span><span class="refDoi"> DOI: 10.1016/j.bcp.2005.11.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2Fj.bcp.2005.11.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=16405869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FlsVGmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=683-692&author=J.+I.+Ven%C3%A4l%C3%A4inenauthor=J.+A.+Garcia-Horsmanauthor=M.+M.+Forsbergauthor=A.+Jalkanenauthor=E.+A.+A.+Wall%C3%A9nauthor=E.+M.+Jarhoauthor=J.+A.+M.+Christiaansauthor=J.+Gyntherauthor=P.+T.+M%C3%A4nnist%C3%B6&title=Binding+kinetics+and+duration+of+in+vivo+action+of+novel+prolyl+oligopeptidase+inhibitors&doi=10.1016%2Fj.bcp.2005.11.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors</span></div><div class="casAuthors">Venalainen Jarkko I; Garcia-Horsman J Arturo; Forsberg Markus M; Jalkanen Aaro; Wallen Erik A A; Jarho Elina M; Christiaans Johannes A M; Gynther Jukka; Mannisto Pekka T</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">683-92</span>
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">Prolyl oligopeptidase (POP) is a serine protease that specifically hydrolyses small peptides at the carboxyl end of the proline residue.  POP has gained pharmaceutical interest, since its inhibitors have been shown to have antiamnesic properties in rat.  We examined the effect of the 2(S)-substituents CN and COCH(2)OH at the P1 site of the parent inhibitors isophthalic acid 2(S)-(cyclopentanecarbonyl)pyrrolidine-l-prolyl-pyrrolidine amide and 4-phenylbutanoyl-l-prolyl-pyrrolidine and bulky 5-t-butyl group at the P2 site l-prolyl residue of the parent inhibitor 4-phenylbutanoyl-l-prolyl-pyrrolidine on the binding kinetics to the enzyme.  In addition, we studied the duration of POP inhibition in the rat tissues in vivo after i.p. administration.  CN and COCH(2)OH substituents at the P1 site pyrrolidine group were found to greatly increase the affinity of the inhibitor and the enzyme-inhibitor complex half-life.  In addition, 5-t-butyl group at the P2 site l-prolyl residue increased the dissociation half-life of the enzyme-inhibitor complex, without much affecting the inhibitory potency.  The duration of the inhibition in the rat tissues followed the inhibition kinetic properties in that the compounds with fast dissociation produced shorter inhibition in the rat tissues than the compounds with slow dissociation.  The duration of POP inhibition of compounds was evidently not governed by their serum clearance.  The fact that the in vivo pharmacodynamic behaviour of POP inhibitors can be predicted by their in vitro-properties may be of importance when designing therapeutically useful POP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAxPFOhRDAONNTrvPZP1IpfW6udTcc2eZ82bAy4_n53Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FlsVGmsw%253D%253D&md5=824fc48bb57153eacaa303c46f47c66e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2005.11.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2005.11.029%26sid%3Dliteratum%253Aachs%26aulast%3DVen%25C3%25A4l%25C3%25A4inen%26aufirst%3DJ.%2BI.%26aulast%3DGarcia-Horsman%26aufirst%3DJ.%2BA.%26aulast%3DForsberg%26aufirst%3DM.%2BM.%26aulast%3DJalkanen%26aufirst%3DA.%26aulast%3DWall%25C3%25A9n%26aufirst%3DE.%2BA.%2BA.%26aulast%3DJarho%26aufirst%3DE.%2BM.%26aulast%3DChristiaans%26aufirst%3DJ.%2BA.%2BM.%26aulast%3DGynther%26aufirst%3DJ.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26atitle%3DBinding%2520kinetics%2520and%2520duration%2520of%2520in%2520vivo%2520action%2520of%2520novel%2520prolyl%2520oligopeptidase%2520inhibitors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D71%26spage%3D683%26epage%3D692%26doi%3D10.1016%2Fj.bcp.2005.11.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Barelli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Nanteuil, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morain, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Checler, F.</span><span> </span><span class="NLM_article-title">S 17092–1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span><span class="refDoi"> DOI: 10.1006/bbrc.1999.0366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1006%2Fbbrc.1999.0366" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1999&pages=657-661&author=H.+Barelliauthor=A.+Petitauthor=E.+Hirschauthor=S.+Wilkauthor=G.+De+Nanteuilauthor=P.+Morainauthor=F.+Checler&title=S+17092%E2%80%931%2C+a+highly+potent%2C+specific+and+cell+permeant+inhibitor+of+human+proline+endopeptidase&doi=10.1006%2Fbbrc.1999.0366"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1999.0366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1999.0366%26sid%3Dliteratum%253Aachs%26aulast%3DBarelli%26aufirst%3DH.%26aulast%3DPetit%26aufirst%3DA.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DWilk%26aufirst%3DS.%26aulast%3DDe%2BNanteuil%26aufirst%3DG.%26aulast%3DMorain%26aufirst%3DP.%26aulast%3DChecler%26aufirst%3DF.%26atitle%3DS%252017092%25E2%2580%25931%252C%2520a%2520highly%2520potent%252C%2520specific%2520and%2520cell%2520permeant%2520inhibitor%2520of%2520human%2520proline%2520endopeptidase%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1999%26volume%3D257%26spage%3D657%26epage%3D661%26doi%3D10.1006%2Fbbrc.1999.0366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Van Der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fülöp, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rea, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Elzen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baekelandt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span> </span><span class="NLM_article-title">P2-substituted N-acylprolylpyrrolidine inhibitors of prolyl oligopeptidase: Biochemical evaluation, binding mode determination, and assessment in a cellular model of synucleinopathy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9856</span><span class="NLM_x">–</span> <span class="NLM_lpage">9867</span><span class="refDoi"> DOI: 10.1021/jm301060g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301060g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1WgsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9856-9867&author=P.+Van+Der+Vekenauthor=V.+F%C3%BCl%C3%B6pauthor=D.+Reaauthor=M.+Gerardauthor=R.+Van+Elzenauthor=J.+Joossensauthor=J.+D.+Chengauthor=V.+Baekelandtauthor=I.+De+Meesterauthor=A.+M.+Lambeirauthor=K.+Augustyns&title=P2-substituted+N-acylprolylpyrrolidine+inhibitors+of+prolyl+oligopeptidase%3A+Biochemical+evaluation%2C+binding+mode+determination%2C+and+assessment+in+a+cellular+model+of+synucleinopathy&doi=10.1021%2Fjm301060g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">P2-Substituted N-Acylprolylpyrrolidine Inhibitors of Prolyl Oligopeptidase: Biochemical Evaluation, Binding Mode Determination, and Assessment in a Cellular Model of Synucleinopathy</span></div><div class="casAuthors">Van der Veken, Pieter; Fulop, Vilmos; Rea, Dean; Gerard, Melanie; Van Elzen, Roos; Joossens, Jurgen; Cheng, Jonathan D.; Baekelandt, Veerle; De Meester, Ingrid; Lambeir, Anne-Marie; Augustyns, Koen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9856-9867</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have investigated the effect of regiospecifically introducing substituents in the P2 part of the typical dipeptide derived basic structure of PREP inhibitors.  This hitherto unexplored modification type can be used to improve target affinity, selectivity, and physicochem. parameters in drug discovery programs focusing on PREP inhibitors.  Biochem. evaluation of the produced inhibitors identified several substituent types that significantly increase target affinity, thereby reducing the need for an electrophilic "warhead" functionality.  Pronounced PREP specificity within the group of Clan SC proteases was generally obsd.  Omission of the P1 electrophilic function did not affect the overall binding mode of three representative compds., as studied by x-ray crystallog., while the P2 substituents were demonstrated to be accommodated in a cavity of PREP that, to date, has not been probed by inhibitors.  Finally, we report on results of selected inhibitors in a SH-SY5Y cellular model of synucleinopathy and demonstrate a significant antiaggregation effect on α-synuclein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEIyxJpiiSubVg90H21EOLACvtfcHk0lj3S2n9LzB5yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1WgsbjE&md5=997a42980beef7491945f79924395e3e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm301060g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301060g%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDer%2BVeken%26aufirst%3DP.%26aulast%3DF%25C3%25BCl%25C3%25B6p%26aufirst%3DV.%26aulast%3DRea%26aufirst%3DD.%26aulast%3DGerard%26aufirst%3DM.%26aulast%3DVan%2BElzen%26aufirst%3DR.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DBaekelandt%26aufirst%3DV.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DAugustyns%26aufirst%3DK.%26atitle%3DP2-substituted%2520N-acylprolylpyrrolidine%2520inhibitors%2520of%2520prolyl%2520oligopeptidase%253A%2520Biochemical%2520evaluation%252C%2520binding%2520mode%2520determination%252C%2520and%2520assessment%2520in%2520a%2520cellular%2520model%2520of%2520synucleinopathy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9856%26epage%3D9867%26doi%3D10.1021%2Fjm301060g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Lambeir, A. M.</span><span> </span><span class="NLM_article-title">Interaction of prolyl oligopeptidase with α-synuclein</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span><span class="refDoi"> DOI: 10.2174/187152711794653878</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.2174%2F187152711794653878" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=21222624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslahtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=349-354&author=A.+M.+Lambeir&title=Interaction+of+prolyl+oligopeptidase+with+%CE%B1-synuclein&doi=10.2174%2F187152711794653878"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of prolyl oligopeptidase with α-synuclein</span></div><div class="casAuthors">Lambeir, Anne-Marie</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-354</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Prolyl oligopeptidase (PO) interacts with α-synuclein in vitro.  It is a weak interaction that induces a nucleation prone conformation of α-synuclein.  PO accelerates aggregation and fibril formation of α-synuclein in a process that can be reversed by specific inhibitors and is also influenced by an impairing mutation in the PO active site.  There is evidence that PO and α-synuclein also interact intracellularly, esp. in conditions where the expression of α-synuclein is high.  Specific PO inhibitors reduce the no. of cells with α-synuclein inclusions in a cellular model of Parkinson's disease.  If these interactions also exist in the human brain, PO may be a target for the treatment of Parkinson's disease and other synucleinopathies.  Whether PO also contributes to the normal physiol. functions of α-synuclein remains an open question, but there are some intriguing parallels between the proposed functions of both proteins that deserve further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsalUgjf0BobVg90H21EOLACvtfcHk0lj3S2n9LzB5yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslahtbo%253D&md5=8562511b17ebfa681a2d7affa64d7296</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F187152711794653878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152711794653878%26sid%3Dliteratum%253Aachs%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26atitle%3DInteraction%2520of%2520prolyl%2520oligopeptidase%2520with%2520%25CE%25B1-synuclein%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2011%26volume%3D10%26spage%3D349%26epage%3D354%26doi%3D10.2174%2F187152711794653878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Myöhänen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannula, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Elzen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Horsman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baekelandt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span> </span><span class="NLM_article-title">A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson’s disease</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">1097</span><span class="NLM_x">–</span> <span class="NLM_lpage">1113</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.01846.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1111%2Fj.1476-5381.2012.01846.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=22233220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC38XotlWmtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=1097-1113&author=T.+T.+My%C3%B6h%C3%A4nenauthor=M.+J.+Hannulaauthor=R.+Van+Elzenauthor=M.+Gerardauthor=P.+Van+Der+Vekenauthor=J.+A.+Garc%C3%ADa-Horsmanauthor=V.+Baekelandtauthor=P.+T.+M%C3%A4nnist%C3%B6author=A.+M.+Lambeir&title=A+prolyl+oligopeptidase+inhibitor%2C+KYP-2047%2C+reduces+%CE%B1-synuclein+protein+levels+and+aggregates+in+cellular+and+animal+models+of+Parkinson%E2%80%99s+disease&doi=10.1111%2Fj.1476-5381.2012.01846.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease</span></div><div class="casAuthors">Myohanen, T. T.; Hannula, M. J.; Van Elzen, R.; Gerard, M.; Van Der Veken, P.; Garcia-Horsman, J. A.; Baekelandt, V.; Mannisto, P. T.; Lambeir, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1097-1113</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose The aggregation of α-synuclein is connected to the pathol. of Parkinson's disease and prolyl oligopeptidase (PREP) accelerates the aggregation of α-synuclein in vitro.  The aim of this study was to investigate the effects of a PREP inhibitor, KYP-2047, on α-synuclein aggregation in cell lines overexpressing wild-type or A30P/A53T mutant human α-syn and in the brains of two A30P α-synuclein transgenic mouse strains.  Exptl. Approach Cells were exposed to oxidative stress and then incubated with the PREP inhibitor during or after the stress.  Wild-type or transgenic mice were treated for 5 days with KYP-2047 (2 × 3 mg·kg-1 a day).  Besides immunohistochem. and thioflavin S staining, sol. and insol. α-synuclein protein levels were measured by Western blot.  α-Synuclein mRNA levels were quantified by PCR.  The colocalization of PREP and α-synuclein, and the effect of KYP-2047 on cell viability were also investigated.  Key Results In cell lines, oxidative stress induced a robust aggregation of α-synuclein, and low concns. of KYP-2047 significantly reduced the no. of cells with α-synuclein inclusions while abolishing the colocalization of α-synuclein and PREP.  KYP-2047 significantly reduced the amt. of aggregated α-synuclein, and it had beneficial effects on cell viability.  In the transgenic mice, a 5-day treatment with the PREP inhibitor reduced the amt. of α-synuclein immunoreactivity and sol. α-synuclein protein in the brain.  Conclusions and Implications The results suggest that the PREP may play a role in brain accumulation and aggregation of α-synuclein, while KYP-2047 seems to effectively prevent these processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxIMPE4nZdtrVg90H21EOLACvtfcHk0lhMp05uKeiqYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotlWmtr4%253D&md5=b83a2f96d66ac2d7a765196055fe1985</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01846.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01846.x%26sid%3Dliteratum%253Aachs%26aulast%3DMy%25C3%25B6h%25C3%25A4nen%26aufirst%3DT.%2BT.%26aulast%3DHannula%26aufirst%3DM.%2BJ.%26aulast%3DVan%2BElzen%26aufirst%3DR.%26aulast%3DGerard%26aufirst%3DM.%26aulast%3DVan%2BDer%2BVeken%26aufirst%3DP.%26aulast%3DGarc%25C3%25ADa-Horsman%26aufirst%3DJ.%2BA.%26aulast%3DBaekelandt%26aufirst%3DV.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26atitle%3DA%2520prolyl%2520oligopeptidase%2520inhibitor%252C%2520KYP-2047%252C%2520reduces%2520%25CE%25B1-synuclein%2520protein%2520levels%2520and%2520aggregates%2520in%2520cellular%2520and%2520animal%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D1097%26epage%3D1113%26doi%3D10.1111%2Fj.1476-5381.2012.01846.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hannula, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myöhänen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenorio-Laranga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Horsman, J. A.</span><span> </span><span class="NLM_article-title">Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson’s and Alzheimer’s diseases</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">242</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2013.03.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2Fj.neuroscience.2013.03.049" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=242&publication_year=2013&pages=140-150&author=M.+J.+Hannulaauthor=T.+T.+My%C3%B6h%C3%A4nenauthor=J.+Tenorio-Larangaauthor=P.+T.+M%C3%A4nnist%C3%B6author=J.+A.+Garcia-Horsman&title=Prolyl+oligopeptidase+colocalizes+with+%CE%B1-synuclein%2C+%CE%B2-amyloid%2C+tau+protein+and+astroglia+in+the+post-mortem+brain+samples+with+Parkinson%E2%80%99s+and+Alzheimer%E2%80%99s+diseases&doi=10.1016%2Fj.neuroscience.2013.03.049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2013.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2013.03.049%26sid%3Dliteratum%253Aachs%26aulast%3DHannula%26aufirst%3DM.%2BJ.%26aulast%3DMy%25C3%25B6h%25C3%25A4nen%26aufirst%3DT.%2BT.%26aulast%3DTenorio-Laranga%26aufirst%3DJ.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DGarcia-Horsman%26aufirst%3DJ.%2BA.%26atitle%3DProlyl%2520oligopeptidase%2520colocalizes%2520with%2520%25CE%25B1-synuclein%252C%2520%25CE%25B2-amyloid%252C%2520tau%2520protein%2520and%2520astroglia%2520in%2520the%2520post-mortem%2520brain%2520samples%2520with%2520Parkinson%25E2%2580%2599s%2520and%2520Alzheimer%25E2%2580%2599s%2520diseases%26jtitle%3DNeuroscience%26date%3D2013%26volume%3D242%26spage%3D140%26epage%3D150%26doi%3D10.1016%2Fj.neuroscience.2013.03.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Lawandi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toumieux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thielges, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6672</span><span class="NLM_x">–</span> <span class="NLM_lpage">6684</span><span class="refDoi"> DOI: 10.1021/jm901013a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901013a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GgsLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6672-6684&author=J.+Lawandiauthor=S.+Toumieuxauthor=V.+Seyerauthor=P.+Campbellauthor=S.+Thielgesauthor=L.+Juillerat-Jeanneretauthor=N.+Moitessier&title=Constrained+peptidomimetics+reveal+detailed+geometric+requirements+of+covalent+prolyl+oligopeptidase+inhibitors&doi=10.1021%2Fjm901013a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors</span></div><div class="casAuthors">Lawandi, Janice; Toumieux, Sylvestre; Seyer, Valentine; Campbell, Philip; Thielges, Sabine; Juillerat-Jeanneret, Lucienne; Moitessier, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6672-6684</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prolyl oligopeptidases cleave peptides on the carboxy side of internal proline residues and their inhibition has potential in the treatment of human brain disorders.  Using our docking program FITTED, we have designed a series of constrained covalent inhibitors, built from a series of bicyclic scaffolds, to study the optimal shape required for these small mols.  These structures bear nitrile functional groups that we predicted to covalently bind to the catalytic serine of the enzyme.  Synthesis and biol. assays using human brain-derived astrocytic cells and endothelial cells and human fibroblasts revealed that these compds. act as selective inhibitors of prolyl oligopeptidase activity compared to prolyl-dipeptidyl-aminopeptidase activity, are able to penetrate the cells and inhibit intracellular activities in intact living cells.  This integrated computational and exptl. study shed light on the binding mode of inhibitors in the enzyme active site and will guide the design of future drug-like mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2IfKJ-jGKWrVg90H21EOLACvtfcHk0lhMp05uKeiqYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GgsLjI&md5=45e3fa6cc2888764519936595561d6e0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm901013a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901013a%26sid%3Dliteratum%253Aachs%26aulast%3DLawandi%26aufirst%3DJ.%26aulast%3DToumieux%26aufirst%3DS.%26aulast%3DSeyer%26aufirst%3DV.%26aulast%3DCampbell%26aufirst%3DP.%26aulast%3DThielges%26aufirst%3DS.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DConstrained%2520peptidomimetics%2520reveal%2520detailed%2520geometric%2520requirements%2520of%2520covalent%2520prolyl%2520oligopeptidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6672%26epage%3D6684%26doi%3D10.1021%2Fjm901013a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">De Cesco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deslandes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therrien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cueto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantin, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittermaier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6306</span><span class="NLM_x">–</span> <span class="NLM_lpage">6315</span><span class="refDoi"> DOI: 10.1021/jm3002839</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3002839" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC38Xps1Onu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6306-6315&author=S.+De+Cescoauthor=S.+Deslandesauthor=E.+Therrienauthor=D.+Levanauthor=M.+Cuetoauthor=R.+Schmidtauthor=L.+D.+Cantinauthor=A.+Mittermaierauthor=L.+Juillerat-Jeanneretauthor=N.+Moitessier&title=Virtual+screening+and+computational+optimization+for+the+discovery+of+covalent+prolyl+oligopeptidase+inhibitors+with+activity+in+human+cells&doi=10.1021%2Fjm3002839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening and Computational Optimization for the Discovery of Covalent Prolyl Oligopeptidase Inhibitors with Activity in Human Cells</span></div><div class="casAuthors">De Cesco, Stephane; Deslandes, Sebastien; Therrien, Eric; Levan, David; Cueto, Mickael; Schmidt, Ralf; Cantin, Louis-David; Mittermaier, Anthony; Juillerat-Jeanneret, Lucienne; Moitessier, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6306-6315</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Our docking program, Fitted, implemented in our computational platform, Forecaster, has been modified to carry out automated virtual screening of covalent inhibitors.  With this modified version of the program, virtual screening and further docking-based optimization of a selected hit led to the identification of potential covalent reversible inhibitors of prolyl oligopeptidase activity.  After visual inspection, a virtual hit mol. together with four analogs were selected for synthesis and made in one-five chem. steps.  Biol. evaluations on recombinant POP and FAPα enzymes, cell exts., and living cells demonstrated high potency and selectivity for POP over FAPα and DPPIV.  Three compds. even exhibited high nanomolar inhibitory activities in intact living human cells and acceptable metabolic stability.  This small set of mols. also demonstrated that covalent binding and/or geometrical constraints to the ligand/protein complex may lead to an increase in bioactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaE7_T4KEl5rVg90H21EOLACvtfcHk0lhp4zuW0aHRHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xps1Onu7Y%253D&md5=4c6cd8245e91cad790e4bab9254dcb3f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm3002839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3002839%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BCesco%26aufirst%3DS.%26aulast%3DDeslandes%26aufirst%3DS.%26aulast%3DTherrien%26aufirst%3DE.%26aulast%3DLevan%26aufirst%3DD.%26aulast%3DCueto%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DR.%26aulast%3DCantin%26aufirst%3DL.%2BD.%26aulast%3DMittermaier%26aufirst%3DA.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DVirtual%2520screening%2520and%2520computational%2520optimization%2520for%2520the%2520discovery%2520of%2520covalent%2520prolyl%2520oligopeptidase%2520inhibitors%2520with%2520activity%2520in%2520human%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6306%26epage%3D6315%26doi%3D10.1021%2Fjm3002839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Lawandi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toumieux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thielges, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6672</span><span class="NLM_x">–</span> <span class="NLM_lpage">6684</span><span class="refDoi"> DOI: 10.1021/jm901013a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901013a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GgsLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6672-6684&author=J.+Lawandiauthor=S.+Toumieuxauthor=V.+Seyerauthor=P.+Campbellauthor=S.+Thielgesauthor=L.+Juillerat-Jeanneretauthor=N.+Moitessier&title=Constrained+peptidomimetics+reveal+detailed+geometric+requirements+of+covalent+prolyl+oligopeptidase+inhibitors&doi=10.1021%2Fjm901013a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors</span></div><div class="casAuthors">Lawandi, Janice; Toumieux, Sylvestre; Seyer, Valentine; Campbell, Philip; Thielges, Sabine; Juillerat-Jeanneret, Lucienne; Moitessier, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6672-6684</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prolyl oligopeptidases cleave peptides on the carboxy side of internal proline residues and their inhibition has potential in the treatment of human brain disorders.  Using our docking program FITTED, we have designed a series of constrained covalent inhibitors, built from a series of bicyclic scaffolds, to study the optimal shape required for these small mols.  These structures bear nitrile functional groups that we predicted to covalently bind to the catalytic serine of the enzyme.  Synthesis and biol. assays using human brain-derived astrocytic cells and endothelial cells and human fibroblasts revealed that these compds. act as selective inhibitors of prolyl oligopeptidase activity compared to prolyl-dipeptidyl-aminopeptidase activity, are able to penetrate the cells and inhibit intracellular activities in intact living cells.  This integrated computational and exptl. study shed light on the binding mode of inhibitors in the enzyme active site and will guide the design of future drug-like mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2IfKJ-jGKWrVg90H21EOLACvtfcHk0lhp4zuW0aHRHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GgsLjI&md5=45e3fa6cc2888764519936595561d6e0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm901013a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901013a%26sid%3Dliteratum%253Aachs%26aulast%3DLawandi%26aufirst%3DJ.%26aulast%3DToumieux%26aufirst%3DS.%26aulast%3DSeyer%26aufirst%3DV.%26aulast%3DCampbell%26aufirst%3DP.%26aulast%3DThielges%26aufirst%3DS.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DConstrained%2520peptidomimetics%2520reveal%2520detailed%2520geometric%2520requirements%2520of%2520covalent%2520prolyl%2520oligopeptidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6672%26epage%3D6684%26doi%3D10.1021%2Fjm901013a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weerapana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Strategies for discovering and derisking covalent, irreversible enzyme inhibitors</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">964</span><span class="refDoi"> DOI: 10.4155/fmc.10.21</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.4155%2Ffmc.10.21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=20640225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFakur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=949-964&author=D.+S.+Johnsonauthor=E.+Weerapanaauthor=B.+F.+Cravatt&title=Strategies+for+discovering+and+derisking+covalent%2C+irreversible+enzyme+inhibitors&doi=10.4155%2Ffmc.10.21"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for discovering and derisking covalent, irreversible enzyme inhibitors</span></div><div class="casAuthors">Johnson, Douglas S.; Weerapana, Eranthie; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">949-964</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  This article presents several covalent inhibitors, including examples of successful drugs, as well as highly selective, irreversible inhibitors of emerging therapeutic targets, such as fatty acid amide hydolase.  Covalent inhibitors have many desirable features, including increased biochem. efficiency of target disruption, less sensitivity toward pharmacokinetic parameters and increased duration of action that outlasts the pharmacokinetics of the compd.  Safety concerns that must be mitigated include lack of specificity and the potential immunogenicity of protein-inhibitor adduct(s).  Particular attention will be given to recent technologies, such as activity-based protein profiling, which allow one to define the proteome-wide selectivity patterns for covalent inhibitors in vitro and in vivo.  For instance, any covalent inhibitor can, in principle, be modified with a 'clickable' tag to generate an activity probe that is almost indistinguishable from the original agent.  These probes can be applied to any living system across a broad dose range to fully inventory their on and off targets.  The substantial no. of drugs on the market today that act by a covalent mechanism belies historical prejudices against the development of irreversibly acting therapeutic small mols.  Emerging proteomic technologies offer a means to systematically discriminate safe (selective) vs. deleterious (nonselective) covalent inhibitors and thus should inspire their future design and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqm0whEybB-LVg90H21EOLACvtfcHk0lhp4zuW0aHRHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFakur4%253D&md5=07e1f89418b168798ae5c1a9fa43e9c1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.21%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStrategies%2520for%2520discovering%2520and%2520derisking%2520covalent%252C%2520irreversible%2520enzyme%2520inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2010%26volume%3D2%26spage%3D949%26epage%3D964%26doi%3D10.4155%2Ffmc.10.21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. Z.</span><span> </span><span class="NLM_article-title">Drug bioactivation, covalent binding to target proteins and toxicity relevance</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1081/DMR-200028812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1081%2FDMR-200028812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=15747500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVegsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2005&pages=41-213&author=S.+Zhouauthor=E.+Chanauthor=W.+Duanauthor=M.+Huangauthor=Y.+Z.+Chen&title=Drug+bioactivation%2C+covalent+binding+to+target+proteins+and+toxicity+relevance&doi=10.1081%2FDMR-200028812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Drug bioactivation, covalent binding to target proteins and toxicity relevance</span></div><div class="casAuthors">Zhou, Shufeng; Chan, Eli; Duan, Wei; Huang, Min; Chen, Yu-Zong</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-213</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  A no. of therapeutic drugs with different structures and mechanisms of action have been reported to undergo metabolic activation by Phase I or Phase II drug-metabolizing enzymes.  The bioactivation gives rise to reactive metabolites/intermediates, which readily confer covalent binding to various target proteins by nucleophilic substitution and/or Schiff's base mechanism.  These drugs include analgesics (e.g., acetaminophen), antibacterial agents (e.g., sulfonamides and macrolide antibiotics), anticancer drugs (e.g., irinotecan), antiepileptic drugs (e.g., carbamazepine), anti-HIV agents (e.g., ritonavir), antipsychotics (e.g., clozapine), cardiovascular drugs (e.g., procainamide and hydralazine), immunosuppressants (e.g., cyclosporine A), inhalational anesthetics (e.g., halothane), nonsteroidal anti-inflammatory drugs (NSAIDSs) (e.g., diclofenac), and steroids and their receptor modulators (e.g., estrogens and tamoxifen).  Some herbal and dietary constituents are also bioactivated to reactive metabolites capable of binding covalently and inactivating cytochrome P450s (CYPs).  A no. of important target proteins of drugs have been identified by mass spectrometric techniques and proteomic approaches.  The covalent binding and formation of drug-protein adducts are generally considered to be related to drug toxicity, and selective protein covalent binding by drug metabolites may lead to selective organ toxicity.  However, the mechanisms involved in the protein adduct-induced toxicity are largely undefined, although it has been suggested that drug-protein adducts may cause toxicity either through impairing physiol. functions of the modified proteins or through immune-mediated mechanisms.  In addn., mechanism-based inhibition of CYPs may result in toxic drug-drug interactions.  The clin. consequences of drug bioactivation and covalent binding to proteins are unpredictable, depending on many factors that are assocd. with the administered drugs and patients.  Further studies using proteomic and genomic approaches with high throughput capacity are needed to identify the protein targets of reactive drug metabolites, and to elucidate the structure-activity relationships of drug's covalent binding to proteins and their clin. outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi5RXf-M8WvrVg90H21EOLACvtfcHk0ljxeKUB1GAwnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVegsrc%253D&md5=bfd4f4652ffe7666a1c7d0e93c48372b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1081%2FDMR-200028812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FDMR-200028812%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%2BZ.%26atitle%3DDrug%2520bioactivation%252C%2520covalent%2520binding%2520to%2520target%2520proteins%2520and%2520toxicity%2520relevance%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2005%26volume%3D37%26spage%3D41%26epage%3D213%26doi%3D10.1081%2FDMR-200028812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Guterman, L.</span><span> </span><span class="NLM_article-title">Covalent Drugs Form Long-Lived Ties</span> <span class="citation_source-journal">Chem. Eng. News</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/doi/10.1021/cen-v089n036.p019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2011&pages=19-26&author=L.+Guterman&title=Covalent+Drugs+Form+Long-Lived+Ties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcen-v089n036.p019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcen-v089n036.p019%26sid%3Dliteratum%253Aachs%26aulast%3DGuterman%26aufirst%3DL.%26atitle%3DCovalent%2520Drugs%2520Form%2520Long-Lived%2520Ties%26jtitle%3DChem.%2520Eng.%2520News%26date%3D2011%26volume%3D89%26spage%3D19%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span> </span><span class="NLM_article-title">Drug discovery for a new generation of covalent drugs</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">581</span><span class="refDoi"> DOI: 10.1517/17460441.2012.688744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1517%2F17460441.2012.688744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=22607458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFWmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=561-581&author=A.+S.+Kalgutkarauthor=D.+K.+Dalvie&title=Drug+discovery+for+a+new+generation+of+covalent+drugs&doi=10.1517%2F17460441.2012.688744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery for a new generation of covalent drugs</span></div><div class="casAuthors">Kalgutkar, Amit S.; Dalvie, Deepak K.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">561-581</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The design of target-specific covalent inhibitors is conceptually attractive because of increased biochem. efficiency through covalency and increased duration of action that outlasts the pharmacokinetics of the agent.  Although many covalent inhibitors have been approved or are in advanced clin. trials to treat indications such as cancer and hepatitis C, there is a general tendency to avoid them as drug candidates because of concerns regarding immune-mediated toxicity that can arise from indiscriminate reactivity with off-target proteins.Areas covered: The review examines potential reason(s) for the excellent safety record of marketed covalent agents and advanced clin. candidates for emerging therapeutic targets.  A significant emphasis is placed on proteomic techniques and chem./biochem. reactivity assays that aim to provide a systematic rank ordering of pharmacol. selectivity relative to off-target protein reactivity of covalent inhibitors.Expert opinion: While tactics to examine selective covalent modification of the pharmacol. target are broadly applicable in drug discovery, it is unclear whether the output from such studies can prospectively predict idiosyncratic immune-mediated drug toxicity.  Opinions regarding an acceptable threshold of protein reactivity/body burden for a toxic electrophile and a non-toxic electrophilic covalent drug have not been defined.  Increasing confidence in proteomic and chem./biochem. reactivity screens will require a retrospective side-by-side profiling of marketed covalent drugs and electrophiles known to cause deleterious toxic effects via non-selective covalent binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowmXy20mDTPbVg90H21EOLACvtfcHk0ljxeKUB1GAwnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFWmt7k%253D&md5=b7fc8e60b263dda5765dd8380f52df17</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1517%2F17460441.2012.688744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2012.688744%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26atitle%3DDrug%2520discovery%2520for%2520a%2520new%2520generation%2520of%2520covalent%2520drugs%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D561%26epage%3D581%26doi%3D10.1517%2F17460441.2012.688744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Robertson, J. G.</span><span> </span><span class="NLM_article-title">Mechanistic basis of enzyme-targeted drugs</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">5561</span><span class="NLM_x">–</span> <span class="NLM_lpage">5571</span><span class="refDoi"> DOI: 10.1021/bi050247e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi050247e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisV2jsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5561-5571&author=J.+G.+Robertson&title=Mechanistic+basis+of+enzyme-targeted+drugs&doi=10.1021%2Fbi050247e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic Basis of Enzyme-Targeted Drugs</span></div><div class="casAuthors">Robertson, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5561-5571</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Enzymes offer unique opportunities for drug design that are not available to cell surface receptors, nuclear hormone receptors, ion channels, transporters, and DNA.  Here, we review the variety of inhibition mechanisms for enzyme-targeted drugs, and establish an enzyme target database for drugs currently marketed in the United States.  From an anal. of the FDA Orange Book, there are 317 marketed drugs that work by inhibiting an enzyme.  These drugs inhibit 71 enzymes, including 48 human, 13 bacterial, five viral, four fungal, and one protozoal enzyme.  Among the 317 drugs, 65% either undergo reactive chem. in the active site of the target enzyme or contain a structural motif related to the substrate.  Among the 71 enzyme targets, 25 are irreversibly inhibited by drugs, and 19 of the 25 irreversibly inhibited enzymes are covalently modified by the drug.  In two addnl. cases, the drug forms a covalent complex with the substrate, and in three more cases, the drug traps a covalent enzyme-substrate intermediate.  Four of the 71 enzymes are inhibited by transition-state analogs.  Moreover, advanced methods for detg. transition-state structure now offer the opportunity for direct drug design without resorting to expensive random testing campaigns.  A full appreciation of enzyme mechanisms sets enzymes apart as a specialized class of targets for highly directed drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgXM1naSit_7Vg90H21EOLACvtfcHk0ljxeKUB1GAwnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisV2jsLg%253D&md5=8122fffab0717e5dbd0ff904d7a94da0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fbi050247e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi050247e%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26atitle%3DMechanistic%2520basis%2520of%2520enzyme-targeted%2520drugs%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D5561%26epage%3D5571%26doi%3D10.1021%2Fbi050247e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span> </span><span class="NLM_article-title">The resurgence of covalent drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span><span class="refDoi"> DOI: 10.1038/nrd3410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1038%2Fnrd3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=21455239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+resurgence+of+covalent+drugs&doi=10.1038%2Fnrd3410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of covalent drugs</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A.; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Covalent drugs haveproved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project.  There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium.  This Review surveys the prevalence and pharmacol. advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDCEmORV_NbVg90H21EOLACvtfcHk0ljxeKUB1GAwnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D&md5=2190289081e151416c097be4a5b04460</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnrd3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3410%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520resurgence%2520of%2520covalent%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317%26doi%3D10.1038%2Fnrd3410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Potashman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span> </span><span class="NLM_article-title">Covalent modifiers: An orthogonal approach to drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1231</span><span class="NLM_x">–</span> <span class="NLM_lpage">1246</span><span class="refDoi"> DOI: 10.1021/jm8008597</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8008597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1231-1246&author=M.+H.+Potashmanauthor=M.+E.+Duggan&title=Covalent+modifiers%3A+An+orthogonal+approach+to+drug+design&doi=10.1021%2Fjm8008597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Modifiers: An Orthogonal Approach to Drug Design</span></div><div class="casAuthors">Potashman, Michele H.; Duggan, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1231-1246</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In this article we review a variety of examples in which therapeutic targets are covalently bound by small-mol. drugs or by compds. in advanced clin. development.  The covalent interactions can be either reversible or irreversible, depending on the reaction partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6BO6g9_F717Vg90H21EOLACvtfcHk0liEnZvj86KALg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sltbw%253D&md5=f8380d5a1cdd8638ad2a1e0405d25267</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm8008597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8008597%26sid%3Dliteratum%253Aachs%26aulast%3DPotashman%26aufirst%3DM.%2BH.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26atitle%3DCovalent%2520modifiers%253A%2520An%2520orthogonal%2520approach%2520to%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1231%26epage%3D1246%26doi%3D10.1021%2Fjm8008597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Smith, A. J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houk, K. N.</span><span> </span><span class="NLM_article-title">Beyond picomolar affinities: Quantitative aspects of noncovalent and covalent binding of drugs to proteins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span><span class="refDoi"> DOI: 10.1021/jm800498e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800498e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1OltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=225-233&author=A.+J.+T.+Smithauthor=X.+Zhangauthor=A.+G.+Leachauthor=K.+N.+Houk&title=Beyond+picomolar+affinities%3A+Quantitative+aspects+of+noncovalent+and+covalent+binding+of+drugs+to+proteins&doi=10.1021%2Fjm800498e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond picomolar affinities: quantitative aspects of noncovalent and covalent binding of drugs to proteins</span></div><div class="casAuthors">Smith, Adam J. T.; Zhang, Xiyun; Leach, Andrew G.; Houk, K. N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-233</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review of 104 refs. summarized quant. aspects of noncovalent and covalent binding of drugs to proteins with subtopics including (1) introduction; (2) factors involved in ligand-recepto binding; (3) distribution of exptl. binding consts.; (3) covalent interactions with transition states as the origins of enzyme proficiency; (4) potential quant. advantages of covalent enzyme inhibitors and colent drugs; (5) selected examples of covalent inhibitors and drugs; (6) prospects for the design of covalent drugs; (7) conclusions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAhUbRxt1fu7Vg90H21EOLACvtfcHk0liEnZvj86KALg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1OltLw%253D&md5=529d4181046100b5e3c37a8fef571218</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm800498e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800498e%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DA.%2BJ.%2BT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DHouk%26aufirst%3DK.%2BN.%26atitle%3DBeyond%2520picomolar%2520affinities%253A%2520Quantitative%2520aspects%2520of%2520noncovalent%2520and%2520covalent%2520binding%2520of%2520drugs%2520to%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D225%26epage%3D233%26doi%3D10.1021%2Fjm800498e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Fleming, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravikumar, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shook, B. C.</span><span> </span><span class="NLM_article-title">Nitrile-containing pharmaceuticals: Efficacious roles of the nitrile pharmacophore</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7902</span><span class="NLM_x">–</span> <span class="NLM_lpage">7917</span><span class="refDoi"> DOI: 10.1021/jm100762r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100762r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2kurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7902-7917&author=F.+F.+Flemingauthor=L.+Yaoauthor=P.+C.+Ravikumarauthor=L.+Funkauthor=B.+C.+Shook&title=Nitrile-containing+pharmaceuticals%3A+Efficacious+roles+of+the+nitrile+pharmacophore&doi=10.1021%2Fjm100762r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore</span></div><div class="casAuthors">Fleming, Fraser F.; Yao, Lihua; Ravikumar, P. C.; Funk, Lee; Shook, Brian C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7902-7917</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review is structured according to the nature of the nitrile-bearing substituent.  As the no. of nitrile-contg. drug leads is vast, the review has focused on launched nitrile-contg. pharmaceuticals and currently active clin. candidates.  Most nitrile-contg. pharmaceuticals are aroms. with aliph.-, alkene-, and nitrogen-bearing nitriles being progressively less frequent.  Within each class, the bioactive nitriles are collated according to common structural elements and mode of action.  The hope is that this survey will allow greater deployment of this versatile functionality within drug leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR6kPPdWVuvLVg90H21EOLACvtfcHk0ljrHhyfhzjo8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2kurvP&md5=040bbaebd9e8c9999d195b9a22221fea</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm100762r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100762r%26sid%3Dliteratum%253Aachs%26aulast%3DFleming%26aufirst%3DF.%2BF.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DRavikumar%26aufirst%3DP.%2BC.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DShook%26aufirst%3DB.%2BC.%26atitle%3DNitrile-containing%2520pharmaceuticals%253A%2520Efficacious%2520roles%2520of%2520the%2520nitrile%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7902%26epage%3D7917%26doi%3D10.1021%2Fjm100762r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Huot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Expedient synthesis of novel bicyclic peptidomimetic scaffolds</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2820</span><span class="NLM_x">–</span> <span class="NLM_lpage">2823</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2010.03.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2Fj.tetlet.2010.03.066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=2820-2823&author=M.+Huotauthor=N.+Moitessier&title=Expedient+synthesis+of+novel+bicyclic+peptidomimetic+scaffolds&doi=10.1016%2Fj.tetlet.2010.03.066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2010.03.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2010.03.066%26sid%3Dliteratum%253Aachs%26aulast%3DHuot%26aufirst%3DM.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DExpedient%2520synthesis%2520of%2520novel%2520bicyclic%2520peptidomimetic%2520scaffolds%26jtitle%3DTetrahedron%2520Lett.%26date%3D2010%26volume%3D51%26spage%3D2820%26epage%3D2823%26doi%3D10.1016%2Fj.tetlet.2010.03.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Szeltner, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rea, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fülöp, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgár, L.</span><span> </span><span class="NLM_article-title">Electrostatic effects and binding determinants in the catalysis of prolyl oligopeptidase: Site-specific mutagenesis at the oxyanion binding site</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">42613</span><span class="NLM_x">–</span> <span class="NLM_lpage">42622</span><span class="refDoi"> DOI: 10.1074/jbc.M208043200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1074%2Fjbc.M208043200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=42613-42622&author=Z.+Szeltnerauthor=D.+Reaauthor=V.+Rennerauthor=V.+F%C3%BCl%C3%B6pauthor=L.+Polg%C3%A1r&title=Electrostatic+effects+and+binding+determinants+in+the+catalysis+of+prolyl+oligopeptidase%3A+Site-specific+mutagenesis+at+the+oxyanion+binding+site&doi=10.1074%2Fjbc.M208043200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M208043200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M208043200%26sid%3Dliteratum%253Aachs%26aulast%3DSzeltner%26aufirst%3DZ.%26aulast%3DRea%26aufirst%3DD.%26aulast%3DRenner%26aufirst%3DV.%26aulast%3DF%25C3%25BCl%25C3%25B6p%26aufirst%3DV.%26aulast%3DPolg%25C3%25A1r%26aufirst%3DL.%26atitle%3DElectrostatic%2520effects%2520and%2520binding%2520determinants%2520in%2520the%2520catalysis%2520of%2520prolyl%2520oligopeptidase%253A%2520Site-specific%2520mutagenesis%2520at%2520the%2520oxyanion%2520binding%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D42613%26epage%3D42622%26doi%3D10.1074%2Fjbc.M208043200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Therrien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weill, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbeil, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Docking ligands into flexible and solvated macromolecules. 7. Impact of protein flexibility and water molecules on docking-based virtual screening accuracy</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3198</span><span class="NLM_x">–</span> <span class="NLM_lpage">3210</span><span class="refDoi"> DOI: 10.1021/ci500299h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500299h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1OitbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=3198-3210&author=E.+Therrienauthor=N.+Weillauthor=A.+Tombergauthor=C.+R.+Corbeilauthor=D.+Leeauthor=N.+Moitessier&title=Docking+ligands+into+flexible+and+solvated+macromolecules.+7.+Impact+of+protein+flexibility+and+water+molecules+on+docking-based+virtual+screening+accuracy&doi=10.1021%2Fci500299h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Docking Ligands into Flexible and Solvated Macromolecules. 7. Impact of Protein Flexibility and Water Molecules on Docking-Based Virtual Screening Accuracy</span></div><div class="casAuthors">Therrien, Eric; Weill, Nathanael; Tomberg, Anna; Corbeil, Christopher R.; Lee, Devin; Moitessier, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3198-3210</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of predictive computational methods in the drug discovery process is in a state of continual growth.  Over the last two decades, an increasingly large no. of docking tools have been developed to identify hits or optimize lead mols. through in-silico screening of chem. libraries to proteins.  In recent years, the focus has been on implementing protein flexibility and water mols.  Our efforts led to the development of 'Fitted' first reported in 2007 and further developed since then.  In this study, we wished to evaluate the impact of protein flexibility and occurrence of water mols. on the accuracy of the 'Fitted' docking program to discriminate active compds. from inactive compds. in virtual screening (VS) campaigns.  For this purpose, a total of 171 proteins cocrystd. with small mols. representing 40 unique enzymes and receptors as well as sets of known ligands and decoys were selected from the Protein Data Bank (PDB) and the Directory of Useful Decoys (DUD), resp.  This study revealed that implementing displaceable crystallog. or computationally placed particle water mols. and protein flexibility can improve the enrichment in active compds.  In addn., an informed decision based on library diversity or research objectives (hit discovery vs lead optimization) on which implementation to use may lead to significant improvements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpte6omTYQarVg90H21EOLACvtfcHk0ljrHhyfhzjo8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1OitbjM&md5=fa34411d7f1020a4e4ed61171f54bf6b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fci500299h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500299h%26sid%3Dliteratum%253Aachs%26aulast%3DTherrien%26aufirst%3DE.%26aulast%3DWeill%26aufirst%3DN.%26aulast%3DTomberg%26aufirst%3DA.%26aulast%3DCorbeil%26aufirst%3DC.%2BR.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DDocking%2520ligands%2520into%2520flexible%2520and%2520solvated%2520macromolecules.%25207.%2520Impact%2520of%2520protein%2520flexibility%2520and%2520water%2520molecules%2520on%2520docking-based%2520virtual%2520screening%2520accuracy%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26spage%3D3198%26epage%3D3210%26doi%3D10.1021%2Fci500299h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Racys, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rea, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fülöp, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wills, M.</span><span> </span><span class="NLM_article-title">Inhibition of prolyl oligopeptidase with a synthetic unnatural dipeptide</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4775</span><span class="NLM_x">–</span> <span class="NLM_lpage">4782</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2Fj.bmc.2010.05.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=4775-4782&author=D.+T.+Racysauthor=D.+Reaauthor=V.+F%C3%BCl%C3%B6pauthor=M.+Wills&title=Inhibition+of+prolyl+oligopeptidase+with+a+synthetic+unnatural+dipeptide&doi=10.1016%2Fj.bmc.2010.05.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DRacys%26aufirst%3DD.%2BT.%26aulast%3DRea%26aufirst%3DD.%26aulast%3DF%25C3%25BCl%25C3%25B6p%26aufirst%3DV.%26aulast%3DWills%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520prolyl%2520oligopeptidase%2520with%2520a%2520synthetic%2520unnatural%2520dipeptide%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D4775%26epage%3D4782%26doi%3D10.1016%2Fj.bmc.2010.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Singh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, B.</span><span> </span><span class="NLM_article-title">AADS - An automated active site identification, docking, and scoring protocol for protein targets based on physicochemical descriptors</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2515</span><span class="NLM_x">–</span> <span class="NLM_lpage">2527</span><span class="refDoi"> DOI: 10.1021/ci200193z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200193z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKnt7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=2515-2527&author=T.+Singhauthor=D.+Biswasauthor=B.+Jayaram&title=AADS+-+An+automated+active+site+identification%2C+docking%2C+and+scoring+protocol+for+protein+targets+based+on+physicochemical+descriptors&doi=10.1021%2Fci200193z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">AADS - An Automated Active Site Identification, Docking, and Scoring Protocol for Protein Targets Based on Physicochemical Descriptors</span></div><div class="casAuthors">Singh, Tanya; Biswas, D.; Jayaram, B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2515-2527</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report here a robust automated active site detection, docking, and scoring (AADS) protocol for proteins with known structures.  The active site finder identifies all cavities in a protein and scores them based on the physicochem. properties of functional groups lining the cavities in the protein.  The accuracy realized on 620 proteins with sizes ranging from 100 to 600 amino acids with known drug active sites is 100% when the top ten cavity points are considered.  These top ten cavity points identified are then submitted for an automated docking of an input ligand/candidate mol.  The docking protocol uses an all atom energy based Monte Carlo method.  Eight low energy docked structures corresponding to different locations and orientations of the candidate mol. are stored at each cavity point giving 80 docked structures overall which are then ranked using an effective free energy function and top five structures are selected.  The predicted structure and energetics of the complexes agree quite well with expt. when tested on a data set of 170 protein-ligand complexes with known structures and binding affinities.  The AADS methodol. is implemented on an 80 processor cluster and presented as a freely accessible, easy to use tool at http://www.scfbio-iitd.res.in/dock/ActiveSite_new.jsp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKgcX1_J1BxbVg90H21EOLACvtfcHk0lihEHiPZILXsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKnt7zM&md5=eb485ecf37cf0da60218974f1093c2c5</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fci200193z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200193z%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DT.%26aulast%3DBiswas%26aufirst%3DD.%26aulast%3DJayaram%26aufirst%3DB.%26atitle%3DAADS%2520-%2520An%2520automated%2520active%2520site%2520identification%252C%2520docking%252C%2520and%2520scoring%2520protocol%2520for%2520protein%2520targets%2520based%2520on%2520physicochemical%2520descriptors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D2515%26epage%3D2527%26doi%3D10.1021%2Fci200193z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Tomberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cesco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Solvent effect in diastereoselective intramolecular Diels–Alder reactions</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6852</span><span class="NLM_x">–</span> <span class="NLM_lpage">6856</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2015.10.086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2Fj.tetlet.2015.10.086" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=6852-6856&author=A.+Tombergauthor=S.+De+Cescoauthor=M.+Huotauthor=N.+Moitessier&title=Solvent+effect+in+diastereoselective+intramolecular+Diels%E2%80%93Alder+reactions&doi=10.1016%2Fj.tetlet.2015.10.086"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2015.10.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2015.10.086%26sid%3Dliteratum%253Aachs%26aulast%3DTomberg%26aufirst%3DA.%26aulast%3DDe%2BCesco%26aufirst%3DS.%26aulast%3DHuot%26aufirst%3DM.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DSolvent%2520effect%2520in%2520diastereoselective%2520intramolecular%2520Diels%25E2%2580%2593Alder%2520reactions%26jtitle%3DTetrahedron%2520Lett.%26date%3D2015%26volume%3D56%26spage%3D6852%26epage%3D6856%26doi%3D10.1016%2Fj.tetlet.2015.10.086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Nguyen, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham-Huy, C.</span><span> </span><span class="NLM_article-title">Chiral drugs: An overview</span> <span class="citation_source-journal">Int. J. Biomed. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=23674971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSltrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=85-100&author=L.+A.+Nguyenauthor=H.+Heauthor=C.+Pham-Huy&title=Chiral+drugs%3A+An+overview"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Chiral drugs. An overview</span></div><div class="casAuthors">Nguyen, Lien Ai; He, Hua; Chuong, Pham-Huy</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biomedical Science (Monterey Park, CA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-100</span>CODEN:
                <span class="NLM_cas:coden">IJBSDB</span>;
        ISSN:<span class="NLM_cas:issn">1550-9702</span>.
    
            (<span class="NLM_cas:orgname">Master Publishing Group</span>)
        </div><div class="casAbstract">A review.  About more than half of the drugs currently in use are chiral compds. and near 90% of the last ones are marketed as racemates consisting of an equimolar mixt. of two enantiomers.  Although they have the same chem. structure, most isomers of chiral drugs exhibit marked differences in biol. activities such as pharmacol., toxicol., pharmacokinetics, metab. etc.  Some mechanisms of these properties are also explained.  Therefore, it is important to promote the chiral sepn. and anal. of racemic drugs in pharmaceutical industry as well as in clinic in order to eliminate the unwanted isomer from the prepn. and to find an optimal treatment and a right therapeutic control for the patient.  In this article, we review the nomenclature, pharmacol., toxicol., pharmacokinetics, metab. etc of some usual chiral drugs as well as their mechanisms.  Different techniques used for the chiral sepn. in pharmaceutical industry as well as in clin. analyses are also examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovoqsLM_3bxLVg90H21EOLACvtfcHk0lihEHiPZILXsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSltrnJ&md5=254cbca060bb4cfd04eac365488f5b62</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DL.%2BA.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DPham-Huy%26aufirst%3DC.%26atitle%3DChiral%2520drugs%253A%2520An%2520overview%26jtitle%3DInt.%2520J.%2520Biomed.%2520Sci.%26date%3D2006%26volume%3D2%26spage%3D85%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span><span class="refDoi"> DOI: 10.1016/0005-2744(69)90420-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2F0005-2744%2869%2990420-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=4980133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADyaF1MXkvVOqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=1969&pages=269-286&author=J.+F.+Morrison&title=Kinetics+of+the+reversible+inhibition+of+enzyme-catalysed+reactions+by+tight-binding+inhibitors&doi=10.1016%2F0005-2744%2869%2990420-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of the reversible inhibition of enzyme-catalyzed reactions by tight-binding inhibitors</span></div><div class="casAuthors">Morrison, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Enzymology</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-86</span>CODEN:
                <span class="NLM_cas:coden">BBEZAD</span>;
        ISSN:<span class="NLM_cas:issn">0924-1086</span>.
    </div><div class="casAbstract">A theoretical kinetic study has been undertaken to det. the kinetic characteristics of enzymic reactions that are reversibly inhibited by a substrate analog. at concns. comparable to that of the enzyme.  A general rate equation, that allows for the combination of such a tight-binding inhibitor with one or more enzyme forms of any reaction mechanism, has been derived and shown to be quadratic with sq. and linear terms in υ which represents the true initial steady-state velocity.  From plots of υ against total enzyme concn. at fixed total inhibitor concn., the concn. of enzyme catalytic sites can be detd. irrespective of the nature of the inhibition and the reaction mechanism.  However, plots of υ (or I/υ) against total inhibitor concn. can be used for this purpose only if the dissocn. const. assocd. with the inhibitor is virtually zero.  Particular initial rate equations have been obtained for the cases in which the tight-binding inhibitor gives rise to competitive, noncompetitive, and uncompetitive inhibition with respect to one of the substrates of a bireactant mechanism.  From these equations it has been deduced that, in the presence of inhibitor, plots of I/υ against the reciprocals of the substrate concns. yield families of concave-down, nonrectangular hyperbolas.  The difficulties assocd. with the detn. of inhibition consts. for tight-binding inhibitors are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj4s_N2iV3CLVg90H21EOLACvtfcHk0lihEHiPZILXsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXkvVOqsbo%253D&md5=74d467477385488dfbb053358534ada6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0005-2744%2869%2990420-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2744%252869%252990420-3%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DKinetics%2520of%2520the%2520reversible%2520inhibition%2520of%2520enzyme-catalysed%2520reactions%2520by%2520tight-binding%2520inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1969%26volume%3D185%26spage%3D269%26epage%3D286%26doi%3D10.1016%2F0005-2744%2869%2990420-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Schiavini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pottel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auclair, K.</span><span> </span><span class="NLM_article-title">Metabolic instability of cyanothiazolidine-based prolyl oligopeptidase inhibitors: A structural assignment challenge and potential medicinal chemistry implications</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1174</span><span class="NLM_x">–</span> <span class="NLM_lpage">1183</span><span class="refDoi"> DOI: 10.1002/cmdc.201500114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1002%2Fcmdc.201500114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1174-1183&author=P.+Schiaviniauthor=J.+Pottelauthor=N.+Moitessierauthor=K.+Auclair&title=Metabolic+instability+of+cyanothiazolidine-based+prolyl+oligopeptidase+inhibitors%3A+A+structural+assignment+challenge+and+potential+medicinal+chemistry+implications&doi=10.1002%2Fcmdc.201500114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500114%26sid%3Dliteratum%253Aachs%26aulast%3DSchiavini%26aufirst%3DP.%26aulast%3DPottel%26aufirst%3DJ.%26aulast%3DMoitessier%26aufirst%3DN.%26aulast%3DAuclair%26aufirst%3DK.%26atitle%3DMetabolic%2520instability%2520of%2520cyanothiazolidine-based%2520prolyl%2520oligopeptidase%2520inhibitors%253A%2520A%2520structural%2520assignment%2520challenge%2520and%2520potential%2520medicinal%2520chemistry%2520implications%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D1174%26epage%3D1183%26doi%3D10.1002%2Fcmdc.201500114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Wong, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, Z.</span><span> </span><span class="NLM_article-title">Regioselective biotransformation of CNS drugs and its clinical impact on adverse drug reactions</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span><span class="refDoi"> DOI: 10.1517/17425255.2012.688027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1517%2F17425255.2012.688027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=22568396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC38XovVWjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=833-854&author=Y.+C.+Wongauthor=S.+Qianauthor=Z.+Zuo&title=Regioselective+biotransformation+of+CNS+drugs+and+its+clinical+impact+on+adverse+drug+reactions&doi=10.1517%2F17425255.2012.688027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective biotransformation of CNS drugs and its clinical impact on adverse drug reactions</span></div><div class="casAuthors">Wong, Yin Cheong; Qian, Shuai; Zuo, Zhong</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">833-854</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Adverse drug reactions (ADRs) continue to be one of the major causes of failure in drug development while limiting the clin. utilities of many drugs.  Contribution of the metabolites formed in vivo to ADRs could be more significant than we might have expected.Areas covered: This review focuses on the relationship between regioselectivity in biotransformation and the ADRs of drugs acting on the central nervous system (CNS).  "Regioselectivity" is defined as an exclusively or significantly preferential metabolic reaction at one (or several) site(s) on the substrate mol.  Several CNS drugs and toxicants, of which the metabolites play pivotal roles in ADRs, are summarized in details with the highlight on the roles of metab. in both toxification and detoxification.  The article also discusses in silico predictions of regioselectivity and the formation of toxic metabolites which are becoming increasingly important.Expert opinion: Researchers working on CNS drugs face particular challenges in predicting drug metab. and potential toxicities of their metabolites.  A no. of factors contribute to the difficulty of accurate prediction of metabolite disposition in the human brain.  Better knowledge of regioselectivity in biotransformation and elucidation of the relationships between biotransformations and ADRs would definitely help designing new compds. with lower bioactivation potentials and rejuvenating the older drugs whose clin. applications are restricted by their ADRs.  Administrating drugs by alternative routes such as the intranasal, transdermal, sublingual, and buccal routes could also be a strategy to reduce unwanted metabolite formations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO2G5dxQiQOrVg90H21EOLACvtfcHk0ljDX-qK0yaVzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovVWjs7s%253D&md5=fc9bd6edda4f400e62e20ff51afdac1e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1517%2F17425255.2012.688027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2012.688027%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DY.%2BC.%26aulast%3DQian%26aufirst%3DS.%26aulast%3DZuo%26aufirst%3DZ.%26atitle%3DRegioselective%2520biotransformation%2520of%2520CNS%2520drugs%2520and%2520its%2520clinical%2520impact%2520on%2520adverse%2520drug%2520reactions%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2012%26volume%3D8%26spage%3D833%26epage%3D854%26doi%3D10.1517%2F17425255.2012.688027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">A comprehensive listing of bioactivation pathways of organic functional groups</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span><span class="refDoi"> DOI: 10.2174/1389200054021799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnellauthor=J.+Boerauthor=S.+P.+Harriman&title=A+comprehensive+listing+of+bioactivation+pathways+of+organic+functional+groups&doi=10.2174%2F1389200054021799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0ljDX-qK0yaVzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520comprehensive%2520listing%2520of%2520bioactivation%2520pathways%2520of%2520organic%2520functional%2520groups%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2005%26volume%3D6%26spage%3D161%26epage%3D225%26doi%3D10.2174%2F1389200054021799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleo, M. D.</span><span> </span><span class="NLM_article-title">Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: A perspective based on the critical examination of trends in the top 200 drugs marketed in the United States</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1410</span><span class="refDoi"> DOI: 10.1021/tx200168d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+alert%2Freactive+metabolite+concept+as+applied+in+medicinal+chemistry+to+mitigate+the+risk+of+idiosyncratic+drug+toxicity%3A+A+perspective+based+on+the+critical+examination+of+trends+in+the+top+200+drugs+marketed+in+the+United+States&doi=10.1021%2Ftx200168d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span></div><div class="casAuthors">Stepan, Antonia F.; Walker, Daniel P.; Bauman, Jonathan; Price, David A.; Baillie, Thomas A.; Kalgutkar, Amit S.; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1410</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Because of a preconceived notion that eliminating reactive metabolite (RM) formation with new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM formation is routinely examd. as part of lead optimization efforts in drug discovery.  Likewise, avoidance of "structural alerts" is almost a norm in drug design.  However, there is a growing concern that the perceived safety hazards assocd. with structural alerts and/or RM screening tools as standalone predictors of toxicity risks may be over exaggerated.  In addn., the multifactorial nature of idiosyncratic toxicity is now well recognized based upon observations that mechanisms other than RM formation (e.g., mitochondrial toxicity and inhibition of bile salt export pump (BSEP)) also can account for certain target organ toxicities.  Hence, fundamental questions arise such as: When is a mol. that contains a structural alert (RM pos. or neg.) a cause for concern.  Could the mol. in its parent form exert toxicity.  Can a low dose drug candidate truly mitigate metab.-dependent and -independent idiosyncratic toxicity risks.  In an effort to address these questions, we have retrospectively examd. 68 drugs (recalled or assocd. with a black box warning due to idiosyncratic toxicity) and the top 200 drugs (prescription and sales) in the United States in 2009 for trends in physiochem. characteristics, daily doses, presence of structural alerts, evidence for RM formation as well as toxicity mechanism(s) potentially mediated by parent drugs.  Collectively, our anal. revealed that a significant proportion (∼78-86%) of drugs assocd. with toxicity contained structural alerts and evidence indicating that RM formation as a causative factor for toxicity has been presented in 62-69% of these mols.  In several cases, mitochondrial toxicity and BSEP inhibition mediated by parent drugs were also noted as potential causative factors.  Most drugs were administered at daily doses exceeding several hundred milligrams.  There was no obvious link between idiosyncratic toxicity and physicochem. properties such as mol. wt., lipophilicity, etc.  Approx. half of the top 200 drugs for 2009 (prescription and sales) also contained one or more alerts in their chem. architecture, and many were found to be RM-pos.  Several instances of BSEP and mitochondrial liabilities were also noted with agents in the top 200 category.  However, with relatively few exceptions, the vast majority of these drugs are rarely assocd. with idiosyncratic toxicity, despite years of patient use.  The major differentiating factor appeared to be the daily dose; most of the drugs in the top 200 list are administered at low daily doses.  In addn., competing detoxication pathways and/or alternate nonmetabolic clearance routes provided suitable justifications for the safety records of RM-pos. drugs in the top 200 category.  Thus, while RM elimination may be a useful and pragmatic starting point in mitigating idiosyncratic toxicity risks, our anal. suggests a need for a more integrated screening paradigm for chem. hazard identification in drug discovery.  Thus, in addn. to a detailed assessment of RM formation potential (in relationship to the overall elimination mechanisms of the compd.(s)) for lead compds., effects on cellular health (e.g., cytotoxicity assays), BSEP inhibition, and mitochondrial toxicity are the recommended suite of assays to characterize compd. liabilities.  However, the prospective use of such data in compd. selection will require further validation of the cellular assays using marketed agents.  Until we gain a better understanding of the pathophysiol. mechanisms assocd. with idiosyncratic toxicities, improving pharmacokinetics and intrinsic potency as means of decreasing the dose size and the assocd. "body burden" of the parent drug and its metabolites will remain an overarching goal in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IhczIcvVDLVg90H21EOLACvtfcHk0ljDX-qK0yaVzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D&md5=632b73f755738e49eb233bc8dca1fbcc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520alert%252Freactive%2520metabolite%2520concept%2520as%2520applied%2520in%2520medicinal%2520chemistry%2520to%2520mitigate%2520the%2520risk%2520of%2520idiosyncratic%2520drug%2520toxicity%253A%2520A%2520perspective%2520based%2520on%2520the%2520critical%2520examination%2520of%2520trends%2520in%2520the%2520top%2520200%2520drugs%2520marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1345%26epage%3D1410%26doi%3D10.1021%2Ftx200168d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Gill, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Hippel, P. H.</span><span> </span><span class="NLM_article-title">Calculation of protein extinction coefficients from amino acid sequence data</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span><span class="refDoi"> DOI: 10.1016/0003-2697(89)90602-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2F0003-2697%2889%2990602-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=2610349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADyaL1MXmt1ygt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=1989&pages=319-326&author=S.+C.+Gillauthor=P.+H.+von+Hippel&title=Calculation+of+protein+extinction+coefficients+from+amino+acid+sequence+data&doi=10.1016%2F0003-2697%2889%2990602-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Calculation of protein extinction coefficients from amino acid sequence data</span></div><div class="casAuthors">Gill, Stanley C.; Von Hippel, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">319-26</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">Quant. study of protein-protein and protein-ligand interactions in soln. requires accurate detn. of protein concn.  Often, for proteins available only in mol. biol. amts., it is difficult or impossible to make an accurate exptl. measurement of the molar extinction coeff. of the protein.  Yet, without a reliable value of this parameter, one cannot det. protein concns. by the usual UV spectroscopic means.  Fortunately, knowledge of amino acid residue sequence and promoter mol. wt. (and thus also of amino acid compn.) is generally available through the DNA sequence, which is usually accurately known for most such proteins.  In this paper, a method is presented for calcg. accurate (to ±5% in most cases) molar extinction coeffs. for proteins at 280 nm, simply from knowledge of the amino acid compn.  The method is calibrated against 18 normal globular proteins whose molar extinction coeffs. are accurately known, and the assumptions underlying the method, as well as its limitations, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEi2o10uRFxbVg90H21EOLACvtfcHk0lgOE5xwpyvKdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXmt1ygt7Y%253D&md5=6f082112135f9f894d5e59b2370f2799</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2889%2990602-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252889%252990602-7%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DS.%2BC.%26aulast%3Dvon%2BHippel%26aufirst%3DP.%2BH.%26atitle%3DCalculation%2520of%2520protein%2520extinction%2520coefficients%2520from%2520amino%2520acid%2520sequence%2520data%26jtitle%3DAnal.%2520Biochem.%26date%3D1989%26volume%3D182%26spage%3D319%26epage%3D326%26doi%3D10.1016%2F0003-2697%2889%2990602-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors</span> <span class="citation_source-journal">Biochimica et Biophysica Acta (BBA) - Enzymology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span><span class="refDoi"> DOI: 10.1016/0005-2744(69)90420-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2F0005-2744%2869%2990420-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=4980133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADyaF1MXkvVOqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=1969&pages=269-286&author=J.+F.+Morrison&title=Kinetics+of+the+reversible+inhibition+of+enzyme-catalysed+reactions+by+tight-binding+inhibitors&doi=10.1016%2F0005-2744%2869%2990420-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of the reversible inhibition of enzyme-catalyzed reactions by tight-binding inhibitors</span></div><div class="casAuthors">Morrison, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Enzymology</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-86</span>CODEN:
                <span class="NLM_cas:coden">BBEZAD</span>;
        ISSN:<span class="NLM_cas:issn">0924-1086</span>.
    </div><div class="casAbstract">A theoretical kinetic study has been undertaken to det. the kinetic characteristics of enzymic reactions that are reversibly inhibited by a substrate analog. at concns. comparable to that of the enzyme.  A general rate equation, that allows for the combination of such a tight-binding inhibitor with one or more enzyme forms of any reaction mechanism, has been derived and shown to be quadratic with sq. and linear terms in υ which represents the true initial steady-state velocity.  From plots of υ against total enzyme concn. at fixed total inhibitor concn., the concn. of enzyme catalytic sites can be detd. irrespective of the nature of the inhibition and the reaction mechanism.  However, plots of υ (or I/υ) against total inhibitor concn. can be used for this purpose only if the dissocn. const. assocd. with the inhibitor is virtually zero.  Particular initial rate equations have been obtained for the cases in which the tight-binding inhibitor gives rise to competitive, noncompetitive, and uncompetitive inhibition with respect to one of the substrates of a bireactant mechanism.  From these equations it has been deduced that, in the presence of inhibitor, plots of I/υ against the reciprocals of the substrate concns. yield families of concave-down, nonrectangular hyperbolas.  The difficulties assocd. with the detn. of inhibition consts. for tight-binding inhibitors are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj4s_N2iV3CLVg90H21EOLACvtfcHk0lgOE5xwpyvKdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXkvVOqsbo%253D&md5=74d467477385488dfbb053358534ada6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2F0005-2744%2869%2990420-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2744%252869%252990420-3%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DKinetics%2520of%2520the%2520reversible%2520inhibition%2520of%2520enzyme-catalysed%2520reactions%2520by%2520tight-binding%2520inhibitors%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Enzymology%26date%3D1969%26volume%3D185%26spage%3D269%26epage%3D286%26doi%3D10.1016%2F0005-2744%2869%2990420-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Corbeil, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englebienne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Docking ligands into flexible and solvated macromolecules. 1. Development and validation of FITTED 1.0</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1021/ci6002637</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci6002637" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVWjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=435-449&author=C.+R.+Corbeilauthor=P.+Englebienneauthor=N.+Moitessier&title=Docking+ligands+into+flexible+and+solvated+macromolecules.+1.+Development+and+validation+of+FITTED+1.0&doi=10.1021%2Fci6002637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Docking Ligands into Flexible and Solvated Macromolecules. 1. Development and Validation of FITTED 1.0</span></div><div class="casAuthors">Corbeil, Christopher R.; Englebienne, Pablo; Moitessier, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report the development and validation of a novel suite of programs, FITTED 1.0, for the docking of flexible ligands into flexible proteins.  This docking tool is unique in that it can deal with both the flexibility of macromols. (side chains and main chains) and the presence of bridging water mols. while treating protein/ligand complexes as realistically dynamic systems.  This software relies on a genetic algorithm to account for the flexibility of the two mols. as well as the location of bridging water mols.  In addn., FITTED 1.0 features a novel application of a switching function to retain or displace key water mols. from the protein-ligand complexes.  Two independent modules, ProCESS and SMART, were developed to set up the proteins and the ligands prior to the docking stage.  Validation of the accuracy of the software was achieved via the application of FITTED 1.0 to the docking of inhibitors of HIV-1 protease, thymidine kinase, trypsin, factor Xa, and MMP to their resp. proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH9ypbBV5-k7Vg90H21EOLACvtfcHk0lgOE5xwpyvKdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVWjtbY%253D&md5=f1b5be0eb418ecc158f5f057c1f9567c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fci6002637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci6002637%26sid%3Dliteratum%253Aachs%26aulast%3DCorbeil%26aufirst%3DC.%2BR.%26aulast%3DEnglebienne%26aufirst%3DP.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DDocking%2520ligands%2520into%2520flexible%2520and%2520solvated%2520macromolecules.%25201.%2520Development%2520and%2520validation%2520of%2520FITTED%25201.0%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fci6002637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Therrien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englebienne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza-Sanchez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbeil, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weill, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campagna-Slater, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulatorswith FORECASTER, a novel platform for drug discovery</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span><span class="refDoi"> DOI: 10.1021/ci2004779</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci2004779" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCru7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=210-224&author=E.+Therrienauthor=P.+Englebienneauthor=A.+G.+Arrowsmithauthor=R.+Mendoza-Sanchezauthor=C.+R.+Corbeilauthor=N.+Weillauthor=V.+Campagna-Slaterauthor=N.+Moitessier&title=Integrating+medicinal+chemistry%2C+organic%2Fcombinatorial+chemistry%2C+and+computational+chemistry+for+the+discovery+of+selective+estrogen+receptor+modulatorswith+FORECASTER%2C+a+novel+platform+for+drug+discovery&doi=10.1021%2Fci2004779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Integrating Medicinal Chemistry, Organic/Combinatorial Chemistry, and Computational Chemistry for the Discovery of Selective Estrogen Receptor Modulators with Forecaster, a Novel Platform for Drug Discovery</span></div><div class="casAuthors">Therrien, Eric; Englebienne, Pablo; Arrowsmith, Andrew G.; Mendoza-Sanchez, Rodrigo; Corbeil, Christopher R.; Weill, Nathanael; Campagna-Slater, Valerie; Moitessier, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">210-224</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of a large medicinal chem. program, we wish to develop novel selective estrogen receptor modulators (SERMs) as potential breast cancer treatments using a combination of exptl. and computational approaches.  However, one of the remaining difficulties nowadays is to fully integrate computational (i.e., virtual, theor.) and medicinal (i.e., exptl., intuitive) chem. to take advantage of the full potential of both.  For this purpose, we have developed a Web-based platform, Forecaster, and a no. of programs (e.g., Prep., React, Select) with the aim of combining computational chem. and medicinal chem. expertise to facilitate drug discovery and development and more specifically to integrate synthesis into computer-aided drug design.  In our quest for potent SERMs, this platform was used to build virtual combinatorial libraries, filter and ext. a highly diverse library from the NCI database, and dock them to the estrogen receptor (ER), with all of these steps being fully automated by computational chemists for use by medicinal chemists.  As a result, virtual screening of a diverse library seeded with active compds. followed by a search for analogs yielded an enrichment factor of 129, with 98% of the seeded active compds. recovered, while the screening of a designed virtual combinatorial library including known actives yielded an area under the receiver operating characteristic (AU-ROC) of 0.78.  The lead optimization proved less successful, further demonstrating the challenge to simulate structure activity relationship studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt6YsO45gkpLVg90H21EOLACvtfcHk0lgHy_ZRtIB7Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCru7vE&md5=a7b3218263c14ae60a38962eed567e87</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fci2004779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci2004779%26sid%3Dliteratum%253Aachs%26aulast%3DTherrien%26aufirst%3DE.%26aulast%3DEnglebienne%26aufirst%3DP.%26aulast%3DArrowsmith%26aufirst%3DA.%2BG.%26aulast%3DMendoza-Sanchez%26aufirst%3DR.%26aulast%3DCorbeil%26aufirst%3DC.%2BR.%26aulast%3DWeill%26aufirst%3DN.%26aulast%3DCampagna-Slater%26aufirst%3DV.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DIntegrating%2520medicinal%2520chemistry%252C%2520organic%252Fcombinatorial%2520chemistry%252C%2520and%2520computational%2520chemistry%2520for%2520the%2520discovery%2520of%2520selective%2520estrogen%2520receptor%2520modulatorswith%2520FORECASTER%252C%2520a%2520novel%2520platform%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D210%26epage%3D224%26doi%3D10.1021%2Fci2004779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span><span> </span><span class="NLM_article-title">A short history of SHELX</span> <span class="citation_source-journal">Acta Crystallogr., Sect. A: Found. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span><span class="refDoi"> DOI: 10.1107/S0108767307043930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1107%2FS0108767307043930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=18156677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=112-122&author=G.+M.+Sheldrick&title=A+short+history+of+SHELX&doi=10.1107%2FS0108767307043930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A short history of SHELX</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An account is given of the development of the SHELX system of computer programs from SHELX-76 to the present day.  In addn. to identifying useful innovations that have come into general use through their implementation in SHELX, a crit. anal. is presented of the less-successful features, missed opportunities and desirable improvements for future releases of the software.  An attempt is made to understand how a program originally designed for photog. intensity data, punched cards and computers over 10000 times slower than an av. modern personal computer has managed to survive for so long.  SHELXL is the most widely used program for small-mol. refinement and SHELXS and SHELXD are often employed for structure soln. despite the availability of objectively superior programs.  SHELXL also finds a niche for the refinement of macromols. against high-resoln. or twinned data; SHELXPRO acts as an interface for macromol. applications.  SHELXC, SHELXD and SHELXE are proving useful for the exptl. phasing of macromols., esp. because they are fast and robust and so are often employed in pipelines for high-throughput phasing.  This paper could serve as a general literature citation when one or more of the open-source SHELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure detn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLPYyJyJ2RbVg90H21EOLACvtfcHk0lgHy_ZRtIB7Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO&md5=8f91f10be4a9df74b2a9dad522c71e6e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0108767307043930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767307043930%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DA%2520short%2520history%2520of%2520SHELX%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D2008%26volume%3D64%26spage%3D112%26epage%3D122%26doi%3D10.1107%2FS0108767307043930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Farrugia, L. J.</span><span> </span><span class="NLM_article-title">WinGX suite for small-molecule single-crystal crystallography</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">838</span><span class="refDoi"> DOI: 10.1107/S0021889899006020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1107%2FS0021889899006020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADyaK1MXlsVSlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1999&pages=837-838&author=L.+J.+Farrugia&title=WinGX+suite+for+small-molecule+single-crystal+crystallography&doi=10.1107%2FS0021889899006020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">WinGX suite for small-molecule single-crystal crystallography</span></div><div class="casAuthors">Farrugia, Louis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">837-838</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">The crystallog. problem:  The processing of a small-mol. structure from single-crystal X-ray or neutron diffraction data through structure soln. and refinement to prepn. of publication material is a well established and usually a reasonably automated procedure.  There are several excellent com. software packages, such as SHELXTL (Siemens, 1995) and TEXSAN (Mol. Structure Corporation, 1995), which provide all the necessary programs to undertake this procedure, but these packages are often quite expensive and usually tied to the sale of specific diffractometer hardware.  The WinGX suite provides an integrated and freely available set of Microsoft Windows programs to accomplish this task.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr53gZdiGzSn7Vg90H21EOLACvtfcHk0lgHy_ZRtIB7Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsVSlurk%253D&md5=06e3e6a405d75250687285442cbbf70a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0021889899006020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889899006020%26sid%3Dliteratum%253Aachs%26aulast%3DFarrugia%26aufirst%3DL.%2BJ.%26atitle%3DWinGX%2520suite%2520for%2520small-molecule%2520single-crystal%2520crystallography%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1999%26volume%3D32%26spage%3D837%26epage%3D838%26doi%3D10.1107%2FS0021889899006020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Gulías, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durán, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castedo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascareñas, J. L.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed [4 + 3] Intramolecular Cycloaddition of Alkylidenecyclopropanes and Dienes</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">11026</span><span class="NLM_x">–</span> <span class="NLM_lpage">11027</span><span class="refDoi"> DOI: 10.1021/ja0756467</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0756467" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Wht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=11026-11027&author=M.+Gul%C3%ADasauthor=J.+Dur%C3%A1nauthor=F.+L%C3%B3pezauthor=L.+Castedoauthor=J.+L.+Mascare%C3%B1as&title=Palladium-Catalyzed+%5B4+%2B+3%5D+Intramolecular+Cycloaddition+of+Alkylidenecyclopropanes+and+Dienes&doi=10.1021%2Fja0756467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed [4 + 3] intramolecular cycloaddition of alkylidenecyclopropanes and dienes</span></div><div class="casAuthors">Gulias, Moises; Duran, Juan; Lopez, Fernando; Castedo, Luis; Mascarenas, Jose L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">11026-11027</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Octa-5,7-dienylidenecyclopropanes underwent intramol. [4 + 3]-cycloaddn. reactions upon treatment with appropriate palladium catalysts to give stereochem. rich bicyclodecene systems, e.g., I, in a completely diastereoselective manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGregIOTXIjeBrVg90H21EOLACvtfcHk0lgHy_ZRtIB7Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Wht7c%253D&md5=1e013f7468f2b60859ea101b9b980006</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fja0756467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0756467%26sid%3Dliteratum%253Aachs%26aulast%3DGul%25C3%25ADas%26aufirst%3DM.%26aulast%3DDur%25C3%25A1n%26aufirst%3DJ.%26aulast%3DL%25C3%25B3pez%26aufirst%3DF.%26aulast%3DCastedo%26aufirst%3DL.%26aulast%3DMascare%25C3%25B1as%26aufirst%3DJ.%2BL.%26atitle%3DPalladium-Catalyzed%2520%255B4%2520%252B%25203%255D%2520Intramolecular%2520Cycloaddition%2520of%2520Alkylidenecyclopropanes%2520and%2520Dienes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D11026%26epage%3D11027%26doi%3D10.1021%2Fja0756467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Mellor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagland, A. M.</span><span> </span><span class="NLM_article-title">Synthesis of hydroisoindoles via intramolecular Diels-Alder reactions of functionalised amido trienes</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1005</span><span class="refDoi"> DOI: 10.1039/p19890000997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1039%2Fp19890000997" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1989&pages=997-1005&author=J.+M.+Mellorauthor=A.+M.+Wagland&title=Synthesis+of+hydroisoindoles+via+intramolecular+Diels-Alder+reactions+of+functionalised+amido+trienes&doi=10.1039%2Fp19890000997"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fp19890000997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp19890000997%26sid%3Dliteratum%253Aachs%26aulast%3DMellor%26aufirst%3DJ.%2BM.%26aulast%3DWagland%26aufirst%3DA.%2BM.%26atitle%3DSynthesis%2520of%2520hydroisoindoles%2520via%2520intramolecular%2520Diels-Alder%2520reactions%2520of%2520functionalised%2520amido%2520trienes%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1989%26spage%3D997%26epage%3D1005%26doi%3D10.1039%2Fp19890000997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 16 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wanlei Wei, Candide Champion, Zhaomin Liu, Stephen J. Barigye, Paul Labute, <span class="NLM_string-name hlFld-ContribAuthor">Nicolas Moitessier</span>. </span><span class="cited-content_cbyCitation_article-title">Torsional Energy Barriers of Biaryls Could Be Predicted by Electron Richness/Deficiency of Aromatic Rings; Advancement of Molecular Mechanics toward Atom-Type Independence. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (11)
                                     , 4764-4777. <a href="https://doi.org/10.1021/acs.jcim.9b00585" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00585</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00585%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DTorsional%252BEnergy%252BBarriers%252Bof%252BBiaryls%252BCould%252BBe%252BPredicted%252Bby%252BElectron%252BRichness%25252FDeficiency%252Bof%252BAromatic%252BRings%25253B%252BAdvancement%252Bof%252BMolecular%252BMechanics%252Btoward%252BAtom-Type%252BIndependence%26aulast%3DWei%26aufirst%3DWanlei%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17072019%26date%3D19092019%26date%3D20082019%26volume%3D59%26issue%3D11%26spage%3D4764%26epage%3D4777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jessica Plescia, Stéphane De Cesco, Mihai Burai Patrascu, Jerry Kurian, Justin Di Trani, Caroline Dufresne, Alexander S. Wahba, Naëla Janmamode, Anthony K. Mittermaier, <span class="NLM_string-name hlFld-ContribAuthor">Nicolas Moitessier</span>. </span><span class="cited-content_cbyCitation_article-title">Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (17)
                                     , 7874-7884. <a href="https://doi.org/10.1021/acs.jmedchem.9b00642" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00642%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIntegrated%252BSynthetic%25252C%252BBiophysical%25252C%252Band%252BComputational%252BInvestigations%252Bof%252BCovalent%252BInhibitors%252Bof%252BProlyl%252BOligopeptidase%252Band%252BFibroblast%252BActivation%252BProtein%252B%2525CE%2525B1%26aulast%3DPlescia%26aufirst%3DJessica%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15042019%26date%3D22082019%26date%3D08082019%26volume%3D62%26issue%3D17%26spage%3D7874%26epage%3D7884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jingjing Xu, Benguo Lin, Xiuqing Jiang, Zejun Jia, Jinlong Wu, <span class="NLM_string-name hlFld-ContribAuthor">Wei-Min Dai</span>. </span><span class="cited-content_cbyCitation_article-title">Intramolecular Diels–Alder Cycloaddition Approach toward the cis-Fused Δ5,6-Hexahydroisoindol-1-one Core of Cytochalasins. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (3)
                                     , 830-834. <a href="https://doi.org/10.1021/acs.orglett.8b04129" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b04129</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b04129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b04129%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DIntramolecular%252BDiels%2525E2%252580%252593Alder%252BCycloaddition%252BApproach%252Btoward%252Bthe%252Bcis-Fused%252B%2525CE%2525945%25252C6-Hexahydroisoindol-1-one%252BCore%252Bof%252BCytochalasins%26aulast%3DXu%26aufirst%3DJingjing%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D26122018%26date%3D15012019%26volume%3D21%26issue%3D3%26spage%3D830%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justin M.  Di Trani</span>, <span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>, and <span class="hlFld-ContribAuthor ">Anthony K.  Mittermaier</span>  . </span><span class="cited-content_cbyCitation_article-title">Measuring Rapid Time-Scale Reaction Kinetics Using Isothermal Titration Calorimetry. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2017,</strong> <em>89 </em>
                                    (13)
                                     , 7022-7030. <a href="https://doi.org/10.1021/acs.analchem.7b00693" title="DOI URL">https://doi.org/10.1021/acs.analchem.7b00693</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.7b00693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.7b00693%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DMeasuring%252BRapid%252BTime-Scale%252BReaction%252BKinetics%252BUsing%252BIsothermal%252BTitration%252BCalorimetry%26aulast%3DDi%2BTrani%26aufirst%3DJustin%2BM.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23022017%26date%3D07062017%26date%3D21062017%26date%3D05072017%26date%3D07062017%26volume%3D89%26issue%3D13%26spage%3D7022%26epage%3D7030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>, <span class="hlFld-ContribAuthor ">Joshua  Pottel</span>, <span class="hlFld-ContribAuthor ">Eric  Therrien</span>, <span class="hlFld-ContribAuthor ">Pablo  Englebienne</span>, <span class="hlFld-ContribAuthor ">Zhaomin  Liu</span>, <span class="hlFld-ContribAuthor ">Anna  Tomberg</span>, and <span class="hlFld-ContribAuthor ">Christopher R.  Corbeil</span>  . </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry Projects Requiring Imaginative Structure-Based Drug Design Methods. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2016,</strong> <em>49 </em>
                                    (9)
                                     , 1646-1657. <a href="https://doi.org/10.1021/acs.accounts.6b00185" title="DOI URL">https://doi.org/10.1021/acs.accounts.6b00185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.6b00185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.6b00185%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DMedicinal%252BChemistry%252BProjects%252BRequiring%252BImaginative%252BStructure-Based%252BDrug%252BDesign%252BMethods%26aulast%3DMoitessier%26aufirst%3DNicolas%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D14042016%26date%3D16082016%26date%3D20092016%26volume%3D49%26issue%3D9%26spage%3D1646%26epage%3D1657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julio  Caballero</span>. </span><span class="cited-content_cbyCitation_article-title">The latest automated docking technologies for novel drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em>16 </em>
                                    (6)
                                     , 625-645. <a href="https://doi.org/10.1080/17460441.2021.1858793" title="DOI URL">https://doi.org/10.1080/17460441.2021.1858793</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1858793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1858793%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DThe%252Blatest%252Bautomated%252Bdocking%252Btechnologies%252Bfor%252Bnovel%252Bdrug%252Bdiscovery%26aulast%3DCaballero%26aufirst%3DJulio%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D6%26spage%3D625%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica  Plescia</span>, <span class="hlFld-ContribAuthor ">Caroline  Dufresne</span>, <span class="hlFld-ContribAuthor ">Naëla  Janmamode</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Wahba</span>, <span class="hlFld-ContribAuthor ">Anthony K.  Mittermaier</span>, <span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of covalent prolyl oligopeptidase boronic ester inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111783. <a href="https://doi.org/10.1016/j.ejmech.2019.111783" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111783</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111783%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bcovalent%252Bprolyl%252Boligopeptidase%252Bboronic%252Bester%252Binhibitors%26aulast%3DPlescia%26aufirst%3DJessica%26date%3D2020%26volume%3D185%26spage%3D111783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raj  Kumar</span>, <span class="hlFld-ContribAuthor ">Saravanan  Parameswaran</span>, <span class="hlFld-ContribAuthor ">Rohit  Bavi</span>, <span class="hlFld-ContribAuthor ">Ayoung  Baek</span>, <span class="hlFld-ContribAuthor ">Minky  Son</span>, <span class="hlFld-ContribAuthor ">Shailima  Rampogu</span>, <span class="hlFld-ContribAuthor ">Chanin  Park</span>, <span class="hlFld-ContribAuthor ">Gihwan  Lee</span>, <span class="hlFld-ContribAuthor ">Amir  Zeb</span>, <span class="hlFld-ContribAuthor ">Shraddha  Parate</span>, <span class="hlFld-ContribAuthor ">Rabia Mukhtar  Rana</span>, <span class="hlFld-ContribAuthor ">Keun Woo  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of novel chemical scaffolds targeting prolyl oligopeptidase for neurological therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2019,</strong> <em>88 </em>, 92-103. <a href="https://doi.org/10.1016/j.jmgm.2018.12.006" title="DOI URL">https://doi.org/10.1016/j.jmgm.2018.12.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2018.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2018.12.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DInvestigation%252Bof%252Bnovel%252Bchemical%252Bscaffolds%252Btargeting%252Bprolyl%252Boligopeptidase%252Bfor%252Bneurological%252Btherapeutics%26aulast%3DKumar%26aufirst%3DRaj%26date%3D2019%26volume%3D88%26spage%3D92%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Chang</span>, <span class="hlFld-ContribAuthor ">Serge  Thorimbert</span>, <span class="hlFld-ContribAuthor ">Luc  Dechoux</span>. </span><span class="cited-content_cbyCitation_article-title">The bio-based methyl coumalate involved Morita–Baylis–Hillman reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (10)
                                     , 2784-2791. <a href="https://doi.org/10.1039/C9OB00328B" title="DOI URL">https://doi.org/10.1039/C9OB00328B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB00328B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB00328B%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DThe%252Bbio-based%252Bmethyl%252Bcoumalate%252Binvolved%252BMorita%2525E2%252580%252593Baylis%2525E2%252580%252593Hillman%252Breaction%26aulast%3DChang%26aufirst%3DLiang%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D10%26spage%3D2784%26epage%3D2791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justin M.  Di Trani</span>, <span class="hlFld-ContribAuthor ">Stephane  De Cesco</span>, <span class="hlFld-ContribAuthor ">Rebecca  O’Leary</span>, <span class="hlFld-ContribAuthor ">Jessica  Plescia</span>, <span class="hlFld-ContribAuthor ">Claudia Jorge  do Nascimento</span>, <span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>, <span class="hlFld-ContribAuthor ">Anthony K.  Mittermaier</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid measurement of inhibitor binding kinetics by isothermal titration calorimetry. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-018-03263-3" title="DOI URL">https://doi.org/10.1038/s41467-018-03263-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-018-03263-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-018-03263-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DRapid%252Bmeasurement%252Bof%252Binhibitor%252Bbinding%252Bkinetics%252Bby%252Bisothermal%252Btitration%252Bcalorimetry%26aulast%3DDi%2BTrani%26aufirst%3DJustin%2BM.%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph  Sotriffer</span>. </span><span class="cited-content_cbyCitation_article-title">Docking of Covalent Ligands: Challenges and Approaches. </span><span class="cited-content_cbyCitation_journal-name">Molecular Informatics</span><span> <strong>2018,</strong> <em>37 </em>
                                    (9-10)
                                     , 1800062. <a href="https://doi.org/10.1002/minf.201800062" title="DOI URL">https://doi.org/10.1002/minf.201800062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/minf.201800062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fminf.201800062%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Informatics%26atitle%3DDocking%252Bof%252BCovalent%252BLigands%25253A%252BChallenges%252Band%252BApproaches%26aulast%3DSotriffer%26aufirst%3DChristoph%26date%3D2018%26date%3D2018%26volume%3D37%26issue%3D9-10%26spage%3D1800062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Salvador  Guardiola</span>, <span class="hlFld-ContribAuthor ">Roger  Prades</span>, <span class="hlFld-ContribAuthor ">Laura  Mendieta</span>, <span class="hlFld-ContribAuthor ">Arwin J.  Brouwer</span>, <span class="hlFld-ContribAuthor ">Jelle  Streefkerk</span>, <span class="hlFld-ContribAuthor ">Laura  Nevola</span>, <span class="hlFld-ContribAuthor ">Teresa  Tarragó</span>, <span class="hlFld-ContribAuthor ">Rob M.J.  Liskamp</span>, <span class="hlFld-ContribAuthor ">Ernest  Giralt</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Covalent Inhibition of Prolyl Oligopeptidase (POP): Discovery of Sulfonylfluoride Peptidomimetics. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2018,</strong> <em>25 </em>
                                    (8)
                                     , 1031-1037.e4. <a href="https://doi.org/10.1016/j.chembiol.2018.04.013" title="DOI URL">https://doi.org/10.1016/j.chembiol.2018.04.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2018.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2018.04.013%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DTargeted%252BCovalent%252BInhibition%252Bof%252BProlyl%252BOligopeptidase%252B%252528POP%252529%25253A%252BDiscovery%252Bof%252BSulfonylfluoride%252BPeptidomimetics%26aulast%3DGuardiola%26aufirst%3DSalvador%26date%3D2018%26volume%3D25%26issue%3D8%26spage%3D1031%26epage%3D1037.e4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ernest  Awoonor-Williams</span>, <span class="hlFld-ContribAuthor ">Andrew G.  Walsh</span>, <span class="hlFld-ContribAuthor ">Christopher N.  Rowley</span>. </span><span class="cited-content_cbyCitation_article-title">Modeling covalent-modifier drugs. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2017,</strong> <em>1865 </em>
                                    (11)
                                     , 1664-1675. <a href="https://doi.org/10.1016/j.bbapap.2017.05.009" title="DOI URL">https://doi.org/10.1016/j.bbapap.2017.05.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2017.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2017.05.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DModeling%252Bcovalent-modifier%252Bdrugs%26aulast%3DAwoonor-Williams%26aufirst%3DErnest%26date%3D2017%26volume%3D1865%26issue%3D11%26spage%3D1664%26epage%3D1675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephane  De Cesco</span>, <span class="hlFld-ContribAuthor ">Jerry  Kurian</span>, <span class="hlFld-ContribAuthor ">Caroline  Dufresne</span>, <span class="hlFld-ContribAuthor ">Anthony K.  Mittermaier</span>, <span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent inhibitors design and discovery. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>138 </em>, 96-114. <a href="https://doi.org/10.1016/j.ejmech.2017.06.019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.06.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.06.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCovalent%252Binhibitors%252Bdesign%252Band%252Bdiscovery%26aulast%3DDe%2BCesco%26aufirst%3DStephane%26date%3D2017%26volume%3D138%26spage%3D96%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan-Jiao  Gao</span>, <span class="hlFld-ContribAuthor ">Shi-Peng  Luo</span>, <span class="hlFld-ContribAuthor ">Jian-Liang  Ye</span>, <span class="hlFld-ContribAuthor ">Pei-Qiang  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">An attempted approach to the tricyclic core of haliclonin A: Structural elucidation of the final product by 2D NMR. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2017,</strong> <em>28 </em>
                                    (6)
                                     , 1176-1181. <a href="https://doi.org/10.1016/j.cclet.2017.04.016" title="DOI URL">https://doi.org/10.1016/j.cclet.2017.04.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2017.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2017.04.016%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DAn%252Battempted%252Bapproach%252Bto%252Bthe%252Btricyclic%252Bcore%252Bof%252Bhaliclonin%252BA%25253A%252BStructural%252Belucidation%252Bof%252Bthe%252Bfinal%252Bproduct%252Bby%252B2D%252BNMR%26aulast%3DGao%26aufirst%3DYan-Jiao%26date%3D2017%26volume%3D28%26issue%3D6%26spage%3D1176%26epage%3D1181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sylvain  Rocheleau</span>, <span class="hlFld-ContribAuthor ">Joshua  Pottel</span>, <span class="hlFld-ContribAuthor ">Igor  Huskić</span>, <span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Regioselective Monoacylation of Unprotected Glucopyranoside Using Transient Directing-Protecting Groups. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (3)
                                     , 646-656. <a href="https://doi.org/10.1002/ejoc.201601457" title="DOI URL">https://doi.org/10.1002/ejoc.201601457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201601457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201601457%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DHighly%252BRegioselective%252BMonoacylation%252Bof%252BUnprotected%252BGlucopyranoside%252BUsing%252BTransient%252BDirecting-Protecting%252BGroups%26aulast%3DRocheleau%26aufirst%3DSylvain%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D3%26spage%3D646%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected POP inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Designed series of potential POP inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Seven most conformationally different POP crystal structures. Left panel, global fold ribbon diagram; right panel, binding site residues. Co-crystallized inhibitors are shown in orange.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Reaction scheme for covalent inhibition. <i>E</i>, enzyme; <i>I</i>, inhibitor; <i>E</i>···<i>I</i>, noncovalent complex; <i>k</i><sub>1</sub>, association rate constant; <i>k</i><sub>–1</sub>, dissociation rate constant.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structure-based design of potential covalent POP inhibitors. (a) Cocrystallized ligand (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xdw">2xdw</a>) together with known inhibitor <b>4</b> docked; (b) <b>8a</b>, R<sup>1</sup> = Me, R<sup>2</sup> = Bn; (c) <b>8a</b>, R<sup>1</sup> = H, R<sup>2</sup> = Bn; (d) <b>8b</b>, R<sup>1</sup> = Me, R<sup>2</sup> = Bn; (e) <b>8a</b>, R<sup>1</sup> = H, R<sup>2</sup> = CbzNH; (f) <b>8a</b>, R<sup>1</sup> = <i>i</i>-Pr, R<sup>2</sup> = Bn.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Generic structure of potential POP inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <sup>1</sup>H NMR spectrum of (a) a mixture of <i>endo</i> and <i>exo</i> adducts <b>14d</b> and <b>13d</b>; (b) <i>exo</i> adduct <b>13d</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Stereochemistry of scaffolds <b>13b</b> ascertained by NOESY and the structure of <b>13d</b> determined by X-ray crystallography (oxygens in red, nitrogen in blue, carbons in gray, and hydrogens in light gray).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/medium/jm-2015-01296v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structure of <b>16d</b> (oxygens in red, nitrogens in blue, carbons in gray, and hydrogens in light gray) as determined by X-ray crystallography and <sup>1</sup>H NMR spectra of the enantiopure compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-9/acs.jmedchem.5b01296/20160506/images/large/jm-2015-01296v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01296&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i64">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35231" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35231" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 45 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lawandi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber-Lemaire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Inhibitors of prolyl oligopeptidases for the therapy of human diseases: Defining diseases and inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3423</span><span class="NLM_x">–</span> <span class="NLM_lpage">3438</span><span class="refDoi"> DOI: 10.1021/jm901104g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901104g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFOmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3423-3438&author=J.+Lawandiauthor=S.+Gerber-Lemaireauthor=L.+Juillerat-Jeanneretauthor=N.+Moitessier&title=Inhibitors+of+prolyl+oligopeptidases+for+the+therapy+of+human+diseases%3A+Defining+diseases+and+inhibitors&doi=10.1021%2Fjm901104g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Prolyl Oligopeptidases for the Therapy of Human Diseases: Defining Diseases and Inhibitors</span></div><div class="casAuthors">Lawandi, Janice; Gerber-Lemaire, Sandrine; Juillerat-Jeanneret, Lucienne; Moitessier, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3423-3438</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Over the past 2 decades, researchers have linked abnormal mammalian prolyl oligopeptidase (POP) activity to neurol. disorders.  To better understand and treat these different diseases and to minimize toxicity and side effects, inhibitors of POP must be potent and also selective for the target enzyme.  Given the many seemingly similar enzymes grouped under proline-specific proteases, we aim to first highlight the similarities and differences between a few of the enzymes of this family.  In a subsequent part of this Perspective, we will focus on one proline-specific peptidase, POP, and discuss the structure-activity relationship of inhibitors developed as potential therapeutic drugs treating neurol. disorders.  Furthermore, we will discuss two possible pharmacophores, one encompassing features to achieve selectivity for POP over other proline-specific proteases and another one ranking features to improve inhibitor potency.  We believe that the data collected within this review will guide the future development of novel, selective POP inhibitors as more effective candidate drugs (CDs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPbicA2SUUkrVg90H21EOLACvtfcHk0lhJR3pPmk7RuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFOmuw%253D%253D&md5=433f511b0177657def61ec228d9a2517</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm901104g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901104g%26sid%3Dliteratum%253Aachs%26aulast%3DLawandi%26aufirst%3DJ.%26aulast%3DGerber-Lemaire%26aufirst%3DS.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DInhibitors%2520of%2520prolyl%2520oligopeptidases%2520for%2520the%2520therapy%2520of%2520human%2520diseases%253A%2520Defining%2520diseases%2520and%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3423%26epage%3D3438%26doi%3D10.1021%2Fjm901104g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lambeir, A. M.</span><span> </span><span class="NLM_article-title">Translational research on prolyl oligopeptidase inhibitors: The long road ahead</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span><span class="refDoi"> DOI: 10.1517/13543776.2011.587803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1517%2F13543776.2011.587803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=21679099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns12msL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=977-981&author=A.+M.+Lambeir&title=Translational+research+on+prolyl+oligopeptidase+inhibitors%3A+The+long+road+ahead&doi=10.1517%2F13543776.2011.587803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Translational research on prolyl oligopeptidase inhibitors: the long road ahead</span></div><div class="casAuthors">Lambeir, Anne-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">977-981</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Despite the fact that some have passed early phases of clin. trials, no prolyl oligopeptidase inhibitors are currently on the market.  Yet, since 2003, there has been a boost in patent applications claiming prolyl oligopeptidase inhibitors for the treatment of Alzheimer's and Parkinson's diseases, and other neurodegenerative and psychiatric disorders.  While experts in the field call for innovative scaffolds to develop more potent inhibitors with more favorable properties, they also relate a lack of knowledge of the toxicol., bioavailability, pharmacokinetics and pharmacodynamics of existing compds. that hinders their assessment.  Yet, with the current insights, it is difficult to correlate specific inhibitor effects with the postulated functions of prolyl oligopeptidase in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRSBH4ms2c2LVg90H21EOLACvtfcHk0lglTWv_FVqqdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns12msL0%253D&md5=f88cc200387e4cb4a590d6c2c600626e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.587803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.587803%26sid%3Dliteratum%253Aachs%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26atitle%3DTranslational%2520research%2520on%2520prolyl%2520oligopeptidase%2520inhibitors%253A%2520The%2520long%2520road%2520ahead%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D977%26epage%3D981%26doi%3D10.1517%2F13543776.2011.587803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">López, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarragó, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giralt, E.</span><span> </span><span class="NLM_article-title">Low molecular weight inhibitors of Prolyl Oligopeptidase: A review of compounds patented from 2003 to 2010</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1023</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span><span class="refDoi"> DOI: 10.1517/13543776.2011.577416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1517%2F13543776.2011.577416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=21539473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A280%3ADC%252BC3Mnht1SmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1023-1044&author=A.+L%C3%B3pezauthor=T.+Tarrag%C3%B3author=E.+Giralt&title=Low+molecular+weight+inhibitors+of+Prolyl+Oligopeptidase%3A+A+review+of+compounds+patented+from+2003+to+2010&doi=10.1517%2F13543776.2011.577416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Low molecular weight inhibitors of Prolyl Oligopeptidase: a review of compounds patented from 2003 to 2010</span></div><div class="casAuthors">Lopez Abraham; Tarrago Teresa; Giralt Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Expert opinion on therapeutic patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1023-44</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Prolyl Oligopeptidase (POP) is a serine peptidase that cleaves post-proline bonds in short peptides.  Besides the direct hydrolytic regulation function over peptides, neuropeptides and peptide hormones, POP is probably involved in the regulation of the inositol pathway and participates in protein-protein interactions.  Experimental data show that POP inhibitors have neuroprotective, anti-amnesic and cognition-enhancing properties.  These compounds are considered therapeutic agents of interest for the treatment of cognitive deficits related to neuropsychiatric and neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.  Recent findings pointed to the involvement of POP in angiogenesis, although the exact mechanism is still under study.  AREAS COVERED:  This review comprises patents and patent applications involving POP inhibitors patented between 2003 and 2010, classified as peptidomimetics, heteroaryl ketones and alkaloids.  The binding processes and the mechanisms of inhibition of these inhibitors are also discussed, together with their in vivo effects.  EXPERT OPINION:  The major part of the repertory of POP inhibitors derived from systematical modification of the canonical compound benzyloxycarbonyl-prolyl-prolinal (ZPP).  Nevertheless, only two of them have progressed into the clinical trials.  One possible reason for this failure is the lack of studies concerning pharmacodynamics, pharmacokinetics and toxicity, together with the absence of suitable animal models.  Moreover, POP is still not a well-defined therapeutic target.  Further studies are required for the elucidation of the biological role of POP and to validate the therapeutic action of inhibitors in cognitive processes.  In contrast, the involvement of POP in protein-protein interactions together with the recent evidences in angiogenesis opens alternative approaches to the traditional active site-directed inhibitors, as well as new therapeutic applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQx4uguBhbB49hSDZx9hyjKfW6udTcc2ebq-YuC9AXn57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mnht1SmtQ%253D%253D&md5=83b58a36c971774516e7635ac1fae5dc</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.577416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.577416%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B3pez%26aufirst%3DA.%26aulast%3DTarrag%25C3%25B3%26aufirst%3DT.%26aulast%3DGiralt%26aufirst%3DE.%26atitle%3DLow%2520molecular%2520weight%2520inhibitors%2520of%2520Prolyl%2520Oligopeptidase%253A%2520A%2520review%2520of%2520compounds%2520patented%2520from%25202003%2520to%25202010%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D1023%26epage%3D1044%26doi%3D10.1517%2F13543776.2011.577416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Cunningham, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, B.</span><span> </span><span class="NLM_article-title">Identification and initial characterisation of a N-benzyloxycarbonyl-prolyl-prolinal (Z-Pro-prolinal)-insensitive 7-(N-benzyloxycarbonyl-glycyl-prolyl-amido)-4- methylcoumarin (Z-Gly-Bro-NH-Mec)-hydrolysing peptidase in bovine serum</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">900</span><span class="NLM_x">–</span> <span class="NLM_lpage">903</span><span class="refDoi"> DOI: 10.1111/j.1432-1033.1997.00900.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1111%2Fj.1432-1033.1997.00900.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=9108263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADyaK2sXisVert7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1997&pages=900-903&author=D.+F.+Cunninghamauthor=B.+O%E2%80%99Connor&title=Identification+and+initial+characterisation+of+a+N-benzyloxycarbonyl-prolyl-prolinal+%28Z-Pro-prolinal%29-insensitive+7-%28N-benzyloxycarbonyl-glycyl-prolyl-amido%29-4-+methylcoumarin+%28Z-Gly-Bro-NH-Mec%29-hydrolysing+peptidase+in+bovine+serum&doi=10.1111%2Fj.1432-1033.1997.00900.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and initial characterization of a N-benzyloxycarbonyl-prolyl-prolinal (Z-Pro-prolinal)-insensitive 7-(N-benzyloxycarbonyl-glycyl-prolyl-amido)-4-methylcoumarin (Z-Gly-Pro-NH-Mec)-hydrolyzing peptidase in bovine serum</span></div><div class="casAuthors">Cunningham, Damian F.; O'Connor, Brendan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">900-903</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Prolyl endopeptidase is an enzyme, which cleaves on the carboxyl side of Pro within peptide substrates.  Its broad specificity towards bioactive peptides has led to its implication in various disease states including neurodegenerative and psychiatric disorders.  This assocn. was based primarily on the abnormal levels of activity obsd. following the enzymes detection with the reportedly specific fluorimetric substrate, 7-(N-benzyloxycarbonyl-glycyl-prolyl-amido)-4-methylcoumarin (2-Gly-Pro-NH-Mec).  The discovery and preliminary characterization of a Z-Gly-Pro-NH-Mec-hydrolyzing activity was reported that is distinct from prolyl oligopeptidase (prolyl endopeptidase).  Following the prodn. of serum from bovine whole blood, Z-Gly-Pro-NH-Mec hydrolysis in serum was detd. to be 7.2 U/mg protein.  In the presence of 350 nM Z-Pro-prolinal, a specific inhibitor of prolyl endopeptidase, residual Z-Gly-Pro-NH-Mec hydrolysis of 2.6 U/mg protein was obsd.  This residual activity was resistant to inhibition by Z-Pro-prolinal at concns. in excess of 200 times its reported Ki value for prolyl endopeptidase and could not be inhibited under conditions of prolonged incubation with the inhibitor.  Following cation-exchange chromatog., Z-Gly-Pro-NH-Mec-hydrolyzing activity was resolved into 2 distinct entities.  The first was inhibited by Z-Pro-prolinal, demonstrated activity towards the thyroliberin analog, 7-(pyroglutamyl-histidyl-prolyl)-4-methylcoumarin (Glp-His-Pro-NH-Mec), and was catalytically enhanced under reduced assay conditions.  This activity was subsequently designated prolyl endopeptidase.  The second activity was totally resistant to Z-Pro-prolinal inhibition, demonstrated no activity towards Glp-His-Pro-NH-Mec, and was unaffected when assayed under reduced conditions.  It was subsequently designated Z-Pro-prolinal-insensitive Z-Gly-Pro-NH-Mec-hydrolyzing peptidase (ZIP).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPJed2zfz-y7Vg90H21EOLACvtfcHk0lgZ7kUb5VSH7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisVert7w%253D&md5=5b2ef7ead8e3fad351eaffcaed99d319</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1997.00900.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1997.00900.x%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DD.%2BF.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DB.%26atitle%3DIdentification%2520and%2520initial%2520characterisation%2520of%2520a%2520N-benzyloxycarbonyl-prolyl-prolinal%2520%2528Z-Pro-prolinal%2529-insensitive%25207-%2528N-benzyloxycarbonyl-glycyl-prolyl-amido%2529-4-%2520methylcoumarin%2520%2528Z-Gly-Bro-NH-Mec%2529-hydrolysing%2520peptidase%2520in%2520bovine%2520serum%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1997%26volume%3D244%26spage%3D900%26epage%3D903%26doi%3D10.1111%2Fj.1432-1033.1997.00900.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Toide, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinoda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uemura, A.</span><span> </span><span class="NLM_article-title">A novel propyl endopeptidase inhibitor, JTP-4819, with potential for treating Alzheimer’s disease</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1016/S0166-4328(97)86059-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2FS0166-4328%2897%2986059-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1997&pages=147-151&author=K.+Toideauthor=M.+Shinodaauthor=Y.+Iwamotoauthor=T.+Fujiwaraauthor=K.+Okamiyaauthor=A.+Uemura&title=A+novel+propyl+endopeptidase+inhibitor%2C+JTP-4819%2C+with+potential+for+treating+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0166-4328%2897%2986059-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0166-4328%2897%2986059-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-4328%252897%252986059-7%26sid%3Dliteratum%253Aachs%26aulast%3DToide%26aufirst%3DK.%26aulast%3DShinoda%26aufirst%3DM.%26aulast%3DIwamoto%26aufirst%3DY.%26aulast%3DFujiwara%26aufirst%3DT.%26aulast%3DOkamiya%26aufirst%3DK.%26aulast%3DUemura%26aufirst%3DA.%26atitle%3DA%2520novel%2520propyl%2520endopeptidase%2520inhibitor%252C%2520JTP-4819%252C%2520with%2520potential%2520for%2520treating%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D1997%26volume%3D83%26spage%3D147%26epage%3D151%26doi%3D10.1016%2FS0166-4328%2897%2986059-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Jarho, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venäläinen, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huuskonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiaans, J. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Horsman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallén, E. A. A.</span><span> </span><span class="NLM_article-title">A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5605</span><span class="NLM_x">–</span> <span class="NLM_lpage">5607</span><span class="refDoi"> DOI: 10.1021/jm049503w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049503w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotVShs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=5605-5607&author=E.+M.+Jarhoauthor=J.+I.+Ven%C3%A4l%C3%A4inenauthor=J.+Huuskonenauthor=J.+A.+M.+Christiaansauthor=J.+A.+Garcia-Horsmanauthor=M.+M.+Forsbergauthor=T.+Jarvinenauthor=J.+Gyntherauthor=P.+T.+M%C3%A4nnist%C3%B6author=E.+A.+A.+Wall%C3%A9n&title=A+cyclopent-2-enecarbonyl+group+mimics+proline+at+the+P2+position+of+prolyl+oligopeptidase+inhibitors&doi=10.1021%2Fjm049503w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A Cyclopent-2-enecarbonyl Group Mimics Proline at the P2 Position of Prolyl Oligopeptidase Inhibitors</span></div><div class="casAuthors">Jarho, Elina M.; Venaelaeinen, Jarkko I.; Huuskonen, Juhani; Christiaans, Johannes A. M.; Forsberg, Markus M.; Jaervinen, Tomi; Gynther, Jukka; Maennistoe, Pekka T.; Wallen, Erik A. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5605-5607</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">With the aim to replace the natural amino acid proline by a proline mimetic structure, a cyclopent-2-enecarbonyl moiety was studied at the P2 position of prolyl oligopeptidase (POP) inhibitors.  The cyclopent-2-enecarbonyl moiety proved to be an excellent proline mimetic at the P2 position of POP inhibitors.  The replacement is particularly useful when increased lipophilicity is needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqRoDNZvMpULVg90H21EOLACvtfcHk0lgZ7kUb5VSH7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotVShs74%253D&md5=31b6a16d9ee708b2e298a4658feff356</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm049503w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049503w%26sid%3Dliteratum%253Aachs%26aulast%3DJarho%26aufirst%3DE.%2BM.%26aulast%3DVen%25C3%25A4l%25C3%25A4inen%26aufirst%3DJ.%2BI.%26aulast%3DHuuskonen%26aufirst%3DJ.%26aulast%3DChristiaans%26aufirst%3DJ.%2BA.%2BM.%26aulast%3DGarcia-Horsman%26aufirst%3DJ.%2BA.%26aulast%3DForsberg%26aufirst%3DM.%2BM.%26aulast%3DJarvinen%26aufirst%3DT.%26aulast%3DGynther%26aufirst%3DJ.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DWall%25C3%25A9n%26aufirst%3DE.%2BA.%2BA.%26atitle%3DA%2520cyclopent-2-enecarbonyl%2520group%2520mimics%2520proline%2520at%2520the%2520P2%2520position%2520of%2520prolyl%2520oligopeptidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D5605%26epage%3D5607%26doi%3D10.1021%2Fjm049503w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Jalkanen, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakkarainen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehtonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venäläinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kääriäinen, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarho, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, M. M.</span><span> </span><span class="NLM_article-title">Brain pharmacokinetics of two prolyl oligopeptidase inhibitors, JTP-4819 and KYP-2047, in the rat</span> <span class="citation_source-journal">Basic Clin. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span><span class="refDoi"> DOI: 10.1111/j.1742-7843.2011.00747.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1111%2Fj.1742-7843.2011.00747.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=21707925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Sqt7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2011&pages=443-451&author=A.+J.+Jalkanenauthor=J.+J.+Hakkarainenauthor=M.+Lehtonenauthor=T.+Ven%C3%A4l%C3%A4inenauthor=T.+M.+K%C3%A4%C3%A4ri%C3%A4inenauthor=E.+Jarhoauthor=M.+Suhonenauthor=M.+M.+Forsberg&title=Brain+pharmacokinetics+of+two+prolyl+oligopeptidase+inhibitors%2C+JTP-4819+and+KYP-2047%2C+in+the+rat&doi=10.1111%2Fj.1742-7843.2011.00747.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Brain pharmacokinetics of two prolyl oligopeptidase inhibitors, JTP-4819 and KYP-2047, in the rat</span></div><div class="casAuthors">Jalkanen, Aaro J.; Hakkarainen, Jenni J.; Lehtonen, Marko; Venalainen, Tetta; Kaariainen, Tiina M.; Jarho, Elina; Suhonen, Marjukka; Forsberg, Markus M.</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">443-451</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Prolyl oligopeptidase (PREP) inhibitors are potential drug candidates for the treatment of neurol. disorders, but little is known about their ability to cross the blood-brain barrier and to reach the target site.  This study characterizes brain pharmacokinetics of two potent PREP inhibitors, JTP-4819 and KYP-2047.  Firstly, the in vitro permeability (Papp) of JTP-4819 and KYP-2047 through a bovine brain microvessel endothelial cell monolayer was assessed.  Then, the in vivo brain/blood ratio was detd. for the total brain and plasma concns. and also for the unbound extracellular drug concns. after a single dose (50 μmol/kg i.p.).  KYP-2047 had a significantly higher Papp than JTP-4819.  In vivo, KYP-2047 had higher total and unbound brain/blood ratios.  KYP-2047 was equally distributed between the cortex, hippocampus and striatum.  In the case of JTP-4819, the unbound brain extracellular concns. could not be readily predicted from the unbound blood levels, probably because of its poor membrane penetration properties.  KYP-2047 displayed a better ability to reach the intracellularly located brain PREP, and it inhibited this enzyme more effectively than JTP-4819 after an equimolar single dose.  In conclusion, KYP-2047 showed better brain penetration characteristics than JTP-4819 both in vitro and in vivo.  KYP-2047 is a brain-penetrating, potent and long-acting PREP inhibitor; thus, it represents a convenient pharmacol. tool for assessing the potential of PREP as a drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomgOXgI1UeVrVg90H21EOLACvtfcHk0liLYzUVTlu_MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Sqt7nO&md5=0da407ae5d96cf8c3dd4f9d09a275515</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-7843.2011.00747.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-7843.2011.00747.x%26sid%3Dliteratum%253Aachs%26aulast%3DJalkanen%26aufirst%3DA.%2BJ.%26aulast%3DHakkarainen%26aufirst%3DJ.%2BJ.%26aulast%3DLehtonen%26aufirst%3DM.%26aulast%3DVen%25C3%25A4l%25C3%25A4inen%26aufirst%3DT.%26aulast%3DK%25C3%25A4%25C3%25A4ri%25C3%25A4inen%26aufirst%3DT.%2BM.%26aulast%3DJarho%26aufirst%3DE.%26aulast%3DSuhonen%26aufirst%3DM.%26aulast%3DForsberg%26aufirst%3DM.%2BM.%26atitle%3DBrain%2520pharmacokinetics%2520of%2520two%2520prolyl%2520oligopeptidase%2520inhibitors%252C%2520JTP-4819%2520and%2520KYP-2047%252C%2520in%2520the%2520rat%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2011%26volume%3D109%26spage%3D443%26epage%3D451%26doi%3D10.1111%2Fj.1742-7843.2011.00747.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Venäläinen, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Horsman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalkanen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallén, E. A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarho, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiaans, J. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gynther, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span> </span><span class="NLM_article-title">Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span><span class="refDoi"> DOI: 10.1016/j.bcp.2005.11.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2Fj.bcp.2005.11.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=16405869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FlsVGmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=683-692&author=J.+I.+Ven%C3%A4l%C3%A4inenauthor=J.+A.+Garcia-Horsmanauthor=M.+M.+Forsbergauthor=A.+Jalkanenauthor=E.+A.+A.+Wall%C3%A9nauthor=E.+M.+Jarhoauthor=J.+A.+M.+Christiaansauthor=J.+Gyntherauthor=P.+T.+M%C3%A4nnist%C3%B6&title=Binding+kinetics+and+duration+of+in+vivo+action+of+novel+prolyl+oligopeptidase+inhibitors&doi=10.1016%2Fj.bcp.2005.11.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors</span></div><div class="casAuthors">Venalainen Jarkko I; Garcia-Horsman J Arturo; Forsberg Markus M; Jalkanen Aaro; Wallen Erik A A; Jarho Elina M; Christiaans Johannes A M; Gynther Jukka; Mannisto Pekka T</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">683-92</span>
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">Prolyl oligopeptidase (POP) is a serine protease that specifically hydrolyses small peptides at the carboxyl end of the proline residue.  POP has gained pharmaceutical interest, since its inhibitors have been shown to have antiamnesic properties in rat.  We examined the effect of the 2(S)-substituents CN and COCH(2)OH at the P1 site of the parent inhibitors isophthalic acid 2(S)-(cyclopentanecarbonyl)pyrrolidine-l-prolyl-pyrrolidine amide and 4-phenylbutanoyl-l-prolyl-pyrrolidine and bulky 5-t-butyl group at the P2 site l-prolyl residue of the parent inhibitor 4-phenylbutanoyl-l-prolyl-pyrrolidine on the binding kinetics to the enzyme.  In addition, we studied the duration of POP inhibition in the rat tissues in vivo after i.p. administration.  CN and COCH(2)OH substituents at the P1 site pyrrolidine group were found to greatly increase the affinity of the inhibitor and the enzyme-inhibitor complex half-life.  In addition, 5-t-butyl group at the P2 site l-prolyl residue increased the dissociation half-life of the enzyme-inhibitor complex, without much affecting the inhibitory potency.  The duration of the inhibition in the rat tissues followed the inhibition kinetic properties in that the compounds with fast dissociation produced shorter inhibition in the rat tissues than the compounds with slow dissociation.  The duration of POP inhibition of compounds was evidently not governed by their serum clearance.  The fact that the in vivo pharmacodynamic behaviour of POP inhibitors can be predicted by their in vitro-properties may be of importance when designing therapeutically useful POP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAxPFOhRDAONNTrvPZP1IpfW6udTcc2eZHJemRTftEDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FlsVGmsw%253D%253D&md5=824fc48bb57153eacaa303c46f47c66e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2005.11.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2005.11.029%26sid%3Dliteratum%253Aachs%26aulast%3DVen%25C3%25A4l%25C3%25A4inen%26aufirst%3DJ.%2BI.%26aulast%3DGarcia-Horsman%26aufirst%3DJ.%2BA.%26aulast%3DForsberg%26aufirst%3DM.%2BM.%26aulast%3DJalkanen%26aufirst%3DA.%26aulast%3DWall%25C3%25A9n%26aufirst%3DE.%2BA.%2BA.%26aulast%3DJarho%26aufirst%3DE.%2BM.%26aulast%3DChristiaans%26aufirst%3DJ.%2BA.%2BM.%26aulast%3DGynther%26aufirst%3DJ.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26atitle%3DBinding%2520kinetics%2520and%2520duration%2520of%2520in%2520vivo%2520action%2520of%2520novel%2520prolyl%2520oligopeptidase%2520inhibitors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D71%26spage%3D683%26epage%3D692%26doi%3D10.1016%2Fj.bcp.2005.11.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Barelli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Nanteuil, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morain, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Checler, F.</span><span> </span><span class="NLM_article-title">S 17092–1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span><span class="refDoi"> DOI: 10.1006/bbrc.1999.0366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1006%2Fbbrc.1999.0366" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1999&pages=657-661&author=H.+Barelliauthor=A.+Petitauthor=E.+Hirschauthor=S.+Wilkauthor=G.+De+Nanteuilauthor=P.+Morainauthor=F.+Checler&title=S+17092%E2%80%931%2C+a+highly+potent%2C+specific+and+cell+permeant+inhibitor+of+human+proline+endopeptidase&doi=10.1006%2Fbbrc.1999.0366"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1999.0366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1999.0366%26sid%3Dliteratum%253Aachs%26aulast%3DBarelli%26aufirst%3DH.%26aulast%3DPetit%26aufirst%3DA.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DWilk%26aufirst%3DS.%26aulast%3DDe%2BNanteuil%26aufirst%3DG.%26aulast%3DMorain%26aufirst%3DP.%26aulast%3DChecler%26aufirst%3DF.%26atitle%3DS%252017092%25E2%2580%25931%252C%2520a%2520highly%2520potent%252C%2520specific%2520and%2520cell%2520permeant%2520inhibitor%2520of%2520human%2520proline%2520endopeptidase%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1999%26volume%3D257%26spage%3D657%26epage%3D661%26doi%3D10.1006%2Fbbrc.1999.0366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Van Der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fülöp, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rea, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Elzen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joossens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baekelandt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span> </span><span class="NLM_article-title">P2-substituted N-acylprolylpyrrolidine inhibitors of prolyl oligopeptidase: Biochemical evaluation, binding mode determination, and assessment in a cellular model of synucleinopathy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9856</span><span class="NLM_x">–</span> <span class="NLM_lpage">9867</span><span class="refDoi"> DOI: 10.1021/jm301060g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301060g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1WgsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9856-9867&author=P.+Van+Der+Vekenauthor=V.+F%C3%BCl%C3%B6pauthor=D.+Reaauthor=M.+Gerardauthor=R.+Van+Elzenauthor=J.+Joossensauthor=J.+D.+Chengauthor=V.+Baekelandtauthor=I.+De+Meesterauthor=A.+M.+Lambeirauthor=K.+Augustyns&title=P2-substituted+N-acylprolylpyrrolidine+inhibitors+of+prolyl+oligopeptidase%3A+Biochemical+evaluation%2C+binding+mode+determination%2C+and+assessment+in+a+cellular+model+of+synucleinopathy&doi=10.1021%2Fjm301060g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">P2-Substituted N-Acylprolylpyrrolidine Inhibitors of Prolyl Oligopeptidase: Biochemical Evaluation, Binding Mode Determination, and Assessment in a Cellular Model of Synucleinopathy</span></div><div class="casAuthors">Van der Veken, Pieter; Fulop, Vilmos; Rea, Dean; Gerard, Melanie; Van Elzen, Roos; Joossens, Jurgen; Cheng, Jonathan D.; Baekelandt, Veerle; De Meester, Ingrid; Lambeir, Anne-Marie; Augustyns, Koen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9856-9867</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have investigated the effect of regiospecifically introducing substituents in the P2 part of the typical dipeptide derived basic structure of PREP inhibitors.  This hitherto unexplored modification type can be used to improve target affinity, selectivity, and physicochem. parameters in drug discovery programs focusing on PREP inhibitors.  Biochem. evaluation of the produced inhibitors identified several substituent types that significantly increase target affinity, thereby reducing the need for an electrophilic "warhead" functionality.  Pronounced PREP specificity within the group of Clan SC proteases was generally obsd.  Omission of the P1 electrophilic function did not affect the overall binding mode of three representative compds., as studied by x-ray crystallog., while the P2 substituents were demonstrated to be accommodated in a cavity of PREP that, to date, has not been probed by inhibitors.  Finally, we report on results of selected inhibitors in a SH-SY5Y cellular model of synucleinopathy and demonstrate a significant antiaggregation effect on α-synuclein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEIyxJpiiSubVg90H21EOLACvtfcHk0lhJB_Je3FRO4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1WgsbjE&md5=997a42980beef7491945f79924395e3e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm301060g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301060g%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDer%2BVeken%26aufirst%3DP.%26aulast%3DF%25C3%25BCl%25C3%25B6p%26aufirst%3DV.%26aulast%3DRea%26aufirst%3DD.%26aulast%3DGerard%26aufirst%3DM.%26aulast%3DVan%2BElzen%26aufirst%3DR.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DBaekelandt%26aufirst%3DV.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DAugustyns%26aufirst%3DK.%26atitle%3DP2-substituted%2520N-acylprolylpyrrolidine%2520inhibitors%2520of%2520prolyl%2520oligopeptidase%253A%2520Biochemical%2520evaluation%252C%2520binding%2520mode%2520determination%252C%2520and%2520assessment%2520in%2520a%2520cellular%2520model%2520of%2520synucleinopathy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9856%26epage%3D9867%26doi%3D10.1021%2Fjm301060g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Lambeir, A. M.</span><span> </span><span class="NLM_article-title">Interaction of prolyl oligopeptidase with α-synuclein</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span><span class="refDoi"> DOI: 10.2174/187152711794653878</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.2174%2F187152711794653878" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=21222624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslahtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=349-354&author=A.+M.+Lambeir&title=Interaction+of+prolyl+oligopeptidase+with+%CE%B1-synuclein&doi=10.2174%2F187152711794653878"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of prolyl oligopeptidase with α-synuclein</span></div><div class="casAuthors">Lambeir, Anne-Marie</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-354</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Prolyl oligopeptidase (PO) interacts with α-synuclein in vitro.  It is a weak interaction that induces a nucleation prone conformation of α-synuclein.  PO accelerates aggregation and fibril formation of α-synuclein in a process that can be reversed by specific inhibitors and is also influenced by an impairing mutation in the PO active site.  There is evidence that PO and α-synuclein also interact intracellularly, esp. in conditions where the expression of α-synuclein is high.  Specific PO inhibitors reduce the no. of cells with α-synuclein inclusions in a cellular model of Parkinson's disease.  If these interactions also exist in the human brain, PO may be a target for the treatment of Parkinson's disease and other synucleinopathies.  Whether PO also contributes to the normal physiol. functions of α-synuclein remains an open question, but there are some intriguing parallels between the proposed functions of both proteins that deserve further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsalUgjf0BobVg90H21EOLACvtfcHk0lhJB_Je3FRO4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslahtbo%253D&md5=8562511b17ebfa681a2d7affa64d7296</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F187152711794653878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152711794653878%26sid%3Dliteratum%253Aachs%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26atitle%3DInteraction%2520of%2520prolyl%2520oligopeptidase%2520with%2520%25CE%25B1-synuclein%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2011%26volume%3D10%26spage%3D349%26epage%3D354%26doi%3D10.2174%2F187152711794653878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Myöhänen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannula, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Elzen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Horsman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baekelandt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span> </span><span class="NLM_article-title">A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson’s disease</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">1097</span><span class="NLM_x">–</span> <span class="NLM_lpage">1113</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.01846.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1111%2Fj.1476-5381.2012.01846.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=22233220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC38XotlWmtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2012&pages=1097-1113&author=T.+T.+My%C3%B6h%C3%A4nenauthor=M.+J.+Hannulaauthor=R.+Van+Elzenauthor=M.+Gerardauthor=P.+Van+Der+Vekenauthor=J.+A.+Garc%C3%ADa-Horsmanauthor=V.+Baekelandtauthor=P.+T.+M%C3%A4nnist%C3%B6author=A.+M.+Lambeir&title=A+prolyl+oligopeptidase+inhibitor%2C+KYP-2047%2C+reduces+%CE%B1-synuclein+protein+levels+and+aggregates+in+cellular+and+animal+models+of+Parkinson%E2%80%99s+disease&doi=10.1111%2Fj.1476-5381.2012.01846.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease</span></div><div class="casAuthors">Myohanen, T. T.; Hannula, M. J.; Van Elzen, R.; Gerard, M.; Van Der Veken, P.; Garcia-Horsman, J. A.; Baekelandt, V.; Mannisto, P. T.; Lambeir, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1097-1113</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose The aggregation of α-synuclein is connected to the pathol. of Parkinson's disease and prolyl oligopeptidase (PREP) accelerates the aggregation of α-synuclein in vitro.  The aim of this study was to investigate the effects of a PREP inhibitor, KYP-2047, on α-synuclein aggregation in cell lines overexpressing wild-type or A30P/A53T mutant human α-syn and in the brains of two A30P α-synuclein transgenic mouse strains.  Exptl. Approach Cells were exposed to oxidative stress and then incubated with the PREP inhibitor during or after the stress.  Wild-type or transgenic mice were treated for 5 days with KYP-2047 (2 × 3 mg·kg-1 a day).  Besides immunohistochem. and thioflavin S staining, sol. and insol. α-synuclein protein levels were measured by Western blot.  α-Synuclein mRNA levels were quantified by PCR.  The colocalization of PREP and α-synuclein, and the effect of KYP-2047 on cell viability were also investigated.  Key Results In cell lines, oxidative stress induced a robust aggregation of α-synuclein, and low concns. of KYP-2047 significantly reduced the no. of cells with α-synuclein inclusions while abolishing the colocalization of α-synuclein and PREP.  KYP-2047 significantly reduced the amt. of aggregated α-synuclein, and it had beneficial effects on cell viability.  In the transgenic mice, a 5-day treatment with the PREP inhibitor reduced the amt. of α-synuclein immunoreactivity and sol. α-synuclein protein in the brain.  Conclusions and Implications The results suggest that the PREP may play a role in brain accumulation and aggregation of α-synuclein, while KYP-2047 seems to effectively prevent these processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxIMPE4nZdtrVg90H21EOLACvtfcHk0liJZ4X5SysICg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotlWmtr4%253D&md5=b83a2f96d66ac2d7a765196055fe1985</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.01846.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.01846.x%26sid%3Dliteratum%253Aachs%26aulast%3DMy%25C3%25B6h%25C3%25A4nen%26aufirst%3DT.%2BT.%26aulast%3DHannula%26aufirst%3DM.%2BJ.%26aulast%3DVan%2BElzen%26aufirst%3DR.%26aulast%3DGerard%26aufirst%3DM.%26aulast%3DVan%2BDer%2BVeken%26aufirst%3DP.%26aulast%3DGarc%25C3%25ADa-Horsman%26aufirst%3DJ.%2BA.%26aulast%3DBaekelandt%26aufirst%3DV.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26atitle%3DA%2520prolyl%2520oligopeptidase%2520inhibitor%252C%2520KYP-2047%252C%2520reduces%2520%25CE%25B1-synuclein%2520protein%2520levels%2520and%2520aggregates%2520in%2520cellular%2520and%2520animal%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D166%26spage%3D1097%26epage%3D1113%26doi%3D10.1111%2Fj.1476-5381.2012.01846.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hannula, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myöhänen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenorio-Laranga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Männistö, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Horsman, J. A.</span><span> </span><span class="NLM_article-title">Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson’s and Alzheimer’s diseases</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">242</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2013.03.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2Fj.neuroscience.2013.03.049" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=242&publication_year=2013&pages=140-150&author=M.+J.+Hannulaauthor=T.+T.+My%C3%B6h%C3%A4nenauthor=J.+Tenorio-Larangaauthor=P.+T.+M%C3%A4nnist%C3%B6author=J.+A.+Garcia-Horsman&title=Prolyl+oligopeptidase+colocalizes+with+%CE%B1-synuclein%2C+%CE%B2-amyloid%2C+tau+protein+and+astroglia+in+the+post-mortem+brain+samples+with+Parkinson%E2%80%99s+and+Alzheimer%E2%80%99s+diseases&doi=10.1016%2Fj.neuroscience.2013.03.049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2013.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2013.03.049%26sid%3Dliteratum%253Aachs%26aulast%3DHannula%26aufirst%3DM.%2BJ.%26aulast%3DMy%25C3%25B6h%25C3%25A4nen%26aufirst%3DT.%2BT.%26aulast%3DTenorio-Laranga%26aufirst%3DJ.%26aulast%3DM%25C3%25A4nnist%25C3%25B6%26aufirst%3DP.%2BT.%26aulast%3DGarcia-Horsman%26aufirst%3DJ.%2BA.%26atitle%3DProlyl%2520oligopeptidase%2520colocalizes%2520with%2520%25CE%25B1-synuclein%252C%2520%25CE%25B2-amyloid%252C%2520tau%2520protein%2520and%2520astroglia%2520in%2520the%2520post-mortem%2520brain%2520samples%2520with%2520Parkinson%25E2%2580%2599s%2520and%2520Alzheimer%25E2%2580%2599s%2520diseases%26jtitle%3DNeuroscience%26date%3D2013%26volume%3D242%26spage%3D140%26epage%3D150%26doi%3D10.1016%2Fj.neuroscience.2013.03.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Lawandi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toumieux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thielges, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6672</span><span class="NLM_x">–</span> <span class="NLM_lpage">6684</span><span class="refDoi"> DOI: 10.1021/jm901013a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901013a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GgsLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6672-6684&author=J.+Lawandiauthor=S.+Toumieuxauthor=V.+Seyerauthor=P.+Campbellauthor=S.+Thielgesauthor=L.+Juillerat-Jeanneretauthor=N.+Moitessier&title=Constrained+peptidomimetics+reveal+detailed+geometric+requirements+of+covalent+prolyl+oligopeptidase+inhibitors&doi=10.1021%2Fjm901013a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors</span></div><div class="casAuthors">Lawandi, Janice; Toumieux, Sylvestre; Seyer, Valentine; Campbell, Philip; Thielges, Sabine; Juillerat-Jeanneret, Lucienne; Moitessier, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6672-6684</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prolyl oligopeptidases cleave peptides on the carboxy side of internal proline residues and their inhibition has potential in the treatment of human brain disorders.  Using our docking program FITTED, we have designed a series of constrained covalent inhibitors, built from a series of bicyclic scaffolds, to study the optimal shape required for these small mols.  These structures bear nitrile functional groups that we predicted to covalently bind to the catalytic serine of the enzyme.  Synthesis and biol. assays using human brain-derived astrocytic cells and endothelial cells and human fibroblasts revealed that these compds. act as selective inhibitors of prolyl oligopeptidase activity compared to prolyl-dipeptidyl-aminopeptidase activity, are able to penetrate the cells and inhibit intracellular activities in intact living cells.  This integrated computational and exptl. study shed light on the binding mode of inhibitors in the enzyme active site and will guide the design of future drug-like mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2IfKJ-jGKWrVg90H21EOLACvtfcHk0lhdkL-JDGr9fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GgsLjI&md5=45e3fa6cc2888764519936595561d6e0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm901013a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901013a%26sid%3Dliteratum%253Aachs%26aulast%3DLawandi%26aufirst%3DJ.%26aulast%3DToumieux%26aufirst%3DS.%26aulast%3DSeyer%26aufirst%3DV.%26aulast%3DCampbell%26aufirst%3DP.%26aulast%3DThielges%26aufirst%3DS.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DConstrained%2520peptidomimetics%2520reveal%2520detailed%2520geometric%2520requirements%2520of%2520covalent%2520prolyl%2520oligopeptidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6672%26epage%3D6684%26doi%3D10.1021%2Fjm901013a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">De Cesco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deslandes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therrien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cueto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantin, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittermaier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6306</span><span class="NLM_x">–</span> <span class="NLM_lpage">6315</span><span class="refDoi"> DOI: 10.1021/jm3002839</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3002839" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC38Xps1Onu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6306-6315&author=S.+De+Cescoauthor=S.+Deslandesauthor=E.+Therrienauthor=D.+Levanauthor=M.+Cuetoauthor=R.+Schmidtauthor=L.+D.+Cantinauthor=A.+Mittermaierauthor=L.+Juillerat-Jeanneretauthor=N.+Moitessier&title=Virtual+screening+and+computational+optimization+for+the+discovery+of+covalent+prolyl+oligopeptidase+inhibitors+with+activity+in+human+cells&doi=10.1021%2Fjm3002839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening and Computational Optimization for the Discovery of Covalent Prolyl Oligopeptidase Inhibitors with Activity in Human Cells</span></div><div class="casAuthors">De Cesco, Stephane; Deslandes, Sebastien; Therrien, Eric; Levan, David; Cueto, Mickael; Schmidt, Ralf; Cantin, Louis-David; Mittermaier, Anthony; Juillerat-Jeanneret, Lucienne; Moitessier, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6306-6315</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Our docking program, Fitted, implemented in our computational platform, Forecaster, has been modified to carry out automated virtual screening of covalent inhibitors.  With this modified version of the program, virtual screening and further docking-based optimization of a selected hit led to the identification of potential covalent reversible inhibitors of prolyl oligopeptidase activity.  After visual inspection, a virtual hit mol. together with four analogs were selected for synthesis and made in one-five chem. steps.  Biol. evaluations on recombinant POP and FAPα enzymes, cell exts., and living cells demonstrated high potency and selectivity for POP over FAPα and DPPIV.  Three compds. even exhibited high nanomolar inhibitory activities in intact living human cells and acceptable metabolic stability.  This small set of mols. also demonstrated that covalent binding and/or geometrical constraints to the ligand/protein complex may lead to an increase in bioactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaE7_T4KEl5rVg90H21EOLACvtfcHk0lhdkL-JDGr9fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xps1Onu7Y%253D&md5=4c6cd8245e91cad790e4bab9254dcb3f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm3002839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3002839%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BCesco%26aufirst%3DS.%26aulast%3DDeslandes%26aufirst%3DS.%26aulast%3DTherrien%26aufirst%3DE.%26aulast%3DLevan%26aufirst%3DD.%26aulast%3DCueto%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DR.%26aulast%3DCantin%26aufirst%3DL.%2BD.%26aulast%3DMittermaier%26aufirst%3DA.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DVirtual%2520screening%2520and%2520computational%2520optimization%2520for%2520the%2520discovery%2520of%2520covalent%2520prolyl%2520oligopeptidase%2520inhibitors%2520with%2520activity%2520in%2520human%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6306%26epage%3D6315%26doi%3D10.1021%2Fjm3002839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Lawandi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toumieux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thielges, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6672</span><span class="NLM_x">–</span> <span class="NLM_lpage">6684</span><span class="refDoi"> DOI: 10.1021/jm901013a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901013a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GgsLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6672-6684&author=J.+Lawandiauthor=S.+Toumieuxauthor=V.+Seyerauthor=P.+Campbellauthor=S.+Thielgesauthor=L.+Juillerat-Jeanneretauthor=N.+Moitessier&title=Constrained+peptidomimetics+reveal+detailed+geometric+requirements+of+covalent+prolyl+oligopeptidase+inhibitors&doi=10.1021%2Fjm901013a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors</span></div><div class="casAuthors">Lawandi, Janice; Toumieux, Sylvestre; Seyer, Valentine; Campbell, Philip; Thielges, Sabine; Juillerat-Jeanneret, Lucienne; Moitessier, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6672-6684</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prolyl oligopeptidases cleave peptides on the carboxy side of internal proline residues and their inhibition has potential in the treatment of human brain disorders.  Using our docking program FITTED, we have designed a series of constrained covalent inhibitors, built from a series of bicyclic scaffolds, to study the optimal shape required for these small mols.  These structures bear nitrile functional groups that we predicted to covalently bind to the catalytic serine of the enzyme.  Synthesis and biol. assays using human brain-derived astrocytic cells and endothelial cells and human fibroblasts revealed that these compds. act as selective inhibitors of prolyl oligopeptidase activity compared to prolyl-dipeptidyl-aminopeptidase activity, are able to penetrate the cells and inhibit intracellular activities in intact living cells.  This integrated computational and exptl. study shed light on the binding mode of inhibitors in the enzyme active site and will guide the design of future drug-like mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2IfKJ-jGKWrVg90H21EOLACvtfcHk0lhdkL-JDGr9fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GgsLjI&md5=45e3fa6cc2888764519936595561d6e0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm901013a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901013a%26sid%3Dliteratum%253Aachs%26aulast%3DLawandi%26aufirst%3DJ.%26aulast%3DToumieux%26aufirst%3DS.%26aulast%3DSeyer%26aufirst%3DV.%26aulast%3DCampbell%26aufirst%3DP.%26aulast%3DThielges%26aufirst%3DS.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DConstrained%2520peptidomimetics%2520reveal%2520detailed%2520geometric%2520requirements%2520of%2520covalent%2520prolyl%2520oligopeptidase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6672%26epage%3D6684%26doi%3D10.1021%2Fjm901013a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weerapana, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Strategies for discovering and derisking covalent, irreversible enzyme inhibitors</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">964</span><span class="refDoi"> DOI: 10.4155/fmc.10.21</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.4155%2Ffmc.10.21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=20640225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFakur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=949-964&author=D.+S.+Johnsonauthor=E.+Weerapanaauthor=B.+F.+Cravatt&title=Strategies+for+discovering+and+derisking+covalent%2C+irreversible+enzyme+inhibitors&doi=10.4155%2Ffmc.10.21"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for discovering and derisking covalent, irreversible enzyme inhibitors</span></div><div class="casAuthors">Johnson, Douglas S.; Weerapana, Eranthie; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">949-964</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  This article presents several covalent inhibitors, including examples of successful drugs, as well as highly selective, irreversible inhibitors of emerging therapeutic targets, such as fatty acid amide hydolase.  Covalent inhibitors have many desirable features, including increased biochem. efficiency of target disruption, less sensitivity toward pharmacokinetic parameters and increased duration of action that outlasts the pharmacokinetics of the compd.  Safety concerns that must be mitigated include lack of specificity and the potential immunogenicity of protein-inhibitor adduct(s).  Particular attention will be given to recent technologies, such as activity-based protein profiling, which allow one to define the proteome-wide selectivity patterns for covalent inhibitors in vitro and in vivo.  For instance, any covalent inhibitor can, in principle, be modified with a 'clickable' tag to generate an activity probe that is almost indistinguishable from the original agent.  These probes can be applied to any living system across a broad dose range to fully inventory their on and off targets.  The substantial no. of drugs on the market today that act by a covalent mechanism belies historical prejudices against the development of irreversibly acting therapeutic small mols.  Emerging proteomic technologies offer a means to systematically discriminate safe (selective) vs. deleterious (nonselective) covalent inhibitors and thus should inspire their future design and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqm0whEybB-LVg90H21EOLACvtfcHk0lhgPPv397IbLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFakur4%253D&md5=07e1f89418b168798ae5c1a9fa43e9c1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.21%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DWeerapana%26aufirst%3DE.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStrategies%2520for%2520discovering%2520and%2520derisking%2520covalent%252C%2520irreversible%2520enzyme%2520inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2010%26volume%3D2%26spage%3D949%26epage%3D964%26doi%3D10.4155%2Ffmc.10.21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. Z.</span><span> </span><span class="NLM_article-title">Drug bioactivation, covalent binding to target proteins and toxicity relevance</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1081/DMR-200028812</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1081%2FDMR-200028812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=15747500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVegsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2005&pages=41-213&author=S.+Zhouauthor=E.+Chanauthor=W.+Duanauthor=M.+Huangauthor=Y.+Z.+Chen&title=Drug+bioactivation%2C+covalent+binding+to+target+proteins+and+toxicity+relevance&doi=10.1081%2FDMR-200028812"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Drug bioactivation, covalent binding to target proteins and toxicity relevance</span></div><div class="casAuthors">Zhou, Shufeng; Chan, Eli; Duan, Wei; Huang, Min; Chen, Yu-Zong</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-213</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  A no. of therapeutic drugs with different structures and mechanisms of action have been reported to undergo metabolic activation by Phase I or Phase II drug-metabolizing enzymes.  The bioactivation gives rise to reactive metabolites/intermediates, which readily confer covalent binding to various target proteins by nucleophilic substitution and/or Schiff's base mechanism.  These drugs include analgesics (e.g., acetaminophen), antibacterial agents (e.g., sulfonamides and macrolide antibiotics), anticancer drugs (e.g., irinotecan), antiepileptic drugs (e.g., carbamazepine), anti-HIV agents (e.g., ritonavir), antipsychotics (e.g., clozapine), cardiovascular drugs (e.g., procainamide and hydralazine), immunosuppressants (e.g., cyclosporine A), inhalational anesthetics (e.g., halothane), nonsteroidal anti-inflammatory drugs (NSAIDSs) (e.g., diclofenac), and steroids and their receptor modulators (e.g., estrogens and tamoxifen).  Some herbal and dietary constituents are also bioactivated to reactive metabolites capable of binding covalently and inactivating cytochrome P450s (CYPs).  A no. of important target proteins of drugs have been identified by mass spectrometric techniques and proteomic approaches.  The covalent binding and formation of drug-protein adducts are generally considered to be related to drug toxicity, and selective protein covalent binding by drug metabolites may lead to selective organ toxicity.  However, the mechanisms involved in the protein adduct-induced toxicity are largely undefined, although it has been suggested that drug-protein adducts may cause toxicity either through impairing physiol. functions of the modified proteins or through immune-mediated mechanisms.  In addn., mechanism-based inhibition of CYPs may result in toxic drug-drug interactions.  The clin. consequences of drug bioactivation and covalent binding to proteins are unpredictable, depending on many factors that are assocd. with the administered drugs and patients.  Further studies using proteomic and genomic approaches with high throughput capacity are needed to identify the protein targets of reactive drug metabolites, and to elucidate the structure-activity relationships of drug's covalent binding to proteins and their clin. outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi5RXf-M8WvrVg90H21EOLACvtfcHk0lhgPPv397IbLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVegsrc%253D&md5=bfd4f4652ffe7666a1c7d0e93c48372b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1081%2FDMR-200028812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FDMR-200028812%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%2BZ.%26atitle%3DDrug%2520bioactivation%252C%2520covalent%2520binding%2520to%2520target%2520proteins%2520and%2520toxicity%2520relevance%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2005%26volume%3D37%26spage%3D41%26epage%3D213%26doi%3D10.1081%2FDMR-200028812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Guterman, L.</span><span> </span><span class="NLM_article-title">Covalent Drugs Form Long-Lived Ties</span> <span class="citation_source-journal">Chem. Eng. News</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/doi/10.1021/cen-v089n036.p019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2011&pages=19-26&author=L.+Guterman&title=Covalent+Drugs+Form+Long-Lived+Ties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcen-v089n036.p019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcen-v089n036.p019%26sid%3Dliteratum%253Aachs%26aulast%3DGuterman%26aufirst%3DL.%26atitle%3DCovalent%2520Drugs%2520Form%2520Long-Lived%2520Ties%26jtitle%3DChem.%2520Eng.%2520News%26date%3D2011%26volume%3D89%26spage%3D19%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span> </span><span class="NLM_article-title">Drug discovery for a new generation of covalent drugs</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">581</span><span class="refDoi"> DOI: 10.1517/17460441.2012.688744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1517%2F17460441.2012.688744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=22607458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFWmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=561-581&author=A.+S.+Kalgutkarauthor=D.+K.+Dalvie&title=Drug+discovery+for+a+new+generation+of+covalent+drugs&doi=10.1517%2F17460441.2012.688744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery for a new generation of covalent drugs</span></div><div class="casAuthors">Kalgutkar, Amit S.; Dalvie, Deepak K.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">561-581</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The design of target-specific covalent inhibitors is conceptually attractive because of increased biochem. efficiency through covalency and increased duration of action that outlasts the pharmacokinetics of the agent.  Although many covalent inhibitors have been approved or are in advanced clin. trials to treat indications such as cancer and hepatitis C, there is a general tendency to avoid them as drug candidates because of concerns regarding immune-mediated toxicity that can arise from indiscriminate reactivity with off-target proteins.Areas covered: The review examines potential reason(s) for the excellent safety record of marketed covalent agents and advanced clin. candidates for emerging therapeutic targets.  A significant emphasis is placed on proteomic techniques and chem./biochem. reactivity assays that aim to provide a systematic rank ordering of pharmacol. selectivity relative to off-target protein reactivity of covalent inhibitors.Expert opinion: While tactics to examine selective covalent modification of the pharmacol. target are broadly applicable in drug discovery, it is unclear whether the output from such studies can prospectively predict idiosyncratic immune-mediated drug toxicity.  Opinions regarding an acceptable threshold of protein reactivity/body burden for a toxic electrophile and a non-toxic electrophilic covalent drug have not been defined.  Increasing confidence in proteomic and chem./biochem. reactivity screens will require a retrospective side-by-side profiling of marketed covalent drugs and electrophiles known to cause deleterious toxic effects via non-selective covalent binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowmXy20mDTPbVg90H21EOLACvtfcHk0lg8RtcvUPseDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFWmt7k%253D&md5=b7fc8e60b263dda5765dd8380f52df17</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1517%2F17460441.2012.688744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2012.688744%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26atitle%3DDrug%2520discovery%2520for%2520a%2520new%2520generation%2520of%2520covalent%2520drugs%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D561%26epage%3D581%26doi%3D10.1517%2F17460441.2012.688744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Robertson, J. G.</span><span> </span><span class="NLM_article-title">Mechanistic basis of enzyme-targeted drugs</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">5561</span><span class="NLM_x">–</span> <span class="NLM_lpage">5571</span><span class="refDoi"> DOI: 10.1021/bi050247e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi050247e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisV2jsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5561-5571&author=J.+G.+Robertson&title=Mechanistic+basis+of+enzyme-targeted+drugs&doi=10.1021%2Fbi050247e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic Basis of Enzyme-Targeted Drugs</span></div><div class="casAuthors">Robertson, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5561-5571</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Enzymes offer unique opportunities for drug design that are not available to cell surface receptors, nuclear hormone receptors, ion channels, transporters, and DNA.  Here, we review the variety of inhibition mechanisms for enzyme-targeted drugs, and establish an enzyme target database for drugs currently marketed in the United States.  From an anal. of the FDA Orange Book, there are 317 marketed drugs that work by inhibiting an enzyme.  These drugs inhibit 71 enzymes, including 48 human, 13 bacterial, five viral, four fungal, and one protozoal enzyme.  Among the 317 drugs, 65% either undergo reactive chem. in the active site of the target enzyme or contain a structural motif related to the substrate.  Among the 71 enzyme targets, 25 are irreversibly inhibited by drugs, and 19 of the 25 irreversibly inhibited enzymes are covalently modified by the drug.  In two addnl. cases, the drug forms a covalent complex with the substrate, and in three more cases, the drug traps a covalent enzyme-substrate intermediate.  Four of the 71 enzymes are inhibited by transition-state analogs.  Moreover, advanced methods for detg. transition-state structure now offer the opportunity for direct drug design without resorting to expensive random testing campaigns.  A full appreciation of enzyme mechanisms sets enzymes apart as a specialized class of targets for highly directed drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgXM1naSit_7Vg90H21EOLACvtfcHk0lg8RtcvUPseDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisV2jsLg%253D&md5=8122fffab0717e5dbd0ff904d7a94da0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fbi050247e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi050247e%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26atitle%3DMechanistic%2520basis%2520of%2520enzyme-targeted%2520drugs%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D5561%26epage%3D5571%26doi%3D10.1021%2Fbi050247e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitty, A.</span><span> </span><span class="NLM_article-title">The resurgence of covalent drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span><span class="refDoi"> DOI: 10.1038/nrd3410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1038%2Fnrd3410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=21455239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=307-317&author=J.+Singhauthor=R.+C.+Petterauthor=T.+A.+Baillieauthor=A.+Whitty&title=The+resurgence+of+covalent+drugs&doi=10.1038%2Fnrd3410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The resurgence of covalent drugs</span></div><div class="casAuthors">Singh, Juswinder; Petter, Russell C.; Baillie, Thomas A.; Whitty, Adrian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-317</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Covalent drugs haveproved to be successful therapies for various indications, but largely owing to safety concerns, they are rarely considered when initiating a target-directed drug discovery project.  There is a need to reassess this important class of drugs, and to reconcile the discordance between the historic success of covalent drugs and the reluctance of most drug discovery teams to include them in their armamentarium.  This Review surveys the prevalence and pharmacol. advantages of covalent drugs, discusses how potential risks and challenges may be addressed through innovative design, and presents the broad opportunities provided by targeted covalent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreDCEmORV_NbVg90H21EOLACvtfcHk0lg8RtcvUPseDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGmu7g%253D&md5=2190289081e151416c097be4a5b04460</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnrd3410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3410%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DWhitty%26aufirst%3DA.%26atitle%3DThe%2520resurgence%2520of%2520covalent%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D307%26epage%3D317%26doi%3D10.1038%2Fnrd3410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Potashman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span> </span><span class="NLM_article-title">Covalent modifiers: An orthogonal approach to drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1231</span><span class="NLM_x">–</span> <span class="NLM_lpage">1246</span><span class="refDoi"> DOI: 10.1021/jm8008597</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8008597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1231-1246&author=M.+H.+Potashmanauthor=M.+E.+Duggan&title=Covalent+modifiers%3A+An+orthogonal+approach+to+drug+design&doi=10.1021%2Fjm8008597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Modifiers: An Orthogonal Approach to Drug Design</span></div><div class="casAuthors">Potashman, Michele H.; Duggan, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1231-1246</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In this article we review a variety of examples in which therapeutic targets are covalently bound by small-mol. drugs or by compds. in advanced clin. development.  The covalent interactions can be either reversible or irreversible, depending on the reaction partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6BO6g9_F717Vg90H21EOLACvtfcHk0ljapnomF1XFSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sltbw%253D&md5=f8380d5a1cdd8638ad2a1e0405d25267</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm8008597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8008597%26sid%3Dliteratum%253Aachs%26aulast%3DPotashman%26aufirst%3DM.%2BH.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26atitle%3DCovalent%2520modifiers%253A%2520An%2520orthogonal%2520approach%2520to%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1231%26epage%3D1246%26doi%3D10.1021%2Fjm8008597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Smith, A. J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houk, K. N.</span><span> </span><span class="NLM_article-title">Beyond picomolar affinities: Quantitative aspects of noncovalent and covalent binding of drugs to proteins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span><span class="refDoi"> DOI: 10.1021/jm800498e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800498e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD1MXis1OltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=225-233&author=A.+J.+T.+Smithauthor=X.+Zhangauthor=A.+G.+Leachauthor=K.+N.+Houk&title=Beyond+picomolar+affinities%3A+Quantitative+aspects+of+noncovalent+and+covalent+binding+of+drugs+to+proteins&doi=10.1021%2Fjm800498e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond picomolar affinities: quantitative aspects of noncovalent and covalent binding of drugs to proteins</span></div><div class="casAuthors">Smith, Adam J. T.; Zhang, Xiyun; Leach, Andrew G.; Houk, K. N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-233</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review of 104 refs. summarized quant. aspects of noncovalent and covalent binding of drugs to proteins with subtopics including (1) introduction; (2) factors involved in ligand-recepto binding; (3) distribution of exptl. binding consts.; (3) covalent interactions with transition states as the origins of enzyme proficiency; (4) potential quant. advantages of covalent enzyme inhibitors and colent drugs; (5) selected examples of covalent inhibitors and drugs; (6) prospects for the design of covalent drugs; (7) conclusions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAhUbRxt1fu7Vg90H21EOLACvtfcHk0ljapnomF1XFSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXis1OltLw%253D&md5=529d4181046100b5e3c37a8fef571218</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm800498e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800498e%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DA.%2BJ.%2BT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DHouk%26aufirst%3DK.%2BN.%26atitle%3DBeyond%2520picomolar%2520affinities%253A%2520Quantitative%2520aspects%2520of%2520noncovalent%2520and%2520covalent%2520binding%2520of%2520drugs%2520to%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D225%26epage%3D233%26doi%3D10.1021%2Fjm800498e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Fleming, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravikumar, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shook, B. C.</span><span> </span><span class="NLM_article-title">Nitrile-containing pharmaceuticals: Efficacious roles of the nitrile pharmacophore</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7902</span><span class="NLM_x">–</span> <span class="NLM_lpage">7917</span><span class="refDoi"> DOI: 10.1021/jm100762r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100762r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2kurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7902-7917&author=F.+F.+Flemingauthor=L.+Yaoauthor=P.+C.+Ravikumarauthor=L.+Funkauthor=B.+C.+Shook&title=Nitrile-containing+pharmaceuticals%3A+Efficacious+roles+of+the+nitrile+pharmacophore&doi=10.1021%2Fjm100762r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore</span></div><div class="casAuthors">Fleming, Fraser F.; Yao, Lihua; Ravikumar, P. C.; Funk, Lee; Shook, Brian C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7902-7917</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review is structured according to the nature of the nitrile-bearing substituent.  As the no. of nitrile-contg. drug leads is vast, the review has focused on launched nitrile-contg. pharmaceuticals and currently active clin. candidates.  Most nitrile-contg. pharmaceuticals are aroms. with aliph.-, alkene-, and nitrogen-bearing nitriles being progressively less frequent.  Within each class, the bioactive nitriles are collated according to common structural elements and mode of action.  The hope is that this survey will allow greater deployment of this versatile functionality within drug leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR6kPPdWVuvLVg90H21EOLACvtfcHk0lgGFBtZBG6fFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2kurvP&md5=040bbaebd9e8c9999d195b9a22221fea</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm100762r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100762r%26sid%3Dliteratum%253Aachs%26aulast%3DFleming%26aufirst%3DF.%2BF.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DRavikumar%26aufirst%3DP.%2BC.%26aulast%3DFunk%26aufirst%3DL.%26aulast%3DShook%26aufirst%3DB.%2BC.%26atitle%3DNitrile-containing%2520pharmaceuticals%253A%2520Efficacious%2520roles%2520of%2520the%2520nitrile%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7902%26epage%3D7917%26doi%3D10.1021%2Fjm100762r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Huot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Expedient synthesis of novel bicyclic peptidomimetic scaffolds</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2820</span><span class="NLM_x">–</span> <span class="NLM_lpage">2823</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2010.03.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2Fj.tetlet.2010.03.066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=2820-2823&author=M.+Huotauthor=N.+Moitessier&title=Expedient+synthesis+of+novel+bicyclic+peptidomimetic+scaffolds&doi=10.1016%2Fj.tetlet.2010.03.066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2010.03.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2010.03.066%26sid%3Dliteratum%253Aachs%26aulast%3DHuot%26aufirst%3DM.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DExpedient%2520synthesis%2520of%2520novel%2520bicyclic%2520peptidomimetic%2520scaffolds%26jtitle%3DTetrahedron%2520Lett.%26date%3D2010%26volume%3D51%26spage%3D2820%26epage%3D2823%26doi%3D10.1016%2Fj.tetlet.2010.03.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Szeltner, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rea, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fülöp, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgár, L.</span><span> </span><span class="NLM_article-title">Electrostatic effects and binding determinants in the catalysis of prolyl oligopeptidase: Site-specific mutagenesis at the oxyanion binding site</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">42613</span><span class="NLM_x">–</span> <span class="NLM_lpage">42622</span><span class="refDoi"> DOI: 10.1074/jbc.M208043200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1074%2Fjbc.M208043200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=42613-42622&author=Z.+Szeltnerauthor=D.+Reaauthor=V.+Rennerauthor=V.+F%C3%BCl%C3%B6pauthor=L.+Polg%C3%A1r&title=Electrostatic+effects+and+binding+determinants+in+the+catalysis+of+prolyl+oligopeptidase%3A+Site-specific+mutagenesis+at+the+oxyanion+binding+site&doi=10.1074%2Fjbc.M208043200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M208043200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M208043200%26sid%3Dliteratum%253Aachs%26aulast%3DSzeltner%26aufirst%3DZ.%26aulast%3DRea%26aufirst%3DD.%26aulast%3DRenner%26aufirst%3DV.%26aulast%3DF%25C3%25BCl%25C3%25B6p%26aufirst%3DV.%26aulast%3DPolg%25C3%25A1r%26aufirst%3DL.%26atitle%3DElectrostatic%2520effects%2520and%2520binding%2520determinants%2520in%2520the%2520catalysis%2520of%2520prolyl%2520oligopeptidase%253A%2520Site-specific%2520mutagenesis%2520at%2520the%2520oxyanion%2520binding%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D42613%26epage%3D42622%26doi%3D10.1074%2Fjbc.M208043200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Therrien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weill, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbeil, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Docking ligands into flexible and solvated macromolecules. 7. Impact of protein flexibility and water molecules on docking-based virtual screening accuracy</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3198</span><span class="NLM_x">–</span> <span class="NLM_lpage">3210</span><span class="refDoi"> DOI: 10.1021/ci500299h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500299h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1OitbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=3198-3210&author=E.+Therrienauthor=N.+Weillauthor=A.+Tombergauthor=C.+R.+Corbeilauthor=D.+Leeauthor=N.+Moitessier&title=Docking+ligands+into+flexible+and+solvated+macromolecules.+7.+Impact+of+protein+flexibility+and+water+molecules+on+docking-based+virtual+screening+accuracy&doi=10.1021%2Fci500299h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Docking Ligands into Flexible and Solvated Macromolecules. 7. Impact of Protein Flexibility and Water Molecules on Docking-Based Virtual Screening Accuracy</span></div><div class="casAuthors">Therrien, Eric; Weill, Nathanael; Tomberg, Anna; Corbeil, Christopher R.; Lee, Devin; Moitessier, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3198-3210</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of predictive computational methods in the drug discovery process is in a state of continual growth.  Over the last two decades, an increasingly large no. of docking tools have been developed to identify hits or optimize lead mols. through in-silico screening of chem. libraries to proteins.  In recent years, the focus has been on implementing protein flexibility and water mols.  Our efforts led to the development of 'Fitted' first reported in 2007 and further developed since then.  In this study, we wished to evaluate the impact of protein flexibility and occurrence of water mols. on the accuracy of the 'Fitted' docking program to discriminate active compds. from inactive compds. in virtual screening (VS) campaigns.  For this purpose, a total of 171 proteins cocrystd. with small mols. representing 40 unique enzymes and receptors as well as sets of known ligands and decoys were selected from the Protein Data Bank (PDB) and the Directory of Useful Decoys (DUD), resp.  This study revealed that implementing displaceable crystallog. or computationally placed particle water mols. and protein flexibility can improve the enrichment in active compds.  In addn., an informed decision based on library diversity or research objectives (hit discovery vs lead optimization) on which implementation to use may lead to significant improvements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpte6omTYQarVg90H21EOLACvtfcHk0lgr7XALgijuDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1OitbjM&md5=fa34411d7f1020a4e4ed61171f54bf6b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fci500299h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500299h%26sid%3Dliteratum%253Aachs%26aulast%3DTherrien%26aufirst%3DE.%26aulast%3DWeill%26aufirst%3DN.%26aulast%3DTomberg%26aufirst%3DA.%26aulast%3DCorbeil%26aufirst%3DC.%2BR.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DDocking%2520ligands%2520into%2520flexible%2520and%2520solvated%2520macromolecules.%25207.%2520Impact%2520of%2520protein%2520flexibility%2520and%2520water%2520molecules%2520on%2520docking-based%2520virtual%2520screening%2520accuracy%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2014%26volume%3D54%26spage%3D3198%26epage%3D3210%26doi%3D10.1021%2Fci500299h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Racys, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rea, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fülöp, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wills, M.</span><span> </span><span class="NLM_article-title">Inhibition of prolyl oligopeptidase with a synthetic unnatural dipeptide</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4775</span><span class="NLM_x">–</span> <span class="NLM_lpage">4782</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2Fj.bmc.2010.05.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=4775-4782&author=D.+T.+Racysauthor=D.+Reaauthor=V.+F%C3%BCl%C3%B6pauthor=M.+Wills&title=Inhibition+of+prolyl+oligopeptidase+with+a+synthetic+unnatural+dipeptide&doi=10.1016%2Fj.bmc.2010.05.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DRacys%26aufirst%3DD.%2BT.%26aulast%3DRea%26aufirst%3DD.%26aulast%3DF%25C3%25BCl%25C3%25B6p%26aufirst%3DV.%26aulast%3DWills%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520prolyl%2520oligopeptidase%2520with%2520a%2520synthetic%2520unnatural%2520dipeptide%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D4775%26epage%3D4782%26doi%3D10.1016%2Fj.bmc.2010.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Singh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biswas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, B.</span><span> </span><span class="NLM_article-title">AADS - An automated active site identification, docking, and scoring protocol for protein targets based on physicochemical descriptors</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2515</span><span class="NLM_x">–</span> <span class="NLM_lpage">2527</span><span class="refDoi"> DOI: 10.1021/ci200193z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200193z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFKnt7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=2515-2527&author=T.+Singhauthor=D.+Biswasauthor=B.+Jayaram&title=AADS+-+An+automated+active+site+identification%2C+docking%2C+and+scoring+protocol+for+protein+targets+based+on+physicochemical+descriptors&doi=10.1021%2Fci200193z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">AADS - An Automated Active Site Identification, Docking, and Scoring Protocol for Protein Targets Based on Physicochemical Descriptors</span></div><div class="casAuthors">Singh, Tanya; Biswas, D.; Jayaram, B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2515-2527</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report here a robust automated active site detection, docking, and scoring (AADS) protocol for proteins with known structures.  The active site finder identifies all cavities in a protein and scores them based on the physicochem. properties of functional groups lining the cavities in the protein.  The accuracy realized on 620 proteins with sizes ranging from 100 to 600 amino acids with known drug active sites is 100% when the top ten cavity points are considered.  These top ten cavity points identified are then submitted for an automated docking of an input ligand/candidate mol.  The docking protocol uses an all atom energy based Monte Carlo method.  Eight low energy docked structures corresponding to different locations and orientations of the candidate mol. are stored at each cavity point giving 80 docked structures overall which are then ranked using an effective free energy function and top five structures are selected.  The predicted structure and energetics of the complexes agree quite well with expt. when tested on a data set of 170 protein-ligand complexes with known structures and binding affinities.  The AADS methodol. is implemented on an 80 processor cluster and presented as a freely accessible, easy to use tool at http://www.scfbio-iitd.res.in/dock/ActiveSite_new.jsp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKgcX1_J1BxbVg90H21EOLACvtfcHk0lizQPTTFQ8IXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFKnt7zM&md5=eb485ecf37cf0da60218974f1093c2c5</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fci200193z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200193z%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DT.%26aulast%3DBiswas%26aufirst%3DD.%26aulast%3DJayaram%26aufirst%3DB.%26atitle%3DAADS%2520-%2520An%2520automated%2520active%2520site%2520identification%252C%2520docking%252C%2520and%2520scoring%2520protocol%2520for%2520protein%2520targets%2520based%2520on%2520physicochemical%2520descriptors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D2515%26epage%3D2527%26doi%3D10.1021%2Fci200193z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Tomberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cesco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Solvent effect in diastereoselective intramolecular Diels–Alder reactions</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6852</span><span class="NLM_x">–</span> <span class="NLM_lpage">6856</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2015.10.086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2Fj.tetlet.2015.10.086" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=6852-6856&author=A.+Tombergauthor=S.+De+Cescoauthor=M.+Huotauthor=N.+Moitessier&title=Solvent+effect+in+diastereoselective+intramolecular+Diels%E2%80%93Alder+reactions&doi=10.1016%2Fj.tetlet.2015.10.086"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2015.10.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2015.10.086%26sid%3Dliteratum%253Aachs%26aulast%3DTomberg%26aufirst%3DA.%26aulast%3DDe%2BCesco%26aufirst%3DS.%26aulast%3DHuot%26aufirst%3DM.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DSolvent%2520effect%2520in%2520diastereoselective%2520intramolecular%2520Diels%25E2%2580%2593Alder%2520reactions%26jtitle%3DTetrahedron%2520Lett.%26date%3D2015%26volume%3D56%26spage%3D6852%26epage%3D6856%26doi%3D10.1016%2Fj.tetlet.2015.10.086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Nguyen, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham-Huy, C.</span><span> </span><span class="NLM_article-title">Chiral drugs: An overview</span> <span class="citation_source-journal">Int. J. Biomed. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=23674971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSltrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=85-100&author=L.+A.+Nguyenauthor=H.+Heauthor=C.+Pham-Huy&title=Chiral+drugs%3A+An+overview"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Chiral drugs. An overview</span></div><div class="casAuthors">Nguyen, Lien Ai; He, Hua; Chuong, Pham-Huy</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biomedical Science (Monterey Park, CA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-100</span>CODEN:
                <span class="NLM_cas:coden">IJBSDB</span>;
        ISSN:<span class="NLM_cas:issn">1550-9702</span>.
    
            (<span class="NLM_cas:orgname">Master Publishing Group</span>)
        </div><div class="casAbstract">A review.  About more than half of the drugs currently in use are chiral compds. and near 90% of the last ones are marketed as racemates consisting of an equimolar mixt. of two enantiomers.  Although they have the same chem. structure, most isomers of chiral drugs exhibit marked differences in biol. activities such as pharmacol., toxicol., pharmacokinetics, metab. etc.  Some mechanisms of these properties are also explained.  Therefore, it is important to promote the chiral sepn. and anal. of racemic drugs in pharmaceutical industry as well as in clinic in order to eliminate the unwanted isomer from the prepn. and to find an optimal treatment and a right therapeutic control for the patient.  In this article, we review the nomenclature, pharmacol., toxicol., pharmacokinetics, metab. etc of some usual chiral drugs as well as their mechanisms.  Different techniques used for the chiral sepn. in pharmaceutical industry as well as in clin. analyses are also examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovoqsLM_3bxLVg90H21EOLACvtfcHk0lizQPTTFQ8IXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSltrnJ&md5=254cbca060bb4cfd04eac365488f5b62</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DL.%2BA.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DPham-Huy%26aufirst%3DC.%26atitle%3DChiral%2520drugs%253A%2520An%2520overview%26jtitle%3DInt.%2520J.%2520Biomed.%2520Sci.%26date%3D2006%26volume%3D2%26spage%3D85%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span><span class="refDoi"> DOI: 10.1016/0005-2744(69)90420-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2F0005-2744%2869%2990420-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=4980133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADyaF1MXkvVOqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=1969&pages=269-286&author=J.+F.+Morrison&title=Kinetics+of+the+reversible+inhibition+of+enzyme-catalysed+reactions+by+tight-binding+inhibitors&doi=10.1016%2F0005-2744%2869%2990420-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of the reversible inhibition of enzyme-catalyzed reactions by tight-binding inhibitors</span></div><div class="casAuthors">Morrison, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Enzymology</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-86</span>CODEN:
                <span class="NLM_cas:coden">BBEZAD</span>;
        ISSN:<span class="NLM_cas:issn">0924-1086</span>.
    </div><div class="casAbstract">A theoretical kinetic study has been undertaken to det. the kinetic characteristics of enzymic reactions that are reversibly inhibited by a substrate analog. at concns. comparable to that of the enzyme.  A general rate equation, that allows for the combination of such a tight-binding inhibitor with one or more enzyme forms of any reaction mechanism, has been derived and shown to be quadratic with sq. and linear terms in υ which represents the true initial steady-state velocity.  From plots of υ against total enzyme concn. at fixed total inhibitor concn., the concn. of enzyme catalytic sites can be detd. irrespective of the nature of the inhibition and the reaction mechanism.  However, plots of υ (or I/υ) against total inhibitor concn. can be used for this purpose only if the dissocn. const. assocd. with the inhibitor is virtually zero.  Particular initial rate equations have been obtained for the cases in which the tight-binding inhibitor gives rise to competitive, noncompetitive, and uncompetitive inhibition with respect to one of the substrates of a bireactant mechanism.  From these equations it has been deduced that, in the presence of inhibitor, plots of I/υ against the reciprocals of the substrate concns. yield families of concave-down, nonrectangular hyperbolas.  The difficulties assocd. with the detn. of inhibition consts. for tight-binding inhibitors are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj4s_N2iV3CLVg90H21EOLACvtfcHk0lj00SMfOHeudg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXkvVOqsbo%253D&md5=74d467477385488dfbb053358534ada6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0005-2744%2869%2990420-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2744%252869%252990420-3%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DKinetics%2520of%2520the%2520reversible%2520inhibition%2520of%2520enzyme-catalysed%2520reactions%2520by%2520tight-binding%2520inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1969%26volume%3D185%26spage%3D269%26epage%3D286%26doi%3D10.1016%2F0005-2744%2869%2990420-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Schiavini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pottel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auclair, K.</span><span> </span><span class="NLM_article-title">Metabolic instability of cyanothiazolidine-based prolyl oligopeptidase inhibitors: A structural assignment challenge and potential medicinal chemistry implications</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1174</span><span class="NLM_x">–</span> <span class="NLM_lpage">1183</span><span class="refDoi"> DOI: 10.1002/cmdc.201500114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1002%2Fcmdc.201500114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1174-1183&author=P.+Schiaviniauthor=J.+Pottelauthor=N.+Moitessierauthor=K.+Auclair&title=Metabolic+instability+of+cyanothiazolidine-based+prolyl+oligopeptidase+inhibitors%3A+A+structural+assignment+challenge+and+potential+medicinal+chemistry+implications&doi=10.1002%2Fcmdc.201500114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500114%26sid%3Dliteratum%253Aachs%26aulast%3DSchiavini%26aufirst%3DP.%26aulast%3DPottel%26aufirst%3DJ.%26aulast%3DMoitessier%26aufirst%3DN.%26aulast%3DAuclair%26aufirst%3DK.%26atitle%3DMetabolic%2520instability%2520of%2520cyanothiazolidine-based%2520prolyl%2520oligopeptidase%2520inhibitors%253A%2520A%2520structural%2520assignment%2520challenge%2520and%2520potential%2520medicinal%2520chemistry%2520implications%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D1174%26epage%3D1183%26doi%3D10.1002%2Fcmdc.201500114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Wong, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, Z.</span><span> </span><span class="NLM_article-title">Regioselective biotransformation of CNS drugs and its clinical impact on adverse drug reactions</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span><span class="refDoi"> DOI: 10.1517/17425255.2012.688027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1517%2F17425255.2012.688027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=22568396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC38XovVWjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=833-854&author=Y.+C.+Wongauthor=S.+Qianauthor=Z.+Zuo&title=Regioselective+biotransformation+of+CNS+drugs+and+its+clinical+impact+on+adverse+drug+reactions&doi=10.1517%2F17425255.2012.688027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective biotransformation of CNS drugs and its clinical impact on adverse drug reactions</span></div><div class="casAuthors">Wong, Yin Cheong; Qian, Shuai; Zuo, Zhong</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">833-854</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Adverse drug reactions (ADRs) continue to be one of the major causes of failure in drug development while limiting the clin. utilities of many drugs.  Contribution of the metabolites formed in vivo to ADRs could be more significant than we might have expected.Areas covered: This review focuses on the relationship between regioselectivity in biotransformation and the ADRs of drugs acting on the central nervous system (CNS).  "Regioselectivity" is defined as an exclusively or significantly preferential metabolic reaction at one (or several) site(s) on the substrate mol.  Several CNS drugs and toxicants, of which the metabolites play pivotal roles in ADRs, are summarized in details with the highlight on the roles of metab. in both toxification and detoxification.  The article also discusses in silico predictions of regioselectivity and the formation of toxic metabolites which are becoming increasingly important.Expert opinion: Researchers working on CNS drugs face particular challenges in predicting drug metab. and potential toxicities of their metabolites.  A no. of factors contribute to the difficulty of accurate prediction of metabolite disposition in the human brain.  Better knowledge of regioselectivity in biotransformation and elucidation of the relationships between biotransformations and ADRs would definitely help designing new compds. with lower bioactivation potentials and rejuvenating the older drugs whose clin. applications are restricted by their ADRs.  Administrating drugs by alternative routes such as the intranasal, transdermal, sublingual, and buccal routes could also be a strategy to reduce unwanted metabolite formations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO2G5dxQiQOrVg90H21EOLACvtfcHk0lj00SMfOHeudg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovVWjs7s%253D&md5=fc9bd6edda4f400e62e20ff51afdac1e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1517%2F17425255.2012.688027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2012.688027%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DY.%2BC.%26aulast%3DQian%26aufirst%3DS.%26aulast%3DZuo%26aufirst%3DZ.%26atitle%3DRegioselective%2520biotransformation%2520of%2520CNS%2520drugs%2520and%2520its%2520clinical%2520impact%2520on%2520adverse%2520drug%2520reactions%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2012%26volume%3D8%26spage%3D833%26epage%3D854%26doi%3D10.1517%2F17425255.2012.688027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">A comprehensive listing of bioactivation pathways of organic functional groups</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span><span class="refDoi"> DOI: 10.2174/1389200054021799</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnellauthor=J.+Boerauthor=S.+P.+Harriman&title=A+comprehensive+listing+of+bioactivation+pathways+of+organic+functional+groups&doi=10.2174%2F1389200054021799"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0ljysJhXvDZetw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520comprehensive%2520listing%2520of%2520bioactivation%2520pathways%2520of%2520organic%2520functional%2520groups%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2005%26volume%3D6%26spage%3D161%26epage%3D225%26doi%3D10.2174%2F1389200054021799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleo, M. D.</span><span> </span><span class="NLM_article-title">Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: A perspective based on the critical examination of trends in the top 200 drugs marketed in the United States</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1410</span><span class="refDoi"> DOI: 10.1021/tx200168d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+alert%2Freactive+metabolite+concept+as+applied+in+medicinal+chemistry+to+mitigate+the+risk+of+idiosyncratic+drug+toxicity%3A+A+perspective+based+on+the+critical+examination+of+trends+in+the+top+200+drugs+marketed+in+the+United+States&doi=10.1021%2Ftx200168d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span></div><div class="casAuthors">Stepan, Antonia F.; Walker, Daniel P.; Bauman, Jonathan; Price, David A.; Baillie, Thomas A.; Kalgutkar, Amit S.; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1410</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Because of a preconceived notion that eliminating reactive metabolite (RM) formation with new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM formation is routinely examd. as part of lead optimization efforts in drug discovery.  Likewise, avoidance of "structural alerts" is almost a norm in drug design.  However, there is a growing concern that the perceived safety hazards assocd. with structural alerts and/or RM screening tools as standalone predictors of toxicity risks may be over exaggerated.  In addn., the multifactorial nature of idiosyncratic toxicity is now well recognized based upon observations that mechanisms other than RM formation (e.g., mitochondrial toxicity and inhibition of bile salt export pump (BSEP)) also can account for certain target organ toxicities.  Hence, fundamental questions arise such as: When is a mol. that contains a structural alert (RM pos. or neg.) a cause for concern.  Could the mol. in its parent form exert toxicity.  Can a low dose drug candidate truly mitigate metab.-dependent and -independent idiosyncratic toxicity risks.  In an effort to address these questions, we have retrospectively examd. 68 drugs (recalled or assocd. with a black box warning due to idiosyncratic toxicity) and the top 200 drugs (prescription and sales) in the United States in 2009 for trends in physiochem. characteristics, daily doses, presence of structural alerts, evidence for RM formation as well as toxicity mechanism(s) potentially mediated by parent drugs.  Collectively, our anal. revealed that a significant proportion (∼78-86%) of drugs assocd. with toxicity contained structural alerts and evidence indicating that RM formation as a causative factor for toxicity has been presented in 62-69% of these mols.  In several cases, mitochondrial toxicity and BSEP inhibition mediated by parent drugs were also noted as potential causative factors.  Most drugs were administered at daily doses exceeding several hundred milligrams.  There was no obvious link between idiosyncratic toxicity and physicochem. properties such as mol. wt., lipophilicity, etc.  Approx. half of the top 200 drugs for 2009 (prescription and sales) also contained one or more alerts in their chem. architecture, and many were found to be RM-pos.  Several instances of BSEP and mitochondrial liabilities were also noted with agents in the top 200 category.  However, with relatively few exceptions, the vast majority of these drugs are rarely assocd. with idiosyncratic toxicity, despite years of patient use.  The major differentiating factor appeared to be the daily dose; most of the drugs in the top 200 list are administered at low daily doses.  In addn., competing detoxication pathways and/or alternate nonmetabolic clearance routes provided suitable justifications for the safety records of RM-pos. drugs in the top 200 category.  Thus, while RM elimination may be a useful and pragmatic starting point in mitigating idiosyncratic toxicity risks, our anal. suggests a need for a more integrated screening paradigm for chem. hazard identification in drug discovery.  Thus, in addn. to a detailed assessment of RM formation potential (in relationship to the overall elimination mechanisms of the compd.(s)) for lead compds., effects on cellular health (e.g., cytotoxicity assays), BSEP inhibition, and mitochondrial toxicity are the recommended suite of assays to characterize compd. liabilities.  However, the prospective use of such data in compd. selection will require further validation of the cellular assays using marketed agents.  Until we gain a better understanding of the pathophysiol. mechanisms assocd. with idiosyncratic toxicities, improving pharmacokinetics and intrinsic potency as means of decreasing the dose size and the assocd. "body burden" of the parent drug and its metabolites will remain an overarching goal in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IhczIcvVDLVg90H21EOLACvtfcHk0ljysJhXvDZetw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D&md5=632b73f755738e49eb233bc8dca1fbcc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520alert%252Freactive%2520metabolite%2520concept%2520as%2520applied%2520in%2520medicinal%2520chemistry%2520to%2520mitigate%2520the%2520risk%2520of%2520idiosyncratic%2520drug%2520toxicity%253A%2520A%2520perspective%2520based%2520on%2520the%2520critical%2520examination%2520of%2520trends%2520in%2520the%2520top%2520200%2520drugs%2520marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1345%26epage%3D1410%26doi%3D10.1021%2Ftx200168d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Gill, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Hippel, P. H.</span><span> </span><span class="NLM_article-title">Calculation of protein extinction coefficients from amino acid sequence data</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span><span class="refDoi"> DOI: 10.1016/0003-2697(89)90602-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2F0003-2697%2889%2990602-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=2610349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADyaL1MXmt1ygt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=1989&pages=319-326&author=S.+C.+Gillauthor=P.+H.+von+Hippel&title=Calculation+of+protein+extinction+coefficients+from+amino+acid+sequence+data&doi=10.1016%2F0003-2697%2889%2990602-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Calculation of protein extinction coefficients from amino acid sequence data</span></div><div class="casAuthors">Gill, Stanley C.; Von Hippel, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">319-26</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    </div><div class="casAbstract">Quant. study of protein-protein and protein-ligand interactions in soln. requires accurate detn. of protein concn.  Often, for proteins available only in mol. biol. amts., it is difficult or impossible to make an accurate exptl. measurement of the molar extinction coeff. of the protein.  Yet, without a reliable value of this parameter, one cannot det. protein concns. by the usual UV spectroscopic means.  Fortunately, knowledge of amino acid residue sequence and promoter mol. wt. (and thus also of amino acid compn.) is generally available through the DNA sequence, which is usually accurately known for most such proteins.  In this paper, a method is presented for calcg. accurate (to ±5% in most cases) molar extinction coeffs. for proteins at 280 nm, simply from knowledge of the amino acid compn.  The method is calibrated against 18 normal globular proteins whose molar extinction coeffs. are accurately known, and the assumptions underlying the method, as well as its limitations, are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEi2o10uRFxbVg90H21EOLACvtfcHk0lizn0WYFD1FAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXmt1ygt7Y%253D&md5=6f082112135f9f894d5e59b2370f2799</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2889%2990602-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252889%252990602-7%26sid%3Dliteratum%253Aachs%26aulast%3DGill%26aufirst%3DS.%2BC.%26aulast%3Dvon%2BHippel%26aufirst%3DP.%2BH.%26atitle%3DCalculation%2520of%2520protein%2520extinction%2520coefficients%2520from%2520amino%2520acid%2520sequence%2520data%26jtitle%3DAnal.%2520Biochem.%26date%3D1989%26volume%3D182%26spage%3D319%26epage%3D326%26doi%3D10.1016%2F0003-2697%2889%2990602-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors</span> <span class="citation_source-journal">Biochimica et Biophysica Acta (BBA) - Enzymology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span><span class="refDoi"> DOI: 10.1016/0005-2744(69)90420-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1016%2F0005-2744%2869%2990420-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=4980133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADyaF1MXkvVOqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=1969&pages=269-286&author=J.+F.+Morrison&title=Kinetics+of+the+reversible+inhibition+of+enzyme-catalysed+reactions+by+tight-binding+inhibitors&doi=10.1016%2F0005-2744%2869%2990420-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of the reversible inhibition of enzyme-catalyzed reactions by tight-binding inhibitors</span></div><div class="casAuthors">Morrison, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Enzymology</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">269-86</span>CODEN:
                <span class="NLM_cas:coden">BBEZAD</span>;
        ISSN:<span class="NLM_cas:issn">0924-1086</span>.
    </div><div class="casAbstract">A theoretical kinetic study has been undertaken to det. the kinetic characteristics of enzymic reactions that are reversibly inhibited by a substrate analog. at concns. comparable to that of the enzyme.  A general rate equation, that allows for the combination of such a tight-binding inhibitor with one or more enzyme forms of any reaction mechanism, has been derived and shown to be quadratic with sq. and linear terms in υ which represents the true initial steady-state velocity.  From plots of υ against total enzyme concn. at fixed total inhibitor concn., the concn. of enzyme catalytic sites can be detd. irrespective of the nature of the inhibition and the reaction mechanism.  However, plots of υ (or I/υ) against total inhibitor concn. can be used for this purpose only if the dissocn. const. assocd. with the inhibitor is virtually zero.  Particular initial rate equations have been obtained for the cases in which the tight-binding inhibitor gives rise to competitive, noncompetitive, and uncompetitive inhibition with respect to one of the substrates of a bireactant mechanism.  From these equations it has been deduced that, in the presence of inhibitor, plots of I/υ against the reciprocals of the substrate concns. yield families of concave-down, nonrectangular hyperbolas.  The difficulties assocd. with the detn. of inhibition consts. for tight-binding inhibitors are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj4s_N2iV3CLVg90H21EOLACvtfcHk0lizn0WYFD1FAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXkvVOqsbo%253D&md5=74d467477385488dfbb053358534ada6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2F0005-2744%2869%2990420-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2744%252869%252990420-3%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DKinetics%2520of%2520the%2520reversible%2520inhibition%2520of%2520enzyme-catalysed%2520reactions%2520by%2520tight-binding%2520inhibitors%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Enzymology%26date%3D1969%26volume%3D185%26spage%3D269%26epage%3D286%26doi%3D10.1016%2F0005-2744%2869%2990420-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Corbeil, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englebienne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Docking ligands into flexible and solvated macromolecules. 1. Development and validation of FITTED 1.0</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1021/ci6002637</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci6002637" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVWjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=435-449&author=C.+R.+Corbeilauthor=P.+Englebienneauthor=N.+Moitessier&title=Docking+ligands+into+flexible+and+solvated+macromolecules.+1.+Development+and+validation+of+FITTED+1.0&doi=10.1021%2Fci6002637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Docking Ligands into Flexible and Solvated Macromolecules. 1. Development and Validation of FITTED 1.0</span></div><div class="casAuthors">Corbeil, Christopher R.; Englebienne, Pablo; Moitessier, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report the development and validation of a novel suite of programs, FITTED 1.0, for the docking of flexible ligands into flexible proteins.  This docking tool is unique in that it can deal with both the flexibility of macromols. (side chains and main chains) and the presence of bridging water mols. while treating protein/ligand complexes as realistically dynamic systems.  This software relies on a genetic algorithm to account for the flexibility of the two mols. as well as the location of bridging water mols.  In addn., FITTED 1.0 features a novel application of a switching function to retain or displace key water mols. from the protein-ligand complexes.  Two independent modules, ProCESS and SMART, were developed to set up the proteins and the ligands prior to the docking stage.  Validation of the accuracy of the software was achieved via the application of FITTED 1.0 to the docking of inhibitors of HIV-1 protease, thymidine kinase, trypsin, factor Xa, and MMP to their resp. proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH9ypbBV5-k7Vg90H21EOLACvtfcHk0lizn0WYFD1FAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVWjtbY%253D&md5=f1b5be0eb418ecc158f5f057c1f9567c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fci6002637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci6002637%26sid%3Dliteratum%253Aachs%26aulast%3DCorbeil%26aufirst%3DC.%2BR.%26aulast%3DEnglebienne%26aufirst%3DP.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DDocking%2520ligands%2520into%2520flexible%2520and%2520solvated%2520macromolecules.%25201.%2520Development%2520and%2520validation%2520of%2520FITTED%25201.0%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fci6002637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Therrien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englebienne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza-Sanchez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbeil, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weill, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campagna-Slater, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moitessier, N.</span><span> </span><span class="NLM_article-title">Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulatorswith FORECASTER, a novel platform for drug discovery</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span><span class="refDoi"> DOI: 10.1021/ci2004779</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci2004779" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFCru7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=210-224&author=E.+Therrienauthor=P.+Englebienneauthor=A.+G.+Arrowsmithauthor=R.+Mendoza-Sanchezauthor=C.+R.+Corbeilauthor=N.+Weillauthor=V.+Campagna-Slaterauthor=N.+Moitessier&title=Integrating+medicinal+chemistry%2C+organic%2Fcombinatorial+chemistry%2C+and+computational+chemistry+for+the+discovery+of+selective+estrogen+receptor+modulatorswith+FORECASTER%2C+a+novel+platform+for+drug+discovery&doi=10.1021%2Fci2004779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Integrating Medicinal Chemistry, Organic/Combinatorial Chemistry, and Computational Chemistry for the Discovery of Selective Estrogen Receptor Modulators with Forecaster, a Novel Platform for Drug Discovery</span></div><div class="casAuthors">Therrien, Eric; Englebienne, Pablo; Arrowsmith, Andrew G.; Mendoza-Sanchez, Rodrigo; Corbeil, Christopher R.; Weill, Nathanael; Campagna-Slater, Valerie; Moitessier, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">210-224</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of a large medicinal chem. program, we wish to develop novel selective estrogen receptor modulators (SERMs) as potential breast cancer treatments using a combination of exptl. and computational approaches.  However, one of the remaining difficulties nowadays is to fully integrate computational (i.e., virtual, theor.) and medicinal (i.e., exptl., intuitive) chem. to take advantage of the full potential of both.  For this purpose, we have developed a Web-based platform, Forecaster, and a no. of programs (e.g., Prep., React, Select) with the aim of combining computational chem. and medicinal chem. expertise to facilitate drug discovery and development and more specifically to integrate synthesis into computer-aided drug design.  In our quest for potent SERMs, this platform was used to build virtual combinatorial libraries, filter and ext. a highly diverse library from the NCI database, and dock them to the estrogen receptor (ER), with all of these steps being fully automated by computational chemists for use by medicinal chemists.  As a result, virtual screening of a diverse library seeded with active compds. followed by a search for analogs yielded an enrichment factor of 129, with 98% of the seeded active compds. recovered, while the screening of a designed virtual combinatorial library including known actives yielded an area under the receiver operating characteristic (AU-ROC) of 0.78.  The lead optimization proved less successful, further demonstrating the challenge to simulate structure activity relationship studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt6YsO45gkpLVg90H21EOLACvtfcHk0lgJylptCiNOjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFCru7vE&md5=a7b3218263c14ae60a38962eed567e87</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fci2004779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci2004779%26sid%3Dliteratum%253Aachs%26aulast%3DTherrien%26aufirst%3DE.%26aulast%3DEnglebienne%26aufirst%3DP.%26aulast%3DArrowsmith%26aufirst%3DA.%2BG.%26aulast%3DMendoza-Sanchez%26aufirst%3DR.%26aulast%3DCorbeil%26aufirst%3DC.%2BR.%26aulast%3DWeill%26aufirst%3DN.%26aulast%3DCampagna-Slater%26aufirst%3DV.%26aulast%3DMoitessier%26aufirst%3DN.%26atitle%3DIntegrating%2520medicinal%2520chemistry%252C%2520organic%252Fcombinatorial%2520chemistry%252C%2520and%2520computational%2520chemistry%2520for%2520the%2520discovery%2520of%2520selective%2520estrogen%2520receptor%2520modulatorswith%2520FORECASTER%252C%2520a%2520novel%2520platform%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D210%26epage%3D224%26doi%3D10.1021%2Fci2004779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Sheldrick, G. M.</span><span> </span><span class="NLM_article-title">A short history of SHELX</span> <span class="citation_source-journal">Acta Crystallogr., Sect. A: Found. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span><span class="refDoi"> DOI: 10.1107/S0108767307043930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1107%2FS0108767307043930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=18156677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=112-122&author=G.+M.+Sheldrick&title=A+short+history+of+SHELX&doi=10.1107%2FS0108767307043930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">A short history of SHELX</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section A: Foundations of Crystallography</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">ACACEQ</span>;
        ISSN:<span class="NLM_cas:issn">0108-7673</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">An account is given of the development of the SHELX system of computer programs from SHELX-76 to the present day.  In addn. to identifying useful innovations that have come into general use through their implementation in SHELX, a crit. anal. is presented of the less-successful features, missed opportunities and desirable improvements for future releases of the software.  An attempt is made to understand how a program originally designed for photog. intensity data, punched cards and computers over 10000 times slower than an av. modern personal computer has managed to survive for so long.  SHELXL is the most widely used program for small-mol. refinement and SHELXS and SHELXD are often employed for structure soln. despite the availability of objectively superior programs.  SHELXL also finds a niche for the refinement of macromols. against high-resoln. or twinned data; SHELXPRO acts as an interface for macromol. applications.  SHELXC, SHELXD and SHELXE are proving useful for the exptl. phasing of macromols., esp. because they are fast and robust and so are often employed in pipelines for high-throughput phasing.  This paper could serve as a general literature citation when one or more of the open-source SHELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure detn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfLPYyJyJ2RbVg90H21EOLACvtfcHk0lgJylptCiNOjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGhurzO&md5=8f91f10be4a9df74b2a9dad522c71e6e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1107%2FS0108767307043930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767307043930%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DA%2520short%2520history%2520of%2520SHELX%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D2008%26volume%3D64%26spage%3D112%26epage%3D122%26doi%3D10.1107%2FS0108767307043930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Farrugia, L. J.</span><span> </span><span class="NLM_article-title">WinGX suite for small-molecule single-crystal crystallography</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">838</span><span class="refDoi"> DOI: 10.1107/S0021889899006020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1107%2FS0021889899006020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADyaK1MXlsVSlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1999&pages=837-838&author=L.+J.+Farrugia&title=WinGX+suite+for+small-molecule+single-crystal+crystallography&doi=10.1107%2FS0021889899006020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">WinGX suite for small-molecule single-crystal crystallography</span></div><div class="casAuthors">Farrugia, Louis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">837-838</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">The crystallog. problem:  The processing of a small-mol. structure from single-crystal X-ray or neutron diffraction data through structure soln. and refinement to prepn. of publication material is a well established and usually a reasonably automated procedure.  There are several excellent com. software packages, such as SHELXTL (Siemens, 1995) and TEXSAN (Mol. Structure Corporation, 1995), which provide all the necessary programs to undertake this procedure, but these packages are often quite expensive and usually tied to the sale of specific diffractometer hardware.  The WinGX suite provides an integrated and freely available set of Microsoft Windows programs to accomplish this task.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr53gZdiGzSn7Vg90H21EOLACvtfcHk0lgJylptCiNOjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsVSlurk%253D&md5=06e3e6a405d75250687285442cbbf70a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0021889899006020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889899006020%26sid%3Dliteratum%253Aachs%26aulast%3DFarrugia%26aufirst%3DL.%2BJ.%26atitle%3DWinGX%2520suite%2520for%2520small-molecule%2520single-crystal%2520crystallography%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1999%26volume%3D32%26spage%3D837%26epage%3D838%26doi%3D10.1107%2FS0021889899006020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Gulías, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durán, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castedo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascareñas, J. L.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed [4 + 3] Intramolecular Cycloaddition of Alkylidenecyclopropanes and Dienes</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">11026</span><span class="NLM_x">–</span> <span class="NLM_lpage">11027</span><span class="refDoi"> DOI: 10.1021/ja0756467</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0756467" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1Wht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=11026-11027&author=M.+Gul%C3%ADasauthor=J.+Dur%C3%A1nauthor=F.+L%C3%B3pezauthor=L.+Castedoauthor=J.+L.+Mascare%C3%B1as&title=Palladium-Catalyzed+%5B4+%2B+3%5D+Intramolecular+Cycloaddition+of+Alkylidenecyclopropanes+and+Dienes&doi=10.1021%2Fja0756467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed [4 + 3] intramolecular cycloaddition of alkylidenecyclopropanes and dienes</span></div><div class="casAuthors">Gulias, Moises; Duran, Juan; Lopez, Fernando; Castedo, Luis; Mascarenas, Jose L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">11026-11027</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Octa-5,7-dienylidenecyclopropanes underwent intramol. [4 + 3]-cycloaddn. reactions upon treatment with appropriate palladium catalysts to give stereochem. rich bicyclodecene systems, e.g., I, in a completely diastereoselective manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGregIOTXIjeBrVg90H21EOLACvtfcHk0ljoIGXuCvSv_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1Wht7c%253D&md5=1e013f7468f2b60859ea101b9b980006</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fja0756467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0756467%26sid%3Dliteratum%253Aachs%26aulast%3DGul%25C3%25ADas%26aufirst%3DM.%26aulast%3DDur%25C3%25A1n%26aufirst%3DJ.%26aulast%3DL%25C3%25B3pez%26aufirst%3DF.%26aulast%3DCastedo%26aufirst%3DL.%26aulast%3DMascare%25C3%25B1as%26aufirst%3DJ.%2BL.%26atitle%3DPalladium-Catalyzed%2520%255B4%2520%252B%25203%255D%2520Intramolecular%2520Cycloaddition%2520of%2520Alkylidenecyclopropanes%2520and%2520Dienes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D11026%26epage%3D11027%26doi%3D10.1021%2Fja0756467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Mellor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagland, A. M.</span><span> </span><span class="NLM_article-title">Synthesis of hydroisoindoles via intramolecular Diels-Alder reactions of functionalised amido trienes</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1005</span><span class="refDoi"> DOI: 10.1039/p19890000997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;key=10.1039%2Fp19890000997" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1989&pages=997-1005&author=J.+M.+Mellorauthor=A.+M.+Wagland&title=Synthesis+of+hydroisoindoles+via+intramolecular+Diels-Alder+reactions+of+functionalised+amido+trienes&doi=10.1039%2Fp19890000997"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2Fp19890000997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fp19890000997%26sid%3Dliteratum%253Aachs%26aulast%3DMellor%26aufirst%3DJ.%2BM.%26aulast%3DWagland%26aufirst%3DA.%2BM.%26atitle%3DSynthesis%2520of%2520hydroisoindoles%2520via%2520intramolecular%2520Diels-Alder%2520reactions%2520of%2520functionalised%2520amido%2520trienes%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1989%26spage%3D997%26epage%3D1005%26doi%3D10.1039%2Fp19890000997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xdw" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2xdw','PDB','2xdw'); return false;">PDB: 2xdw</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XDW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XDW','PDB','2XDW'); return false;">PDB: 2XDW</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i60"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01296">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_66231"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01296">10.1021/acs.jmedchem.5b01296</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental details (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01296/suppl_file/jm5b01296_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Crystallographic data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01296/suppl_file/jm5b01296_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01296/suppl_file/jm5b01296_si_001.pdf">jm5b01296_si_001.pdf (6.28 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01296/suppl_file/jm5b01296_si_002.csv">jm5b01296_si_002.csv (2.35 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01296&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01296%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-9%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01296" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679948fd69b43d60","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
